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ABSTRACT OF DISSERTATION

INSULIN-LIKE GROWTH FACTOR-1 OVEREXPRESSION MEDIATES
HIPPOCAMPAL REMODELING AND PLASTICITY FOLLOWING TBI

Every year over 2.5 million traumatic brain injuries (TBI) occur and are
the leading cause of death and disability among adolescents. There are no approved
treatments for TBI. Survivors suffer from persistent cognitive impairment due to
posttraumatic tissue damage and disruption of neural networks which significantly detract
from their quality of life. Posttraumatic cognitive impairment depends in part on the
brain's limited ability to repair or replace damaged cells. Immature neurons in the
hippocampus dentate gyrus, a brain region required for learning and memory, are
particularly vulnerable to TBI. Insulin-like growth factor-1 (IGF1) is a potential
therapeutic for TBI because it is a potent neurotrophic factor capable of mediating
neuroprotection, neuro-repair, and neurogenesis. We hypothesized that conditional IGF1
overexpression in the mouse hippocampus following experimental controlled cortical
impact injury (CCI) would enhance posttraumatic neurogenesis chronically. To this end,
conditional astrocyte-specific IGF1 overexpressing mice (IGFtg) and wild-type (WT)
mice received CCI or sham injury. The proliferation marker BrdU was used to label

neurons born the first week after injury. Six weeks after injury, when surviving
posttrauma-born neurons would be fully developed, we counted proliferated cells
(BrdU+) and the subset expressing a mature neuronal marker (NeuN+/BrdU+) in the
hippocampus. We also assessed cognitive performance during radial arm water-maze
reversal (RAWM-R) testing, a neurogenesis-sensitive assay. IGF1 promoted end-stage
maturity and decreased mis-migration of neurons born after trauma. These effects
coincide with IGF1 induced improvements in performance on neurogenesis sensitive
cognition following TBI.
Mammalian target of rapamycin (mTOR), an early signaling molecule
downstream of IGF1, has been identified as a potential target for TBI interventions
because of its regulatory role in neuronal plasticity and neurogenesis. However, recent
studies have also reported maladaptive plasticity and recovery associated with
posttraumatic mTOR activation. It is imperative to elucidate the mechanism of action of
IGF1 during pre-clinical evaluations. We hypothesized that IGF1 mediates posttraumatic
neurogenic effects through IGF1 induction of mTOR activation. We injured cohorts of
IGFtg and WT mice and harvested their brains for immunohistochemistry to assess IGF1
overexpression effects on posttraumatic mTOR activation at 1, 3, and 10 days post-injury
(dpi). We found that IGF1 upregulated mTOR activation following TBI in a regionspecific manner at 1 and 3dpi. To determine if IGF1 regulated differentiation and
arborization through the mTOR pathway, injured WT and IGFtg mice received daily i.p.
injections of rapamycin (10mg/kg), the inhibitor of mTOR, or its vehicle for 7 days.
Vehicle and rapamycin administration began 3dpi, after the cells dividing at the peak of

posttraumatic proliferation were labeled with BrdU. IGF1 enhancement of posttraumatic
neurogenesis was not dependent on mTOR activation.
In summary, IGF1 directs newborn neuron localization, promotes end-stage
maturation, and chronically improves cognition. IGF1 can stimulate posttraumatic
neurogenesis and plasticity independent of mTOR activation. These data suggest that
IGF1 can stimulate neuron replacement following trauma-induced hippocampal neuron
loss and cognitive improvement. Further studies should investigate IGF1 and mTOR
inhibition as a combination therapy for neurorehabilitation.

KEYWORDS: Neurogenesis, Insulin-like Growth Factor-1, mTOR, Traumatic
Brain Injury, Cognitive Recovery, Dentate Gyrus
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CHAPTER 1: Introduction
Traumatic Brain Injury
Prevalence and etiology
Traumatic brain injury (TBI) is the disruption of brain function caused by the
application of force to the brain. Pathological force can result from intentional and
unintentional impact on the head. Nearly 2.8 million TBI are reported annually
(Coronado et al. 2012, Taylor et al. 2017), which is still an underestimate since many
mild injuries go unreported (Meehan et al. 2013). Nearly 9 billion US dollars are spent
annually on hospitalization and rehabilitative care for TBI survivors, representing an
alarming economic burden to society (Faul et al. 2015).
Common mechanisms of TBI include being struck by an object, motor-vehicle
accident, intentional self-harm, assault, and falls. Injuries can range from mild to severe.
Different populations are disproportionately affected by different mechanisms of injury.
The elderly and toddlers have a higher frequency of falls, while people 15-44 years of age
are disproportionately receiving TBI from motor-vehicle incidents (Taylor et al. 2017).
Blast-related head trauma disproportionately affects military personnel (Reneer et al.
2011). While legislation has mandated safer driving precautions, improving TBI
surveillance and evidence-based guidelines of care have been shown to lessen TBI
prevalence and improve patient outcomes (Jagger et al. 1987, Coronado et al. 2012).
However, there are still no FDA approved pharmacological treatment options for TBI.
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Lack of treatment options is due in part to the neurological complexity of the brain
pathology (Marklund et al. 2011).
There is a high mortality rate associated with hospitalization for severe TBI. More
than 25% of patients suffering from severe TBI die (Taylor et al. 2017). Multiple discrete
and often overlapping neuroanatomical pathologies present as severe TBI in the clinical
setting (Saatman et al. 2008). Injuries can encompass any combination of pathologies not
limited to skull fractures, epidural hemorrhage, subdural hemorrhage, subarachnoid
hemorrhage, intraventricular hemorrhage, axonal injury and brain contusion.

The

heterogeneity of severe injury makes it difficult to classify and well as challenging to
manage treatment (Morales et al. 2005, Hawryluk et al. 2015).
Clinical manifestations of TBI
Annually, there are approximately 5.3 million people receiving rehabilitative care
for head trauma that suffer from persistent cognitive impairments and disabilities
(Langlois et al. 2006). Early evaluations used during emergency room visits can inform
clinicians of potential motor, cognitive, and behavioral impairments associated with TBI.
Three common indices that can predict outcomes are the Glasgow Coma Scale (GCS),
duration of loss of consciousness, and duration of posttraumatic amnesia. The Glasgow
Coma Scale (GCS) is a crude physical and cognitive evaluation that predicts disability
following TBI (Husson et al. 2010). Patients receiving very low GCS scores within 24
hours of injury are predictive of poor outcomes (Hart et al. 2014). Survivors of TBI can
enter the hospital in a coma, a deep state of unconsciousness and are unresponsive to the
environment. The duration of an individual’s coma can also be reliably used to predict
future impairments (Sherer et al. 2008). A coma duration of fewer than two weeks is
2

rarely associated with severe long-term disabilities (Hart et al. 2014). The length of
posttraumatic amnesia is a powerful predictor of outcomes and disability following
trauma. Amnesia is most commonly experienced as a transient cognitive impairment
following injury (Nakase-Richardson et al. 2009, Friedland et al. 2016). Posttraumatic
amnesia is the inability to retrieve memories stored prior to the injury (Whiting et al.
2006). Posttraumatic amnesia that resolves within a month of injury correlates with a low
likelihood of disability (Nakase-Richardson et al. 2009).
While all evaluations have limitations to their power of predicting outcomes, the
GCS, duration of loss of consciousness, and posttraumatic amnesia are all strong
predictors of future disabilities. No one method is more predictive than the other (Konigs
et al. 2016). The multifactorial nature and complexity of TBI create difficulty in
predicting cognitive disability since many measures rely on the neuro-responsiveness of
the patient. Many studies measure the extent of disability by measuring the time to return
to work. Time to return to work is correlated with widely used measures like GSC,
duration of loss of consciousness, and duration of posttraumatic amnesia (Cifu et al.
1997). The interpretation of these types of outcomes can be confounded by factors like an
injury to other organ systems, access to rehabilitative care, and socioeconomics (Holland
et al. 2003, Forslund et al. 2014). The ability to predict outcomes is further complicated
in the case of mild to moderate TBI injuries. Patients with mild to moderate injuries
rarely have poor GCS, loss of consciousness, or amnesia upon admission to the
emergency room (Konigs et al. 2016).
Although controversy surrounds the best measures to predict and rate cognitive
disability, there is a consensus that brain trauma can initiate, contribute to, and exacerbate
3

cognitive impairment. Over 65% of patients suffering from moderate to severe TBI selfreport long-term cognitive impairments (Whiteneck et al. 2004). Common cognitive
disabilities at all severity levels include memory and executive function deficits
(Rabinowitz et al. 2014). Memory deficit is an important factor underlying the inability to
perform activities of daily living. Impairment of short recall interferes with planning,
decision making, and executing decisions and is often a precursor to dementia (Shively et
al. 2012). Damage to structures including but not limited to cortex, brainstem, and
hippocampus interrupt neuronal conduction, contributing to impairment of new memory
formation (Watson et al. 1995, Cantu 2001). Damage to the hippocampus producing
hippocampal atrophy is associated with chronic memory impairment following TBI
(Ariza et al. 2006). Over 43% of all moderate to severely injured patients have
posttraumatic executive function disorders that last for 6 months or longer (Selassie et al.
2008). Executive function impairment describes limited control and direction of lower
level cognitive function like learning and memory, planning, decision making,
motivation, self-control and emotion-related behavior. Memory disruption affecting
executive function is primarily due to the limited ability to organize information
effectively for encoding and retrieval (Dikmen et al. 2009). These impairments affect
daily activities ranging from making a grocery list, carrying out plans with friends, to
performance at work. Two primary types of injury to the frontal cortex result in executive
function deficits: 1) shearing of axons (diffuse axonal injury) from acceleration and then
rapid deceleration and 2) focal cortical contusion from contact with the head. Both types
of injury result in deep brain damage that not only affects the frontal cortex but also its
areas of projection like the hippocampus (Cicerone et al. 2006). Aging studies suggest
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that prefrontal cortex atrophy can reduce hippocampus-prefrontal cortex connectivity
resulting in impaired long-term episodic memory formation (Mander et al. 2013).
Damage to multiple brain regions together contributes to cognitive impairment following
TBI.
The National Institute of Health’s National Institutes for Neurological Disorders
and Stroke has impacted policy and supplied funding to centralize clinical study design
and protocols for posttraumatic assessment of long-term cognitive disabilities and
reporting (Cicerone et al. 2006, Maas et al. 2007).

The International Mission on

Prognosis and Clinical Trial Design in TBI (IMPACT) study was initiated in 2003 to
create a database for all TBI clinical trial datasets from Trauma Centers all over the
western world. Transforming Research and Clinical Knowledge in Traumatic Brain
Injury (TRACK-TBI) is a multicenter clinical trial that is currently enrolling patients
from all over the US. Through these databases, scientific investigators and clinicians will
have access to shared patient tomography, cognitive assessments, and samples, increasing
the power of the scientific study and promoting collaboration. These initiatives will
provide organization and centralization of TBI clinical data that can inform TBI
neurocritical care management, provide evidence-based treatment recommendations and
guide experimental models of TBI.
Experimental models
Introduction
Due to the heterogeneity of brain damage observed in TBI (Saatman et al. 2008),
it is unlikely that a single target treatment will be able to attenuate cognitive deficits

5

caused by a combination of TBI pathologies that could include any combination of
diffuse axonal injury, epidural/sub-epidural hematoma, intraventricular hematoma, and
focal contusion. Because of the heterogeneous nature of human TBI, researchers
primarily use models that replicate combined trauma pathologies. The most common
injury models are controlled cortical impact injury (CCI), fluid percussion injury (FPI),
acceleration injury (weight-drop), blast injury, and closed head injury (CHI). Less
common models include those that combine hematoma and tissue penetration. Animal
models of TBI give the power to isolate specific pathophysiology and develop targeted
treatments. Rodents are the most widely used animal model because of their cost,
standardized outcome measures and small size. As preclinical treatments move closer to
clinical trial phase, drugs are sometimes screened in larger animals. The development of
animal models has been essential to understanding the mechanisms underlying neural
network disruption and cognitive impairment. Each injury model targets specific aspects
of pathology and its associated cognitive impairment parameters of human TBI.
Focal contusion models
In humans, focal contusion injuries occur as a result of blunt force trauma from
motor vehicle incidents, falls, assaults, and combat. Contusion injuries are amongst the
more severe brain injuries and are present in the majority of TBI-related hospitalizations
that result in death and in long-term cognitive disability (Kurland et al. 2012). Lateral FPI
and CCI are the most common models used to produce moderate to severe TBI. These
injury models have been adapted to rodents, ferrets, swine, and monkeys (Johnson et al.
2015). In addition to contusion, these models can be scaled to concurrently produce
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additional aspects of TBI including subdural hematoma, axonal injury, and intracerebral
hematoma (Xiong et al. 2013).
In the lateral FPI model, a craniotomy is generated midway between bregma and
lambda suture, at the intersection of the parietal and temporal bones. The dura is left
intact, and water pressure is used to displace the exposed brain tissue. This model was
designed to incorporate the contrecoup effects of TBI that are often seen in human TBI
(Eakin et al. 2015). Lateral FPI predominantly models moderate to severe injury and
generates cortical cell death, intracerebral hematoma and edema. Within a week after
injury, distant structures like the hippocampus and the thalamus undergo neuronal
damage in rats (Cortez et al. 1989). Lateral FPI results in progressive cortical damage that
continues beyond 6 months after injury (Pierce et al. 1998). Lateral FPI produces acute
motor deficits and chronic long-term deficits in memory. This model has several
limitations including limited control of parameters like pressure and dwell time. Water
pressure levels are typically set by adjusting the drop height of the pendulum that hits the
fluid reservoir. Additionally, while the lateral FPI severity is scalable, small fluctuations
in craniotomy size can produce vast differences in pathology (Vink et al. 2001). The skull
is rarely left without fracture following severe TBI in humans (Yellinek et al. 2016). the
lateral FPI model is widely used in rats, its application to mice is technically challenging
and has limited its use in this species. This is unfortunate because the majority of
transgenic animal models are generated in mice.
CCI can be used to model moderate to severe injury very reliably. CCI is a TBI
model in which a portion of the brain is exposed, and a pneumatically or
electromagnetically driven piston impacts the intact dura. Parameters such as speed,
7

depth of tissue displacement and dwell time can be adjusted increasing the flexibility of
this model to study specific parameters of injury. The injuries are controlled with
precision, and there is no opportunity for rebound injury since control of the impact is
computerized. CCI lesions are generated to typically target the pre-frontal cortex,
midline, or parietal cortex. Parasagittal CCI is associated with decreased bleeding from
sagittal sutures as compared to other impact locations (Osier et al. 2016), making it an
optimal location for surgery. This model produces aspects of human injury including
cortical tissue cell death, subdural hematoma, axonal injury, the decline in cerebral blood
flow and blood-brain barrier disruptions (Osier et al. 2016). CCI can produce acute motor
impairment and long-term memory and learning deficits beyond 1 year after injury
(Dixon et al. 1999).
Studies have shown that adjusting the measures of impact depth and speed of
impact can each independently be used to cause the graded severity of cognitive
dysfunction (Washington et al. 2012). Because the piston makes direct contact with the
exposed tissue, the piston shape can be adjusted to produce distinctly different injury
pathologies (Pleasant et al. 2011). Severe CCI generated with a flat impactor tip produces
more cortical tissue strain and a faster rate of neurodegeneration compared to CCI injury
produced with a rounded tip (Pleasant et al. 2011). Compared to a rounded tip, the flat
impactor tip produced more neocortical hemorrhage and hippocampal cell death acutely
after injury (Pleasant et al. 2011). The geometry of the tip may play a role in the
development of posttraumatic seizures. Studies that have reported that 9% to 15% of
rodents develop injury-induced seizures following severe CCI injury have used a flat tip
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was used (Hunt et al. 2010, Bolkvadze et al. 2012). Researchers developing studies to
investigate posttraumatic epilepsy should consider tip selection carefully.
The CCI injury model has been essential to studying the pathophysiology that
underlies acute and chronic posttraumatic behavior impairment and cognitive disability.
Rodents are most often used for CCI, primarily due to low cost, ease of surgery, and
standardization of outcomes across research labs. Behavior outcomes are sensitive to the
location of the craniotomy and impact. Injury to the frontal cortex following CCI has
been associated with impairments in emotional behaviors, executive function, and
reversal learning (Morales et al. 2005, Chou et al. 2016, Osier et al. 2016). CCI injury
over the parietal cortex has been associated with impaired spatial learning, reversal
learning, novel object recognition, cognitive flexibility, and anxiety (Washington et al.
2012, Zhao et al. 2012, Bondi et al. 2014). Grading injury severity of CCI is associated
with a graded degree of cognitive dysfunction (Yu et al. 2009, Rabinowitz et al. 2014).
Trauma disrupts learning and memory
CCI: A preclinical model of learning and memory impairment
The sequelae of cognitive dysfunction resulting from TBI depends on the specific
pathology and location of TBI. Trauma to the brain that causes degeneration of the
hippocampus has the potential to impact a wide range of functions, behaviors, and
cognitive abilities. Hippocampi receive and send information to the cingulate cortex,
entorhinal cortex, septal nuclei, ventral striatum, hypothalamus, and thalamus (Shah et al.
2012, Lovblad et al. 2014). Damage to the temporal lobe producing atrophy of the
hippocampus and its major aspect of axonal output, the fornix, contribute to learning and
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memory impairment (Tate et al. 2000, Ariza et al. 2006). A majority of severe TBI
survivors suffer from chronic learning and memory impairments that dramatically inhibit
the daily activities of living (Rabinowitz et al. 2014). Damage to the hippocampus can
produce hippocampus-dependent impairments in spatial learning and memory in both
human TBI and animal models (Miller et al. 2013, Vorhees et al. 2014). A study showed
that caudate putamen and hippocampus interact in a compensatory manner to update
spatial recognition memory when subjects are navigating an environment (Voermans et
al. 2004). TBI leads to progressive damage to axons of neurons that project to the
thalamus and hippocampus, orbital-frontal cortex damage and temporal pole degeneration
(Warner et al. 2010, Leunissen et al. 2014). It is well established that the hippocampus
plays an important role in retrieving spatial memories that encode space, place, time, and
context. Place cells in the human hippocampus activate when people navigate an
environment. These place cells reactivate when a person must recall and retrieve
memories related to the environmental context to complete a task (Miller et al. 2013).
TBI patients have limited ability to ignore old misleading cues, update current
information and adjust responses according to new cue rules. The ability to adapt one’s
behavior in response to changes in the environment is called cognitive flexibility (Dajani
et al. 2015). Cognitive flexibility impairment has been correlated with caudate putamen
volume loss and change of shape after trauma (Leunissen et al. 2014).
Experimental CCI has been used to study motor deficits, alterations in anxiety,
aggression, depression, and learning and memory (Lyeth et al. 1990, Dixon et al. 1999,
Washington et al. 2012). Lesion to the hippocampus following CCI causes deficits in
learning and memory (Dixon et al. 1999). There is widespread cell death throughout the
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hippocampus. Many treatments that enhance hippocampal cell survival also attenuate
learning and memory deficits following trauma (Patel et al. 2010, Barha et al. 2011,
Madathil et al. 2013). The Morris Water Maze (MWM) is a standardized test that is
reliably used to assess learning and memory following severe CCI injury. The MWM test
is designed to test an animal’s spatial working memory and reference memory and
requires episodic memory function to form memories about space and distance in
relationship to its training (Vorhees et al. 2014). The rodents are trained to perform the
MWM task in a circular pool. Aversion to water motivates the animals to use context
cues to learn to locate the escape platform that is hidden beneath the surface of the water.
underwater in a circular pool. When investigators ran batteries of test to determine which
assay was most sensitive to CCI injury severity, MWM consistently revealed a TBI
induced learning and memory deficits that persisted from 7 to 90 days after injury (Scheff
et al. 1997, Washington et al. 2012, Zhao et al. 2012). Like path learning in humans, the
MWM is a hippocampus-dependent task (Vorhees et al. 2014).
The hippocampus is also required to for generating declared episodic memory;
retrievable memories developed from a lived event that represent a past place and time.
Modification of the traditional MWM gives the ability to test different aspects of
learning. After an animal learns the platform location, the escape platform can be moved
to a novel location to test reversal learning. During reversal learning, the animal must
extinguish the old memory and use working memory to adopt a new strategy to find the
platform. The flexibility to replace a previously learned spatial with a new spatial strategy
is impaired by hippocampal volume loss (Kleinknecht et al. 2012). Experimental TBI
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produces deficits in reversal learning and cognitive flexibility that are detectable using
MWM assessments (Yu et al. 2009, Vorhees et al. 2014, Taib et al. 2017).
Primary and secondary injury to the hippocampus
CCI causes pronounced acute and chronic hippocampal neurodegeneration
beneath the site of injury as well as damage in regions the hippocampus projects to (Hall
et al. 2005, Osier et al. 2016). It is well established that the integrity of the hippocampal
circuit is required for appropriate learning and memory function (Dixon et al. 1999,
Xavier et al. 1999, Ariza et al. 2006). The hippocampus can be segmented into three
major regions, the CA1, CA3, and dentate gyrus (DG) (Dillon et al. 2017). Place cells,
pyramidal cells of the CA1, CA3, and DG, are used to make a map of the environment.
The DG is a sub-region of the hippocampus and is required for aspects of spatial learning
in rodents (Garthe et al. 2009, Aimone et al. 2010). The DG is essential to the ability of
the hippocampus to create spatial-temporal context by which it can retrieve stored
memories and apply the information to a new situation. Studies have shown that the DG
is required to separate similar patterns by creating distinct representations of information
(Knierim 2015). Following trauma, the hippocampus undergoes edema, decreased blood
vessel density, free-radical damage, deafferentation and glutamate toxicity resulting in
neuron loss and hippocampal atrophy (Bareyre et al. 1997, Ariza et al. 2006, Greve et al.
2009, Atkins 2011, Hayward et al. 2011). A major source of input to the DG is from
axons of the entorhinal cortex and hippocampal nuclei that synapse onto dendrites of
neurons residing in the granule cell layer (GCL). Axons of granule cells travel through
the polymorphic layer (hilus) and terminate at divergent locations (Amaral et al. 2007).
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In rodents, hippocampal neurons begin expressing markers for cell-mediated
apoptosis within hours after injury in the CA1, CA3, GCL, and hilus (HL) and continue
apoptosis throughout the first week after injury (Schoch et al. 2012). Inhibiting
posttraumatic apoptosis has been shown to improve behavior 7d after CCI and increase
cell survival in the DG (Yang et al. 2016). The DG houses the HL and GCL and is the
only hippocampal site where new neurons are produced throughout adulthood. Dentate
hilar neurons and newborn neurons in the GCL are the most vulnerable populations of
hippocampal neurons following TBI (Witgen et al. 2005). The population of hilar
GABAergic interneurons and mossy cells undergo cell death following injury
(Lowenstein et al. 1992). These two inhibitory neuronal subtypes relay and filter
information from the GCL by mediating excitation of distant granule cells and inhibiting
GCL excitation (Amaral et al. 2007). Within the GCL there are three populations of
neurons altered by TBI; basket neurons, granule neurons and immature neurons. The
basket cell is a local GABAergic interneuron at the polymorphic border of the GCL that
regulates granule cell excitation. GABAergic interneurons have a similar susceptibility to
injury as the other inhibitory cells in the DG (Jinde et al. 2013). The principal cell of the
GCL is the granule cell; its presence in the GCL is 100:1 compared to basket cells.
Granule cells are organized to form a cell layer 60-100µm thick which is bordered by the
HL and ML. The majority of the granule cells in the adult GCL neurons were generated
during development; they express mature neuron marker (NeuN) and generate
glutamatergic output (Amaral et al. 2007). Studies have shown that while there are
dramatic apoptosis and degeneration in the GCL after injury, only a small proportion the
degenerating cells are NeuN positive following injury (Zhou et al. 2012). Rather, most of
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the degenerating cells in the GCL express markers for newly born neurons (Gao et al.
2008). Preferential immature neuron death is a conserved phenotype in multiple
experimental models of TBI irrespective of TBI severity.
Trauma alters hippocampal neurogenesis
Adult neurogenesis
It is widely known that CNS is comprised primarily of post-mitotic cells and that
neurons do not undergo cell division. For many years, it was thought that neurons are
generated during development and that mammals lose the capacity to generate new
neurons once they enter the postnatal period of life. Joseph Altman and colleagues
discovered proliferation and neuron generation in the brain (Altman et al. 1967). The
discovery that humans have adult hippocampal neurogenesis (Spalding et al. 2013)
localized to a region of the brain essential for recovery from learning and memory
impairment has generated a high volume of research regarding this form of plasticity
(Kempermann et al. 2015). Neurogenesis is still a relatively new research field, and the
functional role of human adult neurogenesis is not well understood.
Adult neurogenesis is a multistep process that includes neuron generation and
end-stage maturation. During early survival, neural stem cells (NSC) in the adult
neurogenic niche proliferate and differentiate into neurons. Depending on environmental
stimuli and context, newborn neurons can proceed through development to end-stage
maturation and integrate into the environment (Kempermann et al. 2015). There are two
primary locations where mammals generate new neurons throughout adulthood: along the
lateral ventricles and in the dentate gyrus. New neurons generated in the subventricular

14

niche migrate along the rostral migratory stream to the olfactory bulb. The olfactory bulb
has a high rate of neuron turnover and this population of new neurons continuously
repopulates the olfactory bulb (Conover et al. 2017). The second well-characterized
location resides within the dentate gyrus. The subgranular zone (SGZ) is the microregion
of the GCL where it borders the polymorphic layer. This neurogenesis permissive region
contains neural progenitors and their progeny, as well as endothelial cells, astrocytes,
interneurons, and axon terminals from the ventral tegmental area, the septum and local
interneurons (Palmer et al. 2000, Kempermann et al. 2015). The glia and interneurons
present in the SGZ play an important role in maintaining the neurogenic niche. The SGZ
is heavily vascularized to meet the metabolic needs of neurodevelopment and deliver
humoral and endothelial cell-derived growth factors including FGF, VEGF and IGF1
(Palmer et al. 2000, Ryu et al. 2016). Local and humoral growth factors are required to
mediate proliferation, differentiation, and survival of progenitor cells and immature
neurons (Anderson 2002; Pickel 2016; Ryu). The astrocytes in the SGZ have a dual role
in regulating neurogenesis. SGZ astrocytes serve as niche regulating cells by delivering
factors that mediate neuronal differentiation through cell to cell contact (Song et al. 2002,
Alvarez-Buylla et al. 2004, Ashton et al. 2012). Specialized astrocytes in the SGZ, Type1 radial glia, serve as NSCs that can proliferate and become neural precursors. These
progenitors can transition into immature neurons or astrocytes and exit the SGZ. The
interneurons in the SGZ are responsible for maintaining the quiescence of the stem cell
population. Without local GABA tone, radial glial stem cells exit quiescence and divide
(Song et al. 2012).
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NSCs are primarily a quiescent population in the SGZ that express the stem cell
marker nestin. The morphology of Type-1 radial glia is distinct from other progenitors.
They have apical processes that extend through the GCL and have GABA and AMPA
neurotransmitter receptors to sense external stimuli prompting division. These cells have
division programs to divide asymmetrically (keep stem-ness) and symmetrically (both
cells differentiate). These NSCs divide and produce Type-2 a/b precursors which have a
high capacity to divide, but a completely different morphology. Type-2a cells still
express some astrocyte markers, but they are horizontal cells and do not possess apical
processes that extend through the GCL. These cells still express the stem cell marker
nestin, but they also express the Eomes transcription factor (Tbr2). These are cells
capable of transitioning between proliferation and cell fate selection. Type-2b cells are
Type-1 progeny that develop from Type-2a and select a neuronal fate. At this stage, they
no longer express astrocyte markers, and they begin to express the immature neuron
markers Prox1 and Dcx. When nestin is down-regulated in Dcx positive cells (Type-3)
they have exited the cell cycle and typically have little to no capacity to proliferate
(Jessberger et al. 2005). These cells begin neuronal maturation, a process that lasts 3
weeks. During neuronal maturation, Type-3 neurons primarily receive synaptic
GABAergic somatic and dendritic input, which is excitatory because of their high
internal chloride gradient (Ge et al. 2008). Between 2-3 weeks of age, the Type-3
immature neurons undergo GABA receptor synapse dependent and NMDA receptordependent competitive survival to proceed to end-stage maturity (Tashiro et al. 2006, Ge
et al. 2007, Ge et al. 2008). Only 30-70% of Dcx positive neurons survive to the endstage development, due in part to programmed cell death. Postnatally generated neurons
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only account for 30% of the mature granule cells in the GCL (Kempermann et al. 2015,
Ryu et al. 2016). The adult GCL maintains a relatively constant number of granule cells
(Amaral et al. 2007), revealing a role for programmed cell death. During development,
type-3 neurons that fail to integrate synaptically undergo Bax-mediated cell death
(Oppenheim (Sun et al. 2004). During the Type-3 stage, immature neurons migrate to
positions within the GCL where they will localize permanently. Reelin released by
interneurons of the niche and HL acts as a guidance cue which directs the new granule
cells away from the HL and further into the GCL (Gong et al. 2007). As new neurons exit
the Type-3 phase, they begin to express the mature neuron marker NeuN. These mature
neurons are morphologically and functionally similar to developmentally born granule
cells.
Adult neurogenesis following TBI
Trauma dramatically disrupts the process of neurogenesis. Several methods are
used to trace the lineage and fate of a cell in vivo. Assessment of endogenous protein
expression is a means to study neurons at the different stages of neurogenesis following
injury. However, the majority of the classical NSC markers are also markers of reactive
astrocytes (Gotz et al. 2005, Robel et al. 2011). Ki67 is a well characterized marker of
cell division that labels cells that have exited the cell cycle within 2-3 days of assessment.
Reactive astrocyte proliferation occurs in the hippocampus after injury, presenting
difficulty in interpretation when using markers of cell division to target SGZ
neurogenesis following injury (Borges et al. 2006). PSA-NCAM and POMC are neuronal
proteins that are expressed during the first 3 weeks of neuron birth (Kempermann et al.
2015). These markers label a heterogeneous population of neurons. To accurately
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birthdate a cell, cells can be labeled at the time of their division using
Bromodeoxyuridine (BrdU) or retroviral labeling. BrdU is a thymidine analog that
replaces the thymidine nucleoside during DNA replication (s-phase) of a cell undergoing
division. Retroviruses are used to label cells undergoing cell division because the virus
can integrate into the DNA only when the nuclear envelope dissolves during late
prophase. BrdU labeling is much more widely used because of the cost, ease of delivery,
and reliability of the labeling. However, BrdU labeling of dividing precursors can be
diluted as precursors continue to divide. This should be taken into consideration when
quantifying BrdU positivity using immunoreactivity. There are also methods of genetic
labeling that harness the cell’s upregulation of neurogenesis markers to drive fluorescent
protein production during the developmental stage of interest. Of course, the use of these
tools is dependent on the scientific question being asked.
Type-3 immature neurons are extremely vulnerable to TBI. Within the first week
after injury, markers for cell degeneration predominantly localize to immature neurons
compared with other cell types in the DG (Zhou et al. 2012). However, TBI transiently
increases proliferation of Type-1 and Type-2a cells in rodents (Yu et al. 2008, Gao et al.
2013). Trauma findings are consistent with studies that show that stressors like ischemia
and seizure stimulate hippocampal stem cell proliferation (Yagita et al. 2001, Jessberger
et al. 2005). TBI causes a transient increase in the number of Type-3 immature neurons
within the first 2-3 weeks following injury (Dash et al. 2001, Rola et al. 2006). Reactive
neurogenesis is not a robust means to replace the lost neurons. Many of these new cells
do not survive the final stages of development to become mature neurons (Kernie et al.
2001, Gao et al. 2013, Wang et al. 2016). Additionally, the type-3 neurons present after
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TBI have severely stunted dendritic arbors compared to the same neuron population in
uninjured animals (Carlson et al. 2004, Villasana et al. 2015).
Injury causes the mislocalization of a subset of Type-3 neurons into the hilus
(Villasana et al. 2015, Ibrahim et al. 2016, Shapiro 2017). New neurons may mislocalize
before their transition into Type-3 neurons (Yu et al. 2008). The time frame of
mislocalization coincides with the trauma-induced loss of HL interneurons. HL
interneurons express migratory factors that prevent neuroblasts from migrating into the
HL (Lowenstein et al. 1992, Butler et al. 2016). Developing adult-born neurons typically
migrate radially away from the SGZ and localize a short distance away in the inner third
of the GCL (Cameron et al. 2001). Injury potentiates radial migration of neuroblasts,
resulting in their localization toward the outer edge of the GCL where much older granule
cells localize (Villasana et al. 2015). Nonetheless, posttrauma-born neurons can survive
to end-stage maturity and may functionally integrate wherever they are localized
(Scharfman et al. 2003, Myers et al. 2013, Villasana et al. 2015).
While the functional consequence of altered neurogenesis is not fully understood,
an increase in the number of neurons that stably integrate into the circuit may be
beneficial in attenuating cognitive impairment. The specific role of immature neurons
following injury is controversial. Several studies have noted that increases in immature
neuron density are associated with reduced learning deficits (Griesbach et al. 2004,
Scharfman et al. 2005, Bekinschtein et al. 2013, Bekinschtein et al. 2014, Meng et al.
2014, Jacotte-Simancas et al. 2015). Studies have shown that Type-3 neurons are
important for distinguishing between two similar patterns (pattern separation), even
though they are not synaptically mature (Ge et al. 2008, Clelland et al. 2009). Adult-born
19

neurons that reach end-stage maturity have also been shown to contribute to cognitive
improvement. Increasing the number of postnatal-born end-stage neurons by inhibiting
BAX-mediated apoptosis of NSCs and neuroblasts is sufficient to improve the ability to
discriminate between similar contexts in rodents (Sahay et al. 2011). Decreasing the
number of mature neurons impairs cognitive flexibility, the ability to ignore a previously
learn strategy and replace it with a new strategy as needed (Garthe et al. 2009, Anacker et
al. 2017). Decreasing the number of posttrauma-born neurons that reach end-stage
maturity using a genetic ablation model impairs recovery of DG dependent spatial
learning following CCI (Blaiss et al. 2011). Further studies are required to elucidate the
role of posttraumatic neurogenesis in pattern separation and cognitive flexibility
following injury.
IGF1 in development and injury
IGF1 introduction
Growth factors act on different tissue systems of the body to promote growth,
development, and survival. They are upregulated during prenatal development and
dramatically down-regulated postnatally as mammals age. Several growth factors are
essential to mammalian development, including insulin-like growth factor 1 (IGF1).
Studies have shown that IGF1 is required for normotypic brain growth across species,
including humans (Anlar et al. 1999). The majority of IGF1 is produced by the liver
under control of growth hormone. IGF1 is also locally produced in organs like the brain
and can be expressed independently of growth hormone regulation (Nieto-Estevez et al.
2016). Because of its ability to cross the blood-brain barrier, both locally produced IGF1
and humoral IGF1 regulate brain growth. Global brain expression of IGF1 in the adult
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brain is only 4% of its developmental concentration with production limited to select
regions (Olfactory bulb, cortex, hippocampus) (Ye et al. 1997). While the IGF1 receptor
is ubiquitously expressed on all neural cell types, it is enriched in neuron dense regions
like the hippocampus (Bondy et al. 1992). IGF1 can act in an endocrine, paracrine or
autocrine fashion to mediate growth signaling. Both IGF1 and insulin bind to both the
IGF1 receptor. However, IGF1 binds to the IGF1 receptor with 100x greater affinity than
does insulin (Ocrant et al. 1988, Pomerance et al. 1988, Schumacher et al. 1991). The two
growth factors activate nearly identical signaling mechanisms for metabolism and
plasticity (Pomerance et al. 1988, Zheng et al. 2004, Muhic et al. 2015, Nieto-Estevez et
al. 2016). Insulin signaling is well characterized in fat, muscle and liver tissue and we
have learned much about the function of IGF1 through IGF1/insulin signaling studies.
IGF1 is a member of the insulin family of peptides and peptide hormones. Its
binding is regulated by IGF1 binding proteins which prevent its degradation while in
circulation and mediate IGF1 availability to its receptor. Neurotrophic factor stimulation
of the receptor tyrosine kinase (RTK) activates the PI3K/AKT pathway in CNS tissue.
Free IGF1 binds to the membrane-bound IGF1 RTK to initiate a trophic response
cascade. Upon activation the IGF1 RTK dimerizes and auto-phosphorylates internal
tyrosine residues that serve as a docking site for insulin response substrate (IRS) and Src
homology and Collagen (SHC) adapter kinase (Thirone et al. 1998, Zheng et al. 2004).
IRS and SHC interact in a competitive manner for pathway selection (Sasaoka et al.
2001). IRS activates the phosphatidylinositide 3-kinases (PI3K) and protein kinase B
(AKT), PI3K-AKT signaling pathway. SHC activates the mitogen-activated protein
kinase (MAPK) and extracellular signal-regulated kinase (ERK) kinase signaling
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pathway, MAPK-ERK. These pathways regulate different aspects of proliferation,
growth, differentiation, and survival (D'Ercole et al. 2008), but the PI3K-AKT pathway
predominates in mediating IGF1 actions in CNS.
IGF1 and mTOR signaling in neural development
IGF1 is upregulated during development in regions undergoing neurogenesis and
is dramatically downregulated days after birth. IGF1 has a distinct role in neurogenesis
during development. Studies have shown that during development IGF1 stimulates
proliferation of neuroblasts. The IGF1 receptor is required for maintenance of the DG
stem cell (Type-1 and Type-2a) population during development. Developmental IGF1
receptor deletion in nestin-expressing NSCs causes them to undergo caspase-3 mediated
apoptosis, resulting in progressive postnatal brain atrophy (Liu et al. 2009).
Multiple key effectors mediating the role of IGF1 in neural development have
been identified. One of the most well-studied effectors of IGF1 actions in the brain is
mTOR, the mammalian target of rapamycin. In 1972 the antibiotic rapamycin was
discovered and, in addition to antifungal and antibacterial properties, it was found to
inhibit antigen-induced proliferation of T-cells and B-cells (Abraham et al. 1996). It was
later found to inhibit cancer cell proliferation, which led to the discovery of its target
mTOR (Seto 2012). In addition to mTOR being a downstream target of IGF1 receptor
signaling, many cell growth, cancer, and development studies have shown that IGF1
receptor signaling and mTOR activation produce similar physiological outcomes,
suggesting that IGF1 mediates these functions through mTOR signaling. For example,
chronic treatment with rapamycin increases lifespan in rodents (Garza-Lombo et al.
2016), as does developmental inhibition of the IGF1 receptor (Kappeler et al. 2008).
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However, developmental inhibition of IGF1 or mTOR can cause small birth weights,
brain atrophy, and retardation (Liu et al. 2009, Lee 2015). During brain development both
IGF1 signaling and mTOR signaling mediate neuronal proliferation and differentiation.
Hyperactivation of mTOR through developmental deletion of its suppressor TSC1 causes
CNS tumors due to unchecked expansion of NSCs and their premature differentiation
(Magri et al. 2013). Postnatal deletion of PTEN, an inhibitor of IGF1/PI3K signaling, in
nestin-expressing cells resulted in NSC expansion and premature neuronal differentiation
(Zhu et al. 2012). Drugs that inhibit mTOR activation inhibit NSC proliferation (Park et
al. 2012). This often makes it difficult for researchers to address whether IGF1 signaling
mediates the induction of neuronal differentiation through mTOR activation since no new
neurons are left to analyze. Both IGF1 signaling and mTOR activation promote dendritic
and axonal process outgrowth. When effectors downstream of IGF1 receptor signaling
(PI3K and AKT) are constitutively active in neuronal cultures, dendritic arbor length and
complexity increase in a mTOR dependent manner (Jaworski et al. 2005).
IGF1 and mTOR signaling in trauma
Growth factors may play an essential role in regulating neuronal survival,
oxidative stress, neural plasticity, and cognitive recovery after TBI (Zhou et al. 2003,
DeKosky et al. 2004, Griesbach et al. 2004, Mahmood et al. 2007, Chiaretti et al. 2008,
Ning et al. 2011). Following brain injury in humans, a transient increase in VEGF, nerve
growth factor (NGF), and IGF1 are detectable in the plasma or cerebral spinal fluid of
TBI patients (Wildburger et al. 2001, Chiaretti et al. 2008, Matsuo et al. 2013,
Larpthaveesarp et al. 2015, Feeney et al. 2017). This is consistent with experimental
injury models that show transient upregulation of several growth factors, not limited to
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erythropoietin, VEGF, NGF, and IGF1, in the hippocampus of injured rodents (DeKosky
et al. 2004, Lee et al. 2010, Madathil et al. 2010, Schober et al. 2010). Increased serum
levels in human TBI and increased levels of exogenous IGF1 in experimental TBI are
associated with improved memory (Saatman et al. 1997, Feeney et al. 2017). When rats
were treated with IGF1 following fluid percussion injury, IGF1 attenuated the injuryinduced special memory deficit (Saatman et al. 1997). Increasing brain levels of IGF1
following injury using a transgenic overexpression model attenuated memory impairment
acutely after injury (Madathil et al. 2013).
IGF1 protein upregulation is detectable ipsilateral to injury within 1hr after injury
(Madathil et al. 2010), most noticeably in the peri-contusion area. Protein detection is
limited by the rapid turnover of IGF1. However, increases in posttraumatic IGF1 receptor
activation are still detectable in the hippocampus 24h after injury (Rubovitch et al. 2010).
IGF1 has also been shown to promote survival and decrease the number of degenerating
hippocampal cells in the CA3 and DG of the dentate gyrus (Madathil et al. 2013).
Increasing brain levels of IGF1 following injury by transgenic overexpression or central
infusion enhances posttraumatic neurogenesis in the DG (Carlson et al. 2014, Carlson et
al. 2018). IGF1 restored the dendritic arbor complexity and length of new neurons
following injury (Carlson et al. 2014). It is important to investigate IGF1 as a potential
therapeutic target for brain injury.
How IGF1 regulates neuroprotection and neuroplasticity following injury is less
well understood. After brain injury, PI3K/AKT activity is transiently upregulated within
hours after injury in the cortex and hippocampus (Jenkins et al. 2002, Park et al. 2012).
Additionally, AKT activity has been shown to be potentiated in response to posttraumatic
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increases of IGF1 in the cortex and hippocampus (Madathil et al. 2013). Within 48h of
brain injury mTOR, a factor that mediates the upregulation of protein translation
downstream of PI3K/AKT activity in the injured cortex and hippocampus is transiently
activated (Chen et al. 2007, Park et al. 2012, Guo et al. 2013). S6K and S6, substrates
directly activated by mTOR signaling, have been shown to be upregulated for the first 3
days after injury in the cortex and hippocampus (Park et al. 2012).
The effect of mTOR activation on posttraumatic cognitive recovery has been
incongruent. Chronic mTOR inhibition by central infusion of rapamycin impairs longterm spatial memory storage in naïve rats (Dash et al. 2006). Pretreatment with centrally
infused mTOR inhibitors worsened spatial memory and learning after mild closed head
injury (Zhu et al. 2014). A single injection of rapamycin delivered to the ipsilateral
ventricle immediately before moderate CCI reduced activation of S6 in the hippocampus,
but did not alter posttraumatic spatial learning (Park et al. 2012). Intraperitoneal injection
of rapamycin at 1hr after moderate CCI prevented injury-induced mTOR activation of S6
in the hippocampus and attenuated acute spatial learning deficits (Nikolaeva et al. 2016).
Inhibition of mTOR with an AMPK-dependent mTOR inhibitor, metformin, after
moderate CCI also attenuated TBI induced memory deficits in rodents (Hill et al. 2016).
In experimental models of posttraumatic epilepsy, mTOR inhibition by rapamycin
reduced the development of posttraumatic seizures (Guo et al. 2013, Butler et al. 2015).
Posttraumatic induction of mTOR activation may have to reach a threshold level to
impair cognition. Mice that are haploinsufficient for the endogenous mTOR inhibitor,
TCS1/2, have impaired learning only after mild closed head injury (Rozas et al. 2015). It
is clear that dysregulation of mTOR activity may impair posttraumatic recovery.
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Like IGF1 signaling, mTOR activation can regulate cell survival following
trauma. mTOR regulates apoptosis and survival during CNS development (Magri et al.
2013, Lee 2015). The basic function of mTOR activity is to regulate homeostasis. Cells
undergoing stress can save energy by downregulating mTOR activity to prolong survival.
However, when mTOR activation levels are reduced too low, programmed cell death can
be induced (Feng et al. 2010, Hung et al. 2012). Following injury, mTOR is activated in
NSCs, neurons, and reactive glia in the cortex and hippocampus after injury (Chen et al.
2007, Park et al. 2012, Wang et al. 2016). Inhibiting mTOR activation following weight
drop injury reduced trauma induced caspase activation and apoptosis markers (Wang et
al. 2017). Inhibiting posttraumatic mTOR activation also inhibits injury-induced NSC
proliferation and neurogenesis in the hippocampus (Butler et al. 2015, Wang et al. 2016).
Posttraumatic rapamycin treatment inhibits axonal process outgrowth, inhibiting injuryinduced aberrant sprouting after severe TBI (Guo et al. 2013, Butler et al. 2015). It is
unclear whether and to what extent IGF1 alters mTOR activation and its regulation of
posttraumatic neuronal survival and neurogenesis in the hippocampus.
Summary
TBI is a devastating disease associated with a billion-dollar economic burden and
the potential for long-term disability. There are currently no approved pharmacological
treatments for TBI. IGF1 attenuates injury-induced deficits in hippocampus-dependent
learning and memory tasks. Following injury, IGF1 also confers hippocampal
neuroprotection and stimulates neurogenesis and dendritic arbor recovery. However, the
long-term fate of posttrauma-born neurons following IGF1 intervention and their
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contribution to neurogenesis dependent behaviors after injury is not known. This study
elucidates the long-term effects of IGF1 on posttraumatic neurogenesis and behavior.
The

IGF1

signaling

pathway

confers

neuroprotection

and

stimulates

neuroplasticity following trauma. This study tests the hypothesis that mTOR activation is
critical to the enhancement of hippocampal neurogenesis by IGF1 after injury. This
dissertation provides new insights into the mechanism of post-traumatic IGF1 signaling
in plasticity.
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CHAPTER 2: IGF1 increases long-term survival of posttrauma-born neurons
while inhibiting ectopic localization in the hippocampus
Introduction
TBI is the leading cause of death among people under 40 and is predicted to be
the leading cause of death in the world by 2020 (Fleminger et al. 2005, Popescu et al.
2015). Survivors of mild to severe cases of TBI can suffer from a progressive decline in
cognition and from long-term disability (Watson et al. 1995, Ratcliff et al. 2005,
Flanagan 2015, Schachar et al. 2015). Cognitive impairment is due in part to the brain’s
limited capacity to repair and replace lost neurons.
Throughout adulthood, neural stem cells in the subgranular zone (SGZ) of the
hippocampal dentate gyrus can proliferate and differentiate into new principal granule
neurons of the granule cell layer (GCL) (Amaral et al. 2007). During the normal
progression of adult neurogenesis, nearly 80% of newly born neurons undergo apoptosis
within four weeks of proliferating (Cameron et al. 2001, Dayer et al. 2003, Kempermann
et al. 2003, Ryu et al. 2016). Surviving neurons form synapses and are functionally
integrated into the local hippocampal circuitry (van Praag et al. 2002, Jessberger et al.
2008). Although the function of surviving adult-born neurons is not completely
understood, they have been shown to contribute to contextual fear memory and extinction
(Snyder et al. 2009, Ishikawa et al. 2016), spatial memory (Farioli-Vecchioli et al. 2008)
(Lu et al. 2007), pattern separation (Sahay et al. 2011), and cognitive flexibility )
(Burghardt et al. 2012, Sahay et al. 2011). Increasing the number of new adult-born
neurons that survive to maturity has been shown to be sufficient to increase cognitive
flexibility in naïve mice (Sahay et al. 2011).
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Trauma has a pronounced impact on immature hippocampal neurons and their
development following injury. Contusive brain injury results in the selective death of
immature neurons in the GCL within the first week of injury (Rola et al. 2006, Gao et al.
2008). While brain insults transiently stimulate a period of proliferation, resulting in
recovery of immature neuron numbers (Rola et al. 2006, Carlson et al. 2014), the
majority of post-trauma-born immature neurons do not survive to maturity after TBI (Lu
et al. 2005, Bye et al. 2011, Ning et al. 2011, Gao et al. 2013, Wang et al. 2016). Injury
results in a minimal increase in end-stage mature neurons, diminishing the potential longterm impact of stable posttraumatic neurogenesis. Within the injured hippocampus
posttrauma-born neurons develop with atypical and stunted dendritic arbors (Carlson et
al. 2014, Villasana et al. 2015, Ibrahim et al. 2016), which may inhibit synapsedependent maturation and survival (Tashiro et al. 2006, Ge et al. 2008, Deng et al. 2010).
Brain injury also increases the number of newly born neurons that migrate ectopically
from the GCL into the molecular layer (ML) and hilar layer (HL) (Parent et al. 1997,
Scharfman et al. 2000, Niv et al. 2012, Villasana et al. 2015, Shapiro 2017).
Mislocalization and aberrant development may interfere with the function and survival of
neurons born following TBI.
Insulin-like growth factor-1 (IGF1) is a potent growth factor that is expressed at
high levels during neuronal development and at lower levels in the adult CNS (Ocrant et
al. 1988, Nieto-Estevez et al. 2016). IGF1 stimulates neurite outgrowth (Kim et al. 1997),
is required for appropriate migration of neural progenitors during development (HurtadoChong et al. 2009), and promotes newborn neuron survival (Baker et al. 1999). In the
context of injury, we have shown that IGF1 increases the number of immature neurons
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born after trauma and restores their dendritic arborization to the levels of uninjured
controls (Carlson et al. 2014). Additionally, IGF1 has been shown to attenuate acute
posttraumatic cognitive dysfunction (Saatman et al. 1997, Rubovitch et al. 2010,
Madathil et al. 2013).
Here, we utilized a transgenic mouse model in which conditional overexpression
of IGF1 by astrocytes results in increased hippocampal levels of IGF1 acutely after
contusive brain injury (Madathil et al. 2013). At six weeks post-injury, a time point
beyond the window of maturation-dependent survival of adult-born dentate gyrus granule
cells (Dayer et al. 2003), we examined the effects of IGF1 overexpression on the survival
and localization of matured granule neurons born within the first week after TBI. IGF1
overexpression increased the number of posttrauma-born neurons that survived to endstage maturity and reduced ectopic migration following injury. IGF1 overexpression
improved radial-arm water maze reversal learning during the 6-week period
corresponding to enhanced stable neurogenesis. We show that IGF1 promotes cognitive
flexibility six weeks after TBI.
Materials and Methods
Animal Care
Transgenic mice with astrocyte-specific conditional overexpression of IGF1 were
described previously (Ye et al. 2004, Madathil et al. 2013). The mice were bred in-house
by crossing heterozygous tTAGFAP mice with heterozygous IGF1pTRE mice, yielding
double transgenic mice carrying both transgenes (tTAGFAP/IGF1pTRE ) (Madathil et al.
2013, Carlson et al. 2014). IGF1 double transgenic mice (IGFtg) and their wildtype (WT)

30

littermates were fed doxycycline supplemented chow (200mg/kg) to suppress IGF1
expression from birth until 2 weeks prior to surgery, after which they received standard
chow. The mice were provided with food and water ad libitum at the University of
Kentucky Medical Center animal vivarium. They were housed in temperature controlled
rooms (23 ± 2°C) with a 14/10-h light/dark cycle. All procedures involving animals were
approved by the University of Kentucky’s Institutional Animal Care and Use Committee
(approval # 2013-1156).
Controlled Cortical Impact Injury
Controlled cortical impact (CCI) injury was performed as previously described
(Madathil et al. 2013, Carlson et al. 2014). Briefly, isoflurane-anesthetized mice received
a 5-mm diameter craniotomy over the left parietal cortex. For sham-injured mice, a
cranioplasty was placed over the exposed cortex and the incision was closed. In CCIinjured mice, a cortical contusion was produced using a pneumatically driven impactor
device (Precision System Instruments) or a stereotaxic electromagnetic impactor (Leica
Biosystems). A rounded 3mm diameter impactor tip was used to deliver a 0.8mm
(pneumatic) or 1.1mm (electromagnetic) depth impact at a velocity of 3.5m/s. A cohort of
male and female mice 8-12 weeks old were randomized for CCI or sham injury groups
for GCL immunohistochemical analysis (8-9 CCI and 3 shams per genotype) and a
second cohort was used for behavioral analysis (9-11 CCI per genotype).
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BrdU Administration
Beginning 24h after CCI or sham injury each animal received two i.p. injections
of 5-Bromo-2′-deoxyuridine (BrdU; 50 mg/kg in saline; Fisher Scientific) at an 8h
interval each day until 7 days post-injury (dpi). Proliferating cells were labeled from one
to seven days after injury to capture the majority of the proliferative phase triggered by
TBI (Rola et al. 2006, Carlson et al. 2014).
Histology and Immunohistochemistry
Animals were deeply anesthetized by sodium pentobarbital (Fatal-Plus Solution,
Vortech Pharmaceuticals) and transcardially perfused with heparinized saline followed
by 10% buffered formalin 42d after injury. Brains were removed 24h after post-fixation
in 10% formalin, cryoprotected using 30% sucrose solution, and snap frozen in cold
isopentanes (≤ -25° C). Frozen brains were cut in a coronal plane at 40µm thickness. A
series of 9-10 sections taken at 400 µm intervals spanning the entire cerebrum were
stained with 0.5% Cresyl Violet (Acros Organics).
Immunofluorescence was performed using published protocols for free-floating
sections (Madathil et al. 2013, Carlson et al. 2014) on three tissue sections selected at 400
µm intervals spanning the injury epicenter (between -1.5 to -2.5mm bregma). To expose
BrdU epitopes, the tissue was incubated in 2N HCl (Fisher Scientific) at room
temperature with agitation for 1h, followed by 100mM borate for 10 minutes to neutralize
residual HCl. The tissue was rinsed overnight in TBS at 4ºC prior to a 30 min room
temperature incubation in TBS with 0.1% Triton-X-100 and 5% Normal Horse Serum
(NHS). Primary antibodies were diluted in TBS with 0.1% Triton-X-100 and 5% NHS
and tissue was incubated overnight at 4ºC with agitation. Primary antibodies used were
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anti-NeuN (rabbit, 1:500, Millipore Sigma), anti-GFAP (rabbit polyclonal, 1:1000,
Millipore Sigma), anti-Iba1 (rabbit polyclonal,1:1000, Wako), and anti-BrdU (rat
monoclonal,1:1000, Abcam). Secondary antibodies were conjugated with Alexa-488, Cy3 or Alexa-594 (Invitrogen). The omission of primary antibody served as a negative
control. Sections damaged during processing were omitted from analysis for one mouse
because the tissue was.
Image Acquisition
Images were taken on a confocal epifluorescence microscope (C2 Tie Nikon
confocal microscope) capturing the dentate gyrus for each section per animal. BrdU+ and
BrdU+NeuN+ cells in the densely packed GCL of the hippocampus ipsilateral to impact
were imaged at 100x magnification under oil and at 0.75 µm step intervals through a 25
µm depth. Maximum intensity projection images of glia labeled with BrdU in the ML
were generated from confocal images taken at 1.5 µm step intervals through 20 µm of
each section. Colocalization of markers was confirmed using 3D reconstructions of the
cells of interest to avoid false positives.
Region of Interest Analysis
To control for possible differences in cell counts due to variations in region size
as a function of the anatomical location of section counted, injury or genotype, the
volume of the region was determined. In a profile image of each section, the region of
interest (ROI) was outlined. The GCL area was auto-detected using NIS-Elements’ ROI
area function. The ML region of interest, which had a sparse distribution of labeled
proliferated cells compared to the GCL area of interest, was manually traced. The
outlined ML ROI contained at least 225 DAPI-labeled cells per section in the lateral 2/3
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aspect above the upper blade (0.044mm2 to 0.059mm2 sample area range) (Guzowski et
al. 1999, Orozco et al. 2001, Nixon et al. 2008). The depth of the region imaged on the
confocal microscope was multiplied by the area to determine the volume, expressed as
mm3.
Cell Quantification
To evaluate the effect of IGF1 on adult-born neuronal survival in the GCL, the
number of BrdU+ and BrdU+NeuN+ cells were manually counted in the GCL, ML, and
hilus (HL). Cells were determined to reside in the GCL if they were within one cell
distance (0-10µm) of the GCL border and the soma was adjacent to other NeuN+ cells
along the border (Villasana et al. 2015). As principal granule cells are the only type of
neuron generated by adult neurogenesis in the dentate gyrus, BrdU+NeuN+ neurons
located in the HL and ML are considered ectopic (Amaral et al. 2007, Scharfman 2016).
Colocalization of markers was confirmed by making 3D reconstructions of the cells of
interest to avoid false positives. To determine if IGF1 increased the survival of
posttrauma proliferated glial cells, BrdU+, BrdU+Iba1+, and BrdU+GFAP+ cells were
counted in the ML. The following criteria were used to identify BrdU+ cells in the ML
for automated counts: colocalization of BrdU with DAPI, spherical cell shape, and a
nucleus 5-16 µm in diameter (NIS-elements software). To ensure an unbiased approach,
BrdU+ cells were counted and annotated before evaluation of co-labeling with either cell
type marker (GFAP or Iba1). Cell counts are expressed as density, cells per volume
(mm3).
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Neuronal Positioning Analysis
To localize posttrauma proliferated neurons (BrdU+NeuN+) in the GCL at 42dpi,
the position of the center of the cell in relation to the GCL/HL border was determined as
previously described (Han et al. 2016, Ibrahim et al. 2016). The center of the soma of
BrdU+NeuN+ cells within the GCL was annotated using NIS-elements, and cells were
binned into the inner 1/3 of the GCL (iGCL) or outer 2/3 of the GCL (oGCL).
Radial Arm Water Maze
The water maze behavior assessment describes a spatial learning test in which
animals are trained to locate a fixed platform hidden beneath the surface of a pool. The
water component serves as an aversive motivator that encourages rodents to escape
quickly. Decreased exploration of areas that do not contain the platform over contiguous
trials indicates learning. The reversal paradigm introduces a novel platform location after
animals have learned to find the original location. How quickly rodents decrease
preference for the old location is an indicator of improved cognitive flexibility (Garthe et
al. 2009). Cognitive flexibility has been linked to an increase in the number of mature
adult-born neurons (Garthe et al. 2009).
To measure spatial reference memory and learning, mice were tested using an
established 2-day radial arm water maze (RAWM) protocol (Alamed et al. 2006,
Morganti et al. 2015) beginning 39 days after injury by an observer blinded to animal
genotype. We utilized a six-arm maze with an arm length of 30 cm and a common
circular swim diameter of 40 cm within a 160 cm diameter pool. The pool was filled with
20-21°C water, made opaque using tempura paint (Rich Art Co., Northvale, NJ), to a
level approximately 2 cm above a clear (hidden) circular platform. The platform was
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placed at the end of an arm approximately 7 cm away from the side and back walls.
During visible trials, a cue was placed on the edge of the platform. The pool was enclosed
by a black curtain on which four unique geometric extra-maze visual cues were affixed.
On day 1 (acquisition day), mice were trained over four blocks of 3 trials to
identify the platform location, alternating between visible and hidden platform trials
(Morganti et al. 2015). Block 5 on day 1 consisted of 3 hidden platform trials, yielding a
total of 15 trials. On day 1, mice unable to locate the platform within 60 seconds were
gently guided to it. On day 2, reference memory was tested using 15 hidden platform
trials, conducted in 5 blocks of 3 trials each (blocks 6 to 10). Mice received a third day of
testing, during which the platform was moved to a novel location, at least 1 arm away
from the original location (Alamed et al. 2006, Selenica et al. 2014). On day 3, mice
received 15 hidden platform trials in the novel location performed in five blocks. Mice
were tested in groups of 4-5 and never entered the same start arm as the previous trial. A
mouse was considered to have entered the arm if its whole body crossed the threshold of
the arm. Animals received an error point if they entered the wrong arm or did not make
an arm choice for more than 15s. Entries into the goal arm were not counted as errors
even if the platform was not located. The error data is presented as the average error of
hidden platform trials per block.
Upon completion of RAWM testing visual and swimming deficits were evaluated
using an open pool visible platform test (Alamed et al. 2006). The latency to find the
visible flagged platform in an open pool divided into 4 equal quadrants was assessed over
5 blocks of 3 trials (15 trials total trials). The start position remained constant throughout
the testing, while the goal quadrant varied each trial. Animals were excluded from
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analysis for failing the visible platform test (Alamed et al. 2006) by receiving a latency of
>20 seconds in the last block of the test and ≥45 seconds latency across all 15 open pool
trials (1 WT and 1 IGFtg). Two visually competent mice were excluded from analyses
for non-participation, failing to reach the platform in every trial during the 3 days of
testing (1 WT and 1 IGFtg).
All trials were recorded with a digital camera using EthoVision XT 8.0 video
tracking software (Noldus Information Technology). The error and latency to platform
data was analyzed offline from video analysis by blinded observers. Activity heat-maps
were generated by video analysis using Anymaze software (Stoelting Co.).
Statistical Analyses
Data was assembled by an individual blinded to genotype and injury conditions.
Statistical analyses and graph generation was performed using GraphPad Prism software
6.0. Cell counting and localization assays revealed no differences across bregma levels
within groups. Therefore data was combined across tissue sections for a given animal.
Cell counts and cell positioning data were analyzed using a one-way analysis of variance
(ANOVA), followed by post-hoc Bonferroni's multiple comparison t-tests where
appropriate. Post-hoc comparisons were limited a priori to four, to test for genotype
effects across sham groups and across injured groups, and injury effects (sham versus
CCI) for WT mice and for IGFtg mice. RAWM and RAWM reversal data were analyzed
for each day using a two-way ANOVA with repeated measures. For all comparisons
p<0.05 was considered statistically significant. All data are presented as mean + standard
error of mean (SEM).
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Results
Dentate gyrus cells that proliferate acutely after trauma survive 6 weeks
To determine the effect of IGF1 on long-term survival of cells that proliferate
after TBI, we labelled cells dividing within the first seven days after injury with BrdU
and quantified the number of BrdU+ cells persisting until 42dpi after injury. Proliferated
cells were distributed throughout the dentate gyrus but were more abundant in mice with
TBI (Figure 2.1A). Quantification in the GCL (Figure 2.1B) and the ML (Figure 2.1C)
confirmed a significant increase in the density of acutely proliferated cells (BrdU+) that
survived six weeks in both injured WT and IGFtg mice compared to sham controls.
However, overexpression of IGF-1 did not alter the density of proliferated cells in either
region of the hippocampus.
IGF1 selectively promotes end-stage fate maturation of immature neurons resulting in
stable neurogenesis 6wks post-injury
We identified three major neural cell types represented among the surviving
BrdU+ posttrauma-born cells in the dentate gyrus: neurons, astrocytes, and microglia
(Figure 2.2). We previously showed that IGF1 stimulates an increase in numbers of
immature neurons in the GCL early after CCI brain injury by promoting neuronal
differentiation (Carlson et al. 2014). To determine if overexpression of IGF1 supported
long-term survival of neurons and glia born acutely after trauma, we quantified the
density of proliferated neurons, astrocytes, and microglia at 42 dpi (Figure 2.3). We
observed no significant difference in the number of BrdU+ neurons in the GCL of braininjured WT mice compared to WT shams, suggesting no notable difference in long-term
neurogenesis. In contrast, brain-injured IGFtg mice displayed a marked increase in
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BrdU+NeuN+ cell density compared to IGFtg shams (Figure 2.3A). The density of
surviving posttrauma-born neurons in brain-injured mice overexpressing IGF1 was also
significantly higher than that in injured WT mice. Proliferated astrocytes and microglia
were counted in the ML of the dentate gyrus, a region predominantly populated by glial
cells. Brain injury resulted in a similar increase in the density of proliferated astrocytes
present in the ML for WT and IGFtg mice (Figure 2.3C), suggesting that IGF1
overexpression did not enhance the persistence of proliferated astrocytes in the ML.
Injury resulted in an increase in the density of posttrauma proliferated microglia present
in the ML at 6 weeks post-injury, but this was statistically significant only in WT mice
(Figure 2.3E).
While TBI has been shown to increase the number of posttrauma-born cells in the
GCL, the proportion of proliferating cells that become mature neurons declines (Lu et al.
2007, Gao et al. 2013, Chen et al. 2016). Consistent with these reports, we found that
over 60% of BrdU+ cells co-label as mature neurons in the GCL of sham controls at 6
weeks after surgery, while mature neurons only account for 30% of BrdU+ cells in braininjured WT mice (Figure 2.3B). IGF1 overexpression significantly increased the
proportion of proliferated cells that exhibited a mature neuronal phenotype following
injury (Figure 2.3B), restoring the balance of proliferated neurons to over 60%, a level
equivalent to sham controls. In contrast, the proportion of posttrauma proliferated cells in
the ML that were co-labelled with either glia marker, GFAP or Iba1, was similar for
IGFtg and WT brain-injured mice (Figures 2.3D,F).
Measurement of the area of GFAP and Iba1 immunostaining revealed that IGF1
overexpression promoted an increased area of GFAP and Iba1 labeling in the ML
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compared to uninjured controls (Figure 2.4A). Together these data suggest that while
IGF1 strongly promoted the long-term survival of posttrauma-born neurons, it did not
alter the density or proportion of acutely proliferated astrocytes and microglia in the
dentate gyrus after CCI brain injury. Astrocyte-specific IGF1 overexpression, however,
may stimulate astrocyte hypertrophy, as reported in our previous study of acute responses
to brain trauma (Madathil et al. 2013).
IGF1 enhances outward migration of posttrauma-born neurons in the GCL
Earlier studies that characterized the development and migration of newborn
neurons within the GCL identified two different regions, the inner and outer zones
(Altman et al. 1990, Martin et al. 2002, Kempermann et al. 2003, Zhao et al. 2006).
Neural progenitors proliferate in the inner 1/3 of the GCL (iGCL) and migrate toward the
outer 2/3 of the GCL (oGCL) as they mature (Kempermann et al. 2003, Schmidt-Hieber
et al. 2004, Heigele et al. 2016). Neurons born during development and older granule
neurons are preferentially localized in the outer zones in the adult. Newborn neurons
migrate further following brain injury (Villasana et al. 2015). A study showed that injury
increases the proportion of posttrauma proliferated neurons that localize to the oGCL
(Ibrahim et al. 2016). We examined the relative proportions of posttrauma-born neurons
localized to the oGCL to determine if IGF1 altered outward migration within the GCL
(Figure 2.5A). The majority of the neurons born the first week after surgery localized to
the iGCL in all groups (Figure 2.5D). Injury induced a modest increased the number of
posttrauma-born neurons that localized to the oGCL. The density and proportion of
posttrauma-born neurons localized to oGCL was only significantly higher than control
levels in injured IGFtg mice (Figure 2.5E, Figure 2.6A).
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IGF1 attenuates ectopic localization of posttrauma-born neurons in the dentate gyrus
Granule neurons born after brain injury have an increased probability of
mislocalization to the HL or ML (Parent et al. 1997, Scharfman et al. 2000, Jessberger et
al. 2007, Villasana et al. 2015, Shapiro 2017). Ectopic localization of granule cells may
also be stimulated by neurotrophic factors such as BDNF (Scharfman et al. 2005).
Therefore, we sought to determine whether increased hippocampal neurogenesis in IGF1
overexpressing mice with brain injury was associated with heightened risk for ectopic
localization of adult-born neurons. Ectopically localized new neurons (Figures 2.5B,C)
were observed in both groups of brain-injured mice, but not in sham controls. WT injured
animals had a significantly higher proportion of proliferated neurons localized to the ML
and HL than WT sham mice (Figure 2.5G). Despite increasing the number of proliferated
neurons 3-fold (Figure 2.3A), IGF1 overexpression did not significantly increase the
number of ectopic neurons in the ML and HL of brain-injured mice compared to injured
WT (Figure 2.6B). Compared to WT injured mice, IGF1 overexpression reduced the
proportion of proliferated neurons that were ectopically localized following injury
(Figure 2.5G).
IGF1 improves reversal learning in RAWM 6 weeks after CCI
Cognitive flexibility describes the process of distinguishing between two similar
contexts and then extinguishing a preference for one and replacing it with a novel
preference (Anacker et al. 2017). Water maze platform reversal studies show that adultborn hippocampal neurons contribute to cognitive flexibility (Garthe et al. 2009, Garthe
et al. 2013). Increasing the number of mature adult-born neurons in the GCL was
sufficient to improve pattern separation and cognitive flexibility in naïve animals (Sahay
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et al. 2011). To determine if IGF1 overexpression improved hippocampal dependent
learning ability or cognitive flexibility, mice were evaluated in a 3d RAWM test that
included two days of task acquisition (learning) followed by one day with platform
reversal. On days 1 and 2, the numbers of errors did not differ significantly between
injured WT and IGFtg mice, indicating similar ability to learn the initial platform location
(Figure 2.7A). During day 3 RAWM reversal testing, the platform was moved to a novel
goal arm, requiring mice to change their strategy and identify the new platform location.
Injured WT and IGFtg mice initially made similar numbers of errors during the first
block of day 3 and both learned to find the new platform by the last block of day 3
(Figure 2.7A). Injured IGFtg mice showed an earlier decrease in errors over blocks 10-11
while WT injured mice were more delayed in learning the new location, but this
difference was not statistically significant.
Learning a novel goal location after an initial goal location has been established is
neurogenesis dependent (Garthe et al. 2009, Burghardt et al. 2012, Garthe et al. 2013). A
decrease in time spent in the old (original) location is reflective of the animals’ ability to
extinguish prior memory and learn a new strategy (Garthe et al. 2009, Saha et al. 2017).
Activity maps from day 3 RAWM trials illustrate that injured WT mice had more activity
in the vicinity of the old goal arm in blocks 9, 10 and 11 than did injured IGFtg mice
(Figure 2.7B). Therefore, we quantified the time spent in the old goal arm during
reversal learning on day 3 of the RAWM. Injured IGFtg mice spent significantly less
time in the old arm during day 3 of RAWM testing compared to injured WT mice (Figure
2.7C). Our data provides evidence that IGF1 overexpression enhances posttraumatic
cognitive flexibility, enabling injured mice to more quickly extinguish their memory of
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the old strategy and replace it with a new one. Both WT and IGFtg mice performed
similarly on the visual platform test (Figure 2.7D), indicating that behavioral differences
between groups are not due to motor or visual deficits (Alamed et al. 2006, BromleyBrits et al. 2011).
Discussion
Summary
The fate, localization, and function of posttrauma-born neurons in the dentate
gyrus six weeks following brain injury were examined in IGF1 overexpressing and WT
mice. Three key findings from the studies are presented here. First, of the hippocampal
cell types that proliferate after trauma, the population of posttrauma-born neurons that
survive to maturity is selectively increased by elevated brain levels of IGF1. IGF1
significantly increased the number of mature posttrauma-born neurons but not the
number of astrocytes or microglia proliferated within the first week of injury. Second, we
show for the first time that IGF1 regulates migration of adult-born neurons following
trauma. Brain-injured IGF1 mice had significantly more newly born neurons localized
deep within the GCL. Although IGF1 promoted migration within the GCL, it did not
potentiate injury-induced ectopic granule cell localization to the HL and ML. Third, we
present a novel effect of IGF1 on cognitive flexibility following trauma. At six weeks,
injured IGF1tg mice had improved performance on the day of RAWMR testing, when the
hidden platform was moved to a novel location. This data compels further evaluation of
IGF1 for its therapeutic potential to promote hippocampal neurogenesis and cognitive
flexibility following trauma.
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Survival
We show IGF1 overexpression support survival of posttrauma-born neurons to
end-stage maturity. Consistent with previous studies, the proportion of acutely
proliferated cells that differentiated into neurons and survived to late-stage maturity in
injured WT mice was diminished compared to sham controls (Lu et al. 2007, Gao et al.
2013). Posttraumatic IGF1 overexpression stimulated a 3-fold increase in numbers of
mature neurons 6 weeks after injury. IGF1 overexpression following injury restored the
proportion of proliferated cells that became end-stage mature neurons to sham levels at 6
weeks post-CCI. Posttraumatic IGF1 overexpression dramatically increases neuronal
differentiation of SGZ NSCs within 10d of injury (Carlson et al. 2014). Data from in
vitro studies and developmental studies suggest that IGF1 is largely increasing the
density of neurons that survive to end-stage maturity by inhibition of programmed cell
death and enhanced integration of developing neurons (Baker et al. 1999, Jaworski et al.
2005, Kim et al. 2006, Miltiadous et al. 2011, O'Kusky et al. 2012, Carlson et al. 2014,
Huat et al. 2014, Nieto-Estevez et al. 2016, Nieto-Estevez et al. 2016). Injury drives
extensive cell death of immature neurons and, to a lesser extent, mature neurons in the
GCL (Rola et al. 2006, Gao et al. 2008, Gao et al. 2013). Additional posttrauma-born
neurons will die during the process of maturation. A critical step in the process of adult
neurogenesis is pruning, which maintains a consistent number of principal granule cells
in the GCL as mammals age. The majority of 2-3 week old adult-born neurons do not
reach end-stage maturity; as many as 80% of these neurons undergo apoptosis during
synapse-dependent competitive survival (Cameron et al. 2001, Dayer et al. 2003,
Kempermann et al. 2003, Ryu et al. 2016). IGF1 has been shown to prevent apoptosis in
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the hippocampus and increase immature neuron dendritic arborization (Miltiadous et al.
2011, Madathil et al. 2013, Rong et al. 2015). We found no difference in the numbers of
proliferated cells in the GCL of injured WT and IGFtg mice. By 1-month post-injury only
10-50% of acutely proliferated cells in the GCL of WT mice are mature neurons (Lu et
al. 2005, Wang et al. 2016). Gao and colleagues argue that the reduction in mature
neurons is not merely due to slowing of the maturation process after TBI, as BrdU+ cells
that are NeuN- do not label with the immature neuron marker doublecortin (Gao et al.
2013). Future long-term studies examining the effect of IGF1 overexpression on the rate
of proliferated neuron apoptosis in the GCL are necessary to directly elucidate the
mechanism that produces increased mature neurons after trauma. In any event, IGF1
overexpression following injury provides a pool of mature neurons that can potentially be
recruited to overcome deficits caused by injury.
Although the IGF1 receptor is ubiquitously expressed on all neural cell types
(Ocrant et al. 1988, Muhic et al. 2015), our data suggests that IGF1 is selectively
enhancing stable neurogenesis after TBI. Our data corroborates existing studies that show
that injury stimulates acute glial proliferation in the ML that persists for months after
injury (Kernie et al. 2001). However, IGF1 overexpression did not increase the number of
proliferated astrocytes or microglia localized to the ML 6 weeks after TBI. Our data
contrasts ischemic brain injury findings, that IGF1 treatment stimulates gliosis, producing
an increase in astrocytes, microglia and oligodendrocytes in the white matter tracts of
fetal sheep (Cao et al. 2003). Although we examined neurons, astrocytes, and microglia,
further studies are needed to examine alterations in proliferated oligodendrocyte
densities.
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In our model, IGF1 overexpression is driven by GFAP, an astrocyte-enriched
structural protein. IGF1 overexpressing mice exhibited a significant increase in GFAP
immunoreactive area at 6 weeks after injury in the ML compared to uninjured controls
and injured WT mice, even though neither the density nor proportion of proliferated
astrocytes was increased. This is consistent with our previous finding, that IGF1
overexpression increases GFAP levels in hippocampal homogenates at 24 and 72hrs after
CCI compared to WT injured animals (Madathil et al. 2013). Astrocytes play many
potentially important roles in the injured brain, including regulating synaptic strength of
DG granule cells, attenuating cognitive impairment through hippocampal S100B growth
factor release, reducing glutamate excitotoxicity, and mediating immature neuron
migration along their processes (Deller et al. 1997, Chen et al. 2003, Kleindienst et al.
2005, Becker et al. 2013, Robinson et al. 2016, Jinnou et al. 2018). An increase in GFAP
immunoreactive area was also observed in the GCL and SGZ of injured IGFtg mice
compared to WT and sham controls (data not shown).

Increased GFAP in close

proximity to the GCL and neurogenic niche suggest that astrocytes and possibly GFAPpositive progenitors in the DG may play a role in mediating IGF1 effects on
neurogenesis.
Migration
Mature neurons generated by posttraumatic neurogenesis may play an important
role in replacing mature granule neurons lost after injury. For the first time, we show that
IGF1 can regulate outward migration of posttrauma-born neurons, consistent with a
developmentally born phenotype. Although neurogenesis is an ongoing process, the
approximate number of adult-born neurons in the GCL is maintained and does not
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increase over time (Cameron et al. 2001, Dayer et al. 2003, Kempermann et al. 2003,
Amaral et al. 2007). Developmentally born granule neurons, localized to the oGCL of
adults, continue to die over time. Adult neurogenesis provides a pool of new neurons that
can replace dying hippocampal granule neurons (Dayer et al. 2003). In naïve animals, a
subset of adult-born neurons migrate from the neurogenic niche of the SGZ and into the
iGCL and oGCL within the first 4 weeks of their birth (Kempermann et al. 2002,
Kempermann et al. 2003).
In addition to immature neurons, injury results in a loss of mature granule cells
(Zhou et al. 2012, Wang et al. 2016). Mature granule neurons localized to the oGCL were
found to colocalize with Caspase-3 (a marker for apoptosis) after injury (Zhou et al.
2012). Although injury promotes a modest increase in the number of posttrauma-born
mature neurons that localize to the oGCL, these neurons maintain their injury-induced
aberrant dendritic arbors into maturity at 5 weeks post-trauma (Ibrahim et al. 2016). This
suggests that although injury has been shown to increase posttrauma-born neurons
localized to the oGCL, they may not productively integrate. At 10d post-injury IGF1
overexpression restores immature neuron dendritic arbor length and complexity to
uninjured levels (Carlson et al. 2014). We show here that IGF1 increases the density and
proportion of mature posttrauma-born neurons that migrate to the oGCL. Futures studies
will examine the architecture and function of these cells.
As immature neurons develop in the postnatal brain, they are rarely found
localized to the hilus. During the process of adult neurogenesis, immature neurons that
mislocalize the HL undergo Bax-mediated apoptosis before they are able to mature
(Stallock et al. 2003, Myers et al. 2013). Several models of brain injury, including TBI,
47

cause adult-born granule neurons to ectopically localize to the HL (Parent et al. 1997,
Scharfman et al. 2007, Myers et al. 2013, Shapiro 2017). Consistent with other studies,
we show that injury increases the density of ectopically localized posttrauma-born
granule cells. However, we are the first to show that IGF decreases the proportion of new
neurons that migrate ectopically into the HL. Large numbers of ectopically localized
neurons are generated in the epileptic brain and these mislocalized neurons are implicated
in seizure development (Parent et al. 1997, Scharfman et al. 2003). Ectopically localized
mature granule cells integrate into the hilus are suggested to lower seizure threshold
(Scharfman et al. 2003). It was recently reported that IGF1 treatment decreased seizure
severity in a kainic acid model of temporal lobe epilepsy (Miltiadous et al. 2011). The
magnitude of brain injury induced ectopic localization of neurons is much lower than that
observed in models of seizure (Scharfman et al. 2000, Ibrahim et al. 2016), so the role of
ectopic hilar neurons is less clear in TBI. IGF1 may be a potential therapeutic for
posttraumatic epilepsy.
IGF1 regulates known factors of neuronal migration including GSK3B, PSANCAM, CDK5 and reelin (Wang et al. 1999, Jessberger et al. 2008, Hurtado-Chong et al.
2009). Signaling studies have also revealed that inhibiting the activity of GSK3B, a
protein inactivated downstream of IGF1 signaling, is sufficient to increase the number of
adult-born neurons localized to the oGCL (Ng et al. 2016). During development, IGF1
regulates reelin expression and distribution, as well as reelin-dependent neuron migration
levels in naïve mice (Hurtado-Chong et al. 2009). There is also evidence that IGF1 may
regulate immature neuron migration indirectly through its effects on other neural cell
types. Reelin is a migratory stop signal for dentate granule cells that is expressed by hilar
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basket cells (Myers et al. 2013), preventing granule cells from migrating ectopically into
the hilus (Gong et al. 2007). While injury causes degeneration of hilar neurons
(Lowenstein et al. 1992, Hall et al. 2005, Hunt et al. 2011), IGF1 mediates survival of
hilar neurons following trauma (Madathil et al. 2013).
IGF1 and cognitive flexibility
Increasing the number of mature adult-born neurons was sufficient to improve
discrimination between two similar contexts, extinguish a learned strategy, and replace it
with a new strategy when a novel location goal arm was introduced (Idris et al. 2010,
Sahay et al. 2011). Further reinforcing the contribution of posttrauma-born neurons to
cognitive flexibility, ablating adult neurogenesis has been shown to impair pattern
recognition and cognitive flexibility (Clelland et al. 2009, Burghardt et al. 2012).
Inhibiting adult neurogenesis using the anti-proliferation drug temozolomide caused a
strong and lasting preference for the old goal arm during Morris water maze testing when
the goal arm was moved to a novel location (reversal testing) (Garthe et al. 2009). This
study provides evidence that enhancement of neurogenesis through posttraumatic IGF1
overexpression supports long-term cognitive flexibility. Here, WT and IGFtg mice
learned to find a hidden platform similarly on days 1-2. The ability to learn where the
constant platform goal arm is in the RAWM is dependent on the prefrontal cortex and
striatum function of working memory and reference memory (Hyde et al. 1998, ShukittHale et al. 2004). Functional neurogenesis is recruited for the reversal learning aspect of
water maze spatial learning tests (Horster et al. 2017). Injured IGFtg mice had a higher
density of mature posttrauma-born neurons and learned a new strategy more quickly that
WT mice during RAWM reversal. This is consistent with other neurogenesis studies
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(Bekinschtein et al. 2013, Bekinschtein et al. 2014, Horster et al. 2017), in which the
modification of adult neurogenesis did not interfere the ability to learn a strategy.
However, the ability of mice to choose a new strategy when a novel goal location is
introduced has been shown to be hippocampus and dentate gyrus dependent (Day et al.
1999, Xavier et al. 1999). When a novel platform location was introduced on day 3,
injured IGFtg mice learned to find the new platform earlier and spent significantly less
time in the old goal arm compared to injured WT mice. IGFtg mice have a 3-fold
increase in the number of mature posttrauma-born neurons at six weeks after injury, a
time which parallels their improved cognitive flexibility. This study provides evidence
that post-traumatic IGF1 overexpression enhances neurogenesis-sensitive cognition
including cognitive flexibility.
Our novel data show that posttraumatic increases in IGF1 are sufficient to
improve neurogenesis-sensitive cognitive flexibility. These data have important
implications for long-term posttraumatic cognitive impairment. Although frontal lobes
are known to dominate directing these functions in human, a role for the hippocampus in
cognitive flexibility has been recently defined (Rubin et al. 2014). Over 65% of moderate
to severe TBI patients report long-term cognitive deficits (Rabinowitz et al. 2014).
Executive function disabilities include impairments in high-level cognition: the ability to
plan, make decisions, social behaviours, goal-setting and cognitive flexibility.
Modulation of adult hippocampal neurogenesis is potentially a therapeutic target for TBI
recovery.
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Figure 2.1: Hippocampal cells that proliferate acutely after injury persist long-term
in the dentate gyrus.
(A) Cells dividing within seven days following surgery were detected in the
dentate gyrus of sham controls, injured wild-type (WT), and injured IGF1-overexpressing
(IGFtg) mice at 42d after injury using bromodeoxyuridine (BrdU, red) immunoreactivity.
DAPI labeling is shown in blue. Scale bar represents 50µm. Controlled cortical impact
(CCI) stimulates proliferation in both WT and IGFtg mice. Quantification of BrdU+ cells
in (B) the granule cell layer (GCL) and (C) the molecular layer (ML) shows that WT and
IGFtg injured mice have increased numbers relative to their respective sham controls.
Data presented as mean + SEM (mm3/1000); sham n=3/genotype, CCI n=8-9/genotype;
One-way ANOVA, followed by post-hoc Bonferroni's selected comparisons t-tests;
*p<0.05 and ** p<0.01, compared to respective sham groups.
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Figure 2.2: End-stage fate maturation of cells proliferated during the first week
after injury results in long-term neurogenesis and gliogenesis.
(A) Representative microphotographs from confocal imaging of immunoreactivity
of mature neuron-specific protein, Neuronal Nuclei (NeuN, green) with proliferation
reporter, bromodeoxyuridine (BrdU, red). Mature posttrauma-born neurons were detected
in the granule cell layer (GCL) of sham controls, wild-type (WT) injured, and IGF1overexpressing (IGFtg) injured mice at 42d after injury. (B) Posttrauma-born astrocytes
were co-labeled with glial fibrillary acidic protein (GFAP, green) and BrdU in the
molecular layer (ML). (C) Posttrauma-born microglia were co-labeled with ionized
calcium binding adaptor molecule 1 (Iba1, green) and BrdU in the ML. The phenotype of
posttrauma proliferated cells was confirmed by 3D reconstruction of confocal images.
(D) A high-magnification image in the x, y, and z planes of the BrdU+NeuN+ area
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indicated by the red box in (A). Figure A-C, scale bar is 10µm. Figure D, scale bar is
5µm. DAPI is blue; BrdU is red.
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Figure 2.3: IGF1 selectively enhances long-term neurogenesis but not gliogenesis.
Following injury, IGF1 (A) increased the density of surviving posttrauma-born
neurons in the granule cell layer (GCL) without increasing the density of posttrauma-born
(C) astrocytes or (E) microglia in the molecular layer (ML) compared to injured WT. (B)
Injured WT mice exhibited a reduction in the proportion of proliferated progenitors that
mature into end-stage neurons, while IGF1 restored this proportion to sham levels. IGF1
overexpression did not increase the proportion of proliferated cells that differentiated into
(D) astrocytes or (F) microglia compared to injured WT mice. Data presented as mean +
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SEM (1000/mm3). Sham n=3/genotype, CCI n=6-9/genotype; One-way ANOVA,
followed by Bonferroni's selected comparisons post-hoc t-tests *p<0.05; **p<0.01; and
***p<0.001 compared to respective sham group. &&p<0.01 and &&&p<0.001 compared
to injured WT.
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Figure 2.4: IGF1 overexpressing mice had increased glial marker immunolabeling
in the ML 6weeks post-CCI.
IGF1 overexpression increased the area of (A) GFAP and (B) Iba1 positive
immunoreactivity in the ML following injury compared to IGFtg sham controls. Data
presented as mean + SEM (mm2); sham n=3/genotype, CCI n=5-9/genotype; One-way
ANOVA, followed by Bonferroni's selected comparisons post-hoc t-tests; *p<0.05 and
** p<0.01, compared to respective sham group.
.
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Figure 2.5: IGF1 increases the proportion of new mature neurons that migrate deep
within the granule cell layer but decreases the proportion that localizes ectopically
to the hilus and molecular layer after injury.
Examples of mature neurons localized to (A) the inner granule cell layer (iGCL)
and the outer 2/3rd region of the granule cell layer (oGCL), (B) the molecular layer
(ML), and (C) the hilar layer (HL) after controlled cortical impact (CCI) using confocal
imaging of Neuronal Nuclei (NeuN, green) and the proliferation reporter,
bromodeoxyuridine (BrdU, red). (D) IGF1 overexpression potentiates injury-induced
migration of new neurons to the oGCL; (E) IGF1 overexpression increased proportion of
mature posttrauma-born GCL neurons localized to the oGCL compared to sham controls.
(F) Injury increased ectopic migration of new neurons into the ML and HL. (G) IGF1
overexpression reduced the proportion of recently born mature neurons that ectopically
localized to the ML and HL. Figures A-C, scale bar represents 10µm. Figures D-G, data
presented as mean + SEM. Sham n=3/genotype, CCI n=8-9/genotype; One-way
ANOVA, followed by Bonferroni's selected comparisons post-hoc t-tests. *p<0.05;
**p<0.01; and ***p<0.001 compared to respective sham group; &p<0.05 compared to
injured WT. SGZ, subgranular zone
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Figure 2.6: IGF1 overexpression increased the density of outward migrating
NeuN+BrdU+ in the GCL, but not the density of ectopically localized neurons.
(A) At six weeks after injury, IGF1 overexpression increased the density of
proliferated neurons localized to the oGCL compared to sham controls and injured WT.
(B) At six weeks after injury, ectopically localized neurons were observed in the ML and
HL. Data presented as mean + SEM (1000/mm3). Sham n=3/genotype, CCI n=89/genotype; One-way ANOVA, followed by Bonferroni's selected comparisons post-hoc
t-tests. *p<0.05 compared to respective sham group. &p<0.05 compared to injured WT.
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Figure 2.7: Injured mice extinguish memory of old goal arm earlier following IGF1
overexpression.
(A) WT and IGF1 mice learned to find the hidden platform during radial-arm
water maze (RAWM) testing and RAWM-reversal. Both WT and IGFtg mice show a
decrease in numbers of errors over training days. (B) Maps show activity of
representative WT and IGFtg mice during the first three blocks of RAWM reversal
testing. IGFtg mice extinguish memory of the old goal arm sooner, after the platform
was moved from the original training location (green square) to a novel location (red
asterisk) during day 3 RAWM reversal testing. (C) WT mice consistently spent more
time in the previous platform location than the IGFtg mice during RAWM reversal
testing. (D) Differences between groups were not due to sensory or motor dysfunction.
Injured WT and IGFtg mice have similar times to locate the platform at 6 weeks after
CCI. Heatmap blue to red coloration indicates increasing amount of time. Data presented
as mean + SEM. CCI n=9-11/genotype; Repeated measures ANOVA, p values reported
in image.
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CHAPTER 3: IGF1 posttraumatic hippocampal remodeling is independent of
mTOR
Introduction
A 2006 study showed that approximately 5 million people who sustained
traumatic brain injuries (TBI) are suffering from long-term cognitive impairment and
disability (Langlois et al. 2006). The disruption of neural networks resulting from axonal
degeneration, neuronal cell death and a limited ability to replace and repair lost cells
contributes to cognitive disability (Mander et al. 2013). In response to injury, the brain
upregulates signaling that activates developmental plasticity programs which are
typically downregulated in adulthood (Anlar et al. 1999). Many forms of adaptive
plasticity occur following TBI including cellular reorganization, neural cell-type
proliferation, angiogenesis, altered neurotransmitter release, and neurogenesis (Lyeth et
al. 1990, Osier et al. 2016)
Hippocampal adult neurogenesis begins with proliferation of neural stem cells
(NSCs) in the subgranular zone (SGZ), a unique neurogenic niche in the dentate gyrus
that is capable of generating new neurons throughout adulthood (Kempermann et al.
2015). Adult neurogenesis is upregulated in the hippocampal dentate gyrus following
TBI in humans (Zheng et al. 2013), primates (Perera et al. 2011) and rodents
(Kempermann et al. 2015). The extent and duration of injury-induced neurogenesis is
sensitive to injury severity (Wang et al. 2016) and animal model (Snyder et al. 2009).
Although upregulation of neurogenesis appears to be a conserved response to brain
injury, whether it is beneficial or harmful to recovery remains controversial. Stimulating
hippocampal neurogenesis in a healthy brain using growth factors and exercise improves
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memory and learning (Deng et al. 2010). Posttraumatic neurogenesis supports spatial
learning, reference memory and pattern separation (Sahay et al. 2011, Burghardt et al.
2012, Washington et al. 2012, Bekinschtein et al. 2014). However, it is also a hallmark of
posttraumatic seizure activity (Parent et al. 1997, Jessberger et al. 2005, Butler et al.
2015). While the functional role of neurons born following trauma is unclear, ablating
posttraumatic neurogenesis can impair cognitive recovery (Blaiss et al. 2011). Further,
the environment of trauma alters immature neuron development. Neurons born after
trauma develop with stunted dendritic arbors (Carlson et al. 2014) and maintain this
aberrant phenotype as they mature (Villasana et al. 2015, Ibrahim et al. 2016). Trauma
alters migration of immature neurons within the granule cell layer (GCL) (Ibrahim et al.
2016) and promotes ectopic migration of new neurons to the hilus (HL) (Shapiro 2017).
A subset of posttrauma-born neurons develop into mature neurons capable of synaptic
integration with their local environment (Scharfman et al. 2003, Villasana et al. 2015).
Insulin-like Growth factor 1 (IGF1) is an endogenous growth factor that promotes
neural plasticity. In the absence of injury, cultured dorsal root ganglia neurons treated
with IGF1 had increased process growth (Jones et al. 2003). During development IGF1
stimulates neurogenesis and process outgrowth and mediates immature neuron migration
(Hurtado-Chong et al. 2009, Nieto-Estevez et al. 2016). We previously showed that IGF1
overexpression increases immature neuron differentiation and rescues immature neuron
dendritic arborization from a stunted injury-induced phenotype (Carlson et al. 2014).
Two well described pathways by which IGF1 mediates neuronal growth and survival are
the RAS/MAPK/ERK pathway and the PI3K/AKT/mTOR pathway (Kim et al. 1997,
Harrington et al. 2004, Zheng et al. 2004, Huat et al. 2014, Nieto-Estevez et al. 2016,
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Rhim et al. 2016).

In the nervous system PI3K/AKT signaling predominates in

mediating many functions of IGF1, including precursor proliferation and differentiation.
AKT activity is transiently induced by injury (Park et al. 2012) and increased
brain levels of IGF1 potentiate injury-induced AKT activity in the hippocampus
(Madathil et al. 2013). AKT is known activator of the mammalian target of rapamycin
(mTOR). A plethora of PI3K/AKT developmental plasticity events are mediated through
mTOR signaling including differentiation, migration, process growth and survival of new
neurons (Jaworski et al. 2005, Wahane et al. 2014). mTOR activity is transiently
increased at 24h to 72h after injury in mature neurons, astrocytes and microglia of the
hippocampus (Chen et al. 2007, Park et al. 2012).
It was recently found that injury also activates mTOR activity in NSCs in the
neurogenic niche of the hippocampus (Wang et al. 2016). Rapamycin, the specific
inhibitor of mTOR, decreases posttraumatic neurogenesis by preventing injury-induced
proliferation of NSCs (Butler et al. 2015, Wang et al. 2016). In addition to regulating
posttraumatic proliferation, mTOR activation can also mediate maladaptive plasticity.
Treatment with rapamycin has been shown to attenuate aberrant sprouting of mossy
fibers and seizure activity in models of posttraumatic epilepsy (Butler et al. 2015). It is
unclear whether IGF1 overexpression is mediating its effect on posttraumatic
neurogenesis through mTOR signaling.
To this end we utilized conditional IGF1 overexpressing animals to determine
whether 1) IGF1 overexpression enhanced posttraumatic mTOR activation following
moderate or severe controlled cortical impact (CCI) injury and 2) if the neurogenic
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effects of IGF1 overexpression in the injured brain are mediated through the mTOR
pathway.
Materials and Methods
Animals
We took advantage of injury-induced reactive astrocytosis to conditionally elevate
IGF1 levels after injury using a tetracycline inducible mouse model of IGF1
overexpression driven by the glial fibrillary acidic protein (GFAP) promoter. To generate
astrocyte-specific IGF1 transgenic mice with conditional overexpression, heterozygous
tTAGFAP mice were bred with heterozygous IGF1pTRE mice as previously described
(Ye et al. 1997, Madathil et al. 2013). Briefly, by crossing tTAGFAP mice with
IGF1pTRE

mice,

double

transgenic

mice

carrying

both

the

transgenes

(tTAGFAP/IGF1pTRE) were generated. In the absence of doxycycline, human IGF1
(hIGF) overexpression expression is astrocyte-specific. IGF1 double transgenic (IGFtg)
mice and their wild-type (WT) littermates were fed with doxycycline supplemented
mouse chow (200mg/kg) ad libitum until two weeks prior to surgery to block hIGF1
transcription. They received standard mouse chow for at least two weeks to allow
transgene expression prior to surgery/injury. The mice were provided with food and
water ad libitum at the University of Kentucky Medical Centre animal vivarium where
they were housed at a constant temperature (23 ± 2°C) with a 14/10-h light/dark cycle.
All procedures involving animals were approved by the University of Kentucky’s
Institutional Animal Care and Use Committee.
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Controlled Cortical Impact Injury
Both male and female littermates were randomly assigned to CCI or sham injury
groups once they reached sexual maturity (>8 weeks of age). Surgeons blinded to mouse
genotypes and treatments performed moderate or severe CCI on IGFtg (n=47) and WT
(n=42) mice. Surgeries were performed as previously described (Madathil et al. 2013).
Briefly, anaesthesia was induced using 3% isoflurane. After securing the head of the
animal in a stereotaxic frame (David Kopf Instruments, CA), anaesthesia was maintained
using 2.5% isoflurane delivered through a nose cone. A midline scalp incision was made,
and a 5-mm diameter craniotomy was performed over the left parietal cortex, lateral to
the sagittal suture (2.5mm lateral) midway between Bregma and lambda (approximately 1.9 mm). Cortical contusion was produced using a stereotaxic electromagnetic impactor
(Leica Biosystems) with a 3mm diameter rounded impactor tip, with a velocity of 3.5m/s
to produce moderate (1.0-1.1mm depth) or severe (1.5mm depth) brain injury (Figure
3.1A). IGFtg (n=5) and WT (n=7) sham-injured mice received a craniotomy under
isoflurane anaesthesia. After CCI or sham injury, a circular disk made from dental
cement was glued over the craniotomy to protect the brain surface, and the scalp was
sutured. Mice were placed on a Hova-Bator Incubator (model 1583, Randall Burkey Co.,
TX) to maintain body temperature until they regained consciousness, after which they
were returned to their home cages.
Rapamycin administration
Rapamycin (LC Laboratories, Woburn, MA) was dissolved in 100% ethanol
(30mg/ml) and stored at -20°C until use. Immediately before injection, rapamycin was
diluted (1:10) into vehicle (5% Tween80, 5% PEG400, 5% EtOH in 1x PBS). Moderately
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injured IGFtg and WT mice in a 3-day survival cohort (Figure 3.1B) and in a 10-day
survival cohort (Figure 3.1C) were randomly assigned to either vehicle or rapamycin
treatment groups for each experiment. The 3-day survival cohort received daily i.p.
injections of 10mg/kg rapamycin (n=3/genotype) or vehicle (n= 3/genotype) beginning
1h after CCI. The 10-day survival cohort mice received a daily i.p. injection of 10mg/kg
rapamycin (n=8/genotype) or vehicle (n= 6-7/genotype) beginning 4h after the last BrdU
injection.
BrdU Administration
5-Bromo-2′-deoxyuridine (BrdU) (Fisher Scientific, Hampton NH) was stored at 20°C until use. The moderate injury 10-day survival cohort of IGFtg and WT mice
received 3 intraperitoneal injection (i.p.) injections of BrdU (50 mg/kg in saline) at 4h
intervals beginning 72hr after injury (Figure 3.1C). Intraperitoneal BrdU typically
incorporates into dividing cells within 4h after injection (Taupin 2007).
Immunohistochemistry and histology
Animals were deeply anesthetised by sodium pentobarbital (FATAL-PLUS
SOLUTION V.P.L. 9373 0298-9373-68) and transcardially perfused with heparinised
saline followed by 10% buffered formalin. Brains were removed 24h after post-fixation
in 10% formalin, then cryoprotected using 30% sucrose solution, and snap frozen in cold
isopentanes (≤ -25°C). The tissue was cut in a coronal plane at 40µm thickness. Freefloating immunohistochemistry was performed as previously described on three tissue
sections (between -1.5 to -2.5mm bregma) selected at 400 µm intervals spanning the
injury epicentre (Madathil et al. 2013, Carlson et al. 2014).
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To quantify the extent of mTOR activation, sections were immunolabeled for
phosphorylated ribosomal protein S6 (pS6), a well characterized downstream effector of
mTOR (Chen et al. 2007). Antigen retrieval was performed using 10mM citric acid pH
6.0 at 60°C. Following three washes in TBS, the sections were incubated in blocking
solution (5% normal horse serum in 0.1% Triton X-100 TBS) for 1h. The tissue was then
incubated with primary antibody at 4°C overnight. Tissue was immunolabeled for the
microtubule protein doublecortin (Dcx), a commonly used immature neuron marker.
Posttrauma-born immature neurons were identified by co-immunolabeling the tissue for
Dcx and BrdU. To expose BrdU epitopes, the tissue was incubated in 2N HCl (Fisher
Scientific) at room temperature with agitation for 1h, followed by 100mM borate for 10
minutes to neutralize residual HCl. The tissue was rinsed overnight in TBS at 4ºC prior to
a 1h incubation in blocking solution. The tissue was then incubated with primary
antibody at 4°C overnight. Primary antibodies used were anti-phospho-S6 (1:100, rabbit,
Cell Signalling), anti-Dcx (rabbit monoclonal, 1:2000, Abcam) and anti-BrdU (rat).
Secondary antibodies were conjugated with Alexa-488, Cy-3 or Alexa-594 (Invitrogen,
CA). Omission of primary antibody served as a negative control.
Microscopy image analysis
All image acquisition and the subsequent analysis was completed by an
investigator blinded to the genotype and treatment status of each animal.
Positive immunoreactive area imaging and analysis
For all pS6 analyses, image acquisition software (NIS-Elements software, C2 Tie
Nikon confocal microscope) was used to identify the center of the section (tissue depth
that contained the maximum area under the curve in the histogram of voxels at each
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intensity level). Profile images were then taken at 20x magnification using an
epifluorescence microscope (C2 Tie Nikon confocal microscope) capturing the dentate
gyrus. All images had identical laser and camera setting, area/pixel (1.23µm) and pixel
intensity range (0–4095 pixel intensity per 12 bit image). Once all animal sections were
imaged, pS6 immunoreactivity was measured using semi-automated image analysis.
The area of pS6 immunoreactivity in the respective region of interest (ROI: GCL,
ML, and HL) was identified using thresholding. The binary mask labelled the soma of
positively stained cells. For each ROI, the area (mm2) of positive pixels was quantified
and normalized to the ROI area. Positive pS6 data was averaged from 3 sections per
animal from sham (IGFtg n=5 and WT n=7), moderate CCI (IGFtg n=21 and WT n=18),
and severe CCI (IGFtg n=18 and WT n=16) experimental groups.
Cell counting imaging and analysis
For all BrdU+ and BrdU+Dcx+ analyses, images were taken on a confocal
epifluorescence microscope (Nikon A1R inverted confocal microscope, Galvano scanner)
capturing the epicentre of injury in the dentate gyrus for each animal. The entire
ipsilateral DG was imaged at 100x magnification under oil and at 0.75 µm step intervals
through a 20 µm depth to ensure optical resolution to assess the densely packed
BrdU+Dcx+ cells in the GCL. To evaluate the effect of IGF1 on proliferated cells, the
number of BrdU+ and BrdU+Dcx+ cells were manually counted in the GCL, HL and
ML. Cells were determined to reside in the GCL if they were within one cell distance (010µm) of the GCL border and the soma was adjacent to other Dcx+ cells along the border
(Villasana et al. 2015). Colocalization of markers was confirmed by making 3D
reconstructions of the cells of interest to avoid false positives. The volume (mm3) of the
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respective ROI (GCL, ML, and HL) was quantified in each section. Cell counts are
expressed in density.
Cell localization
Images obtained for BrdU+Dcx+ cell counts were used to assess posttraumatic
cell localization. The distance from the hilar border of the SGZ to the center of the cell
soma was measured for BrdU+Dcx+ cells in the upper blade of the GCL. The inner GCL
(iGCL) layer is defined as the GCL area emanating 0 to 50µm from the SGZ (Ibrahim
2016). The outer GCL (oGCL) describes the location of cells residing outward, beyond
the iGCL range. Cells localized to the HL, greater than 0-10µm from the GCL border
were considered ectopic (Villasana et al. 2015). Cell counts and distances were manually
quantified.
Sholl analysis
Images obtained for BrdU+Dcx+ cell counts were used to assess dendritic
morphology. The Dcx channel immunolabeled hippocampi were acquired as a z-stack
(0.75 μm step size) at 100x magnification using a confocal microscope (Nikon A1R
inverted confocal microscope, Melville, NY) from a randomly selected subset of mice
(n=4 mice per genotype/treatment). Confocal images were obtained of 8 Dcx-positive
immature neurons randomly selected from the DG GCL within a section at the epicenter
of injury (−1.9 mm Bregma). BrdU positivity was not assessed during the random
selection of neurons. The neuron was not utilized if dendritic processes could not be
traced through the confocal z-stack images. Dendritic processes of Dcx-expressing
hippocampal granular neurons were semi-manually traced in z-stack images using Image
J Simple Neurite Tracer (NIH). The dendritic length was automatically quantified from
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trace files by Simple Neurite Tracer. The number of dendritic intersections was
quantified for each Dcx-positive neuron by a series of concentric circles (10μm intervals)
drawn from the center of the cell body using a Sholl analysis plug-in for NIH ImageJ.
Statistical Analyses
Data acquisition was performed by a blinded observer. Graphs were generated
and data was analyzed using GraphPad Prism software 5.0. Data presented as mean +
standard error of the mean (SEM). Unless otherwise noted, statistical analysis was
performed using a one-way analysis of variance (ANOVA) followed by Bonferroni
selected comparisons post-hoc tests where appropriate. Sholl analysis and cell
localization quantified in relationship to distance from the cell soma were analyzed by
two-way ANOVA followed by Bonferroni post-hoc tests where appropriate. For all
comparisons p<0.05 was considered statistically significant.
Results
IGF1 overexpression potentiates injury-induced mTOR activation in predominantly
neuronal sub-regions of DG
To determine if posttraumatic overexpression of IGF1 potentiates injury-induced
mTOR activation in the hippocampal DG following injury, we quantified the expression
of pS6, a well characterized downstream target of mTOR. The DG of WT (Figure 3.2AC) and IGFtg (Figure3.2D-F) brain-injured mice and their sham controls were
immunostained for pS6 24h and 72h after moderate (1.0mm) injury. Although pS6
immunoreactivity in WT mice was modestly elevated in the GCL, ML, and HL at 24h
after injury, areas within these sub-regions were not significantly different than sham
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controls (Figure 3.2G, I, K). At 72h after injury pS6 expression in the DG of injured WT
mice was indistinguishable from WT controls (Figure 3.2H, J, L). Injury significantly
increased pS6 in the GCL and HL of IGF1 overexpressing mice at 24h after injury in
moderately injured mice compared to sham controls (Figure 3.2G, K). The area of pS6 in
the GCL of IGFtg mice was also significantly higher than injured WT mice at 24h. Like
injured WT mice, pS6 immunoreactivity in the ML of IGFtg mice was not significantly
different than sham controls 24h after moderate injury (Figure 3.2I). In IGF1
overexpressing mice, mTOR activity remained elevated in predominantly neuronal
regions of the DG at 72h after moderate injury. Both the GCL and HL of IGFtg mice had
significantly more pS6 than injured WT and sham controls at 72h after moderate injury
(Figure 3.2H, I).
We also examined pS6 immunoreactivity in the DG of WT (Figure 3.3A-C) and
IGFtg (Figure 3.3D-F) mice at 24h and 72h after severe injury (1.5mm). Following
severe CCI, pS6 immunoreactivity in the GCL of WT mice was indistinguishable from
sham controls at 24h and 72h after injury (Figure 3.3G, H). In contrast, severe injury
stimulated a robust increase in pS6 expression in the ML of WT mice at 24h and 72h
after injury (Figure 3.3I, J) and a transient increase in the HL (Figure 3.3K) compared to
sham controls. pS6 in the ML, a predominantly non-neuronal layer, co-labeled with the
glial marker for astrocytes (Figure 3.4A). As with moderate injury, IGF1 overexpression
resulted in significantly increased pS6 signal in the GCL following severe injury. At 24h
after severe injury, pS6 immunoreactivity in IGFtg mice was significantly elevated
compared to shams controls only in the GCL (Figure 3.3G), whereas at 72h pS6 was
significantly increased in the GCL, ML and HL compared to sham controls (Figure 3.3H,
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J, L). In the predominantly neuronal regions of the DG (GCL and HL), pS6
immunoreactivity was also significantly higher than injured WT mice (Figure 3.3H, L).
Taken together, injury-induced mTOR signaling in the DG is sensitive to injury
severity. pS6 immunoreactivity is increased at 24h following moderate injury and 72h
following severe injury in IGFtg mice. By 10d after injury pS6 expression in the DG of
WT and IGFtg mice is indistinguishable from sham controls (data not shown).
Interestingly, regardless of severity, injury strongly induces mTOR activation in the GCL
of IGF1 overexpressing mice. IGF1 is such a potent activator of mTOR that 72h after
moderate injury, even the contralateral GCL and HL displayed increased mTOR activity
in IGF1 overexpressing mice compared to injured WT mice and shams (Figure 3.5).
Based on these initial findings that 1) IGF1 overexpression sufficiently potentiated
mTOR activation after moderate CCI and 2) moderate injury produced selective effects
on neuronal regions of the DG of IGFtg mice, the remaining cohorts (Figure 3.1B, C)
received moderate injury.
Potentiation of mTOR activation by IGF1 overexpression does not enhance early
posttraumatic proliferation
To first validate that the selected and well characterized dose of rapamycin
(10mg/kg) (Butler et al. 2015, Butler et al. 2016) was sufficient to inhibit mTOR activity,
injured WT and IGFtg mice were treated with daily injections of rapamycin or its vehicle
for 3d beginning 1h after CCI (Figure 3.1B). At 72h after moderate injury, S6 activity
was effectively silenced in both rapamycin treated WT and IGFtg mice compared to
vehicle treated mice (Figure 3.6). This dose was used then to examine the effect of
mTOR inhibition on posttraumatic neurogenesis following IGF1 overexpression.
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Three days after moderate injury, at the peak of trauma-induced proliferation
(Rola et al. 2006), dividing cells in WT (n= 15) and IGFtg (n=14) mice were labeled with
BrdU (Figure 3.7A-D). To prevent rapamycin-induced inhibition of posttraumatic NSC
proliferation (Paliouras et al. 2012, Butler et al. 2015, Wang et al. 2016), we delayed
rapamycin treatment until the labeling of cells proliferated 3dpi had been completed.
Although IGF1 overexpression potentiates mTOR activation in the DG within the first 3
days after TBI, both vehicle treated WT (n=7) and IGFtg (n=6) mice had similar densities
of proliferated cells in the DG at 10dpi (Figure 3.7E). Similarly, rapamycin did not alter
the density of proliferated cells that survived to 10 days in the DG of WT (n=8) and
IGFtg (n=8) mice. All four injury groups had similar BrdU+ cell densities throughout the
DG (Figure 3.7E) and between DG sub-regions (GCL, ML and HL) (Data not shown).
Injured WT mice irrespective of treatment tended to have a higher proportion proliferated
DG cells residing in the ML compared to injured IGFtg (1-way ANOVA, p=0.09). Taken
together, IGF1 overexpression did not promote increased acute proliferation and the
survival of these proliferated cells was not altered by delayed rapamycin treatment. We
next examined the role of mTOR signaling in posttraumatic neural differentiation,
migration, and growth in these mice.
Rapamycin administration increases posttraumatic neural differentiation in IGF1
overexpressing mice.
The pathway by which IGF1 stimulates neuronal differentiation in the context of
injury is unknown. To determine whether mTOR signaling is important for cell fate
determination in posttrauma proliferated progenitors following IGF1 overexpression, we
quantified the numbers of pretreatment-proliferated (BrdU+) cells that expressed
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immature neuron marker (Dcx+) at 10dpi in WT and IGFtg mice following vehicle or
rapamycin administration (Figure 3.8A-D). The density of posttrauma proliferated
immature neurons in injured WT mice was not altered by rapamycin treatment (Figure
3.8E). IGF1 overexpression did not induce a significant increase in the density of 3dpi
proliferated immature neurons (15 ± 1.2 1000/mm3) when compared to WT mice (8 ±
1.3 1000/mm3) following vehicle treatment. However, following rapamycin treatment the
density of 3dpi proliferated immature neurons in IGFtg mice (27 ± 3.8 1000/mm3) was
2.5 fold higher than in WT mice (11 ± 2.6 1000/mm3) and nearly 2-fold higher that
vehicle-treated IGFtg mice. Rapamycin treatment increased the proportion of BrdU+
cells that commit to a neuronal fate in IGF1 overexpressing mice (78 ± 6%) compared to
WT mice (42 ± 8 %) (Figure 3.8F). The proportion of proliferated cells that had
differentiated into immature neurons by 10dpi was similar for both groups of vehicletreated mice and for WT mice treated with rapamycin. Taken together, rapamycin
treatment increased neuronal differentiation in IGF1 overexpressing mice.
Rapamycin treatment does not alter posttraumatic positioning of immature neurons
Injury stimulates migration of SGZ generated immature neurons radially, deeper
into the GCL (Villasana et al. 2015, Ibrahim et al. 2016), and ectopically, aberrantly into
the hilus (Shapiro 2017). The signaling governing this process is not well understood.
Endogenous signaling of both IGF1 and mTOR has been implicated in the regulation of
adult-born neurons in the uninjured brain (Garza-Lombo et al. 2016, Nieto-Estevez et al.
2016). At 10dpi the positioning of posttrauma proliferated immature neurons (BrdU+
Dcx+) within the DG of WT and IGFtg mice following mTOR inhibition was examined.
The majority of 7-day old neurons in the GCL of both WT and IGFtg mice migrated
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within 30µm of the SGZ and localized to iGCL irrespective of treatment group (Figure
3.9B). Similar numbers of posttrauma-born immature neurons localized to the iGCL in
vehicle-treated WT and IGFtg mice, as well as in rapamycin-treated WT mice (Figure
3.9B). Reflective of the dramatic increase in posttraumatic neural differentiation, the
number of 7-day old neurons localized to the iGCL in rapamycin-treated IGF1
overexpressing mice was significantly increased compared to all other groups (Figure
3.9B). Similar numbers and proportion of 7-day old immature neurons migrated deep
within the GCL and localized to the oGCL in all injury groups (Figure 3.9C). The
population of oGCL-positioned, posttrauma-born immature neurons at 10dpi was not
altered by IGF1 overexpression or inhibition of mTOR activation.
To investigate the effect of mTOR activation on injury-induced ectopic migration,
the number of 7-day old BrdU+Dcx+ neurons in the HL was quantified. A small number
of posttrauma-born neurons localized to the HL in all injury groups (Figure 3.9A). IGF1
overexpressing mice had an increased density of ectopically localized 7-day old neurons
(2.4 ± 0.95 1000/mm3) compared WT mice (0.22 ± 0.15 1000/mm3) following vehicle
treatment (Figure 3.9D). Rapamycin treatment had no significant effect on injury-induced
ectopic localization of 3dpi proliferated neurons in WT (0.62 ± 0.25 1000/mm3) or IGFtg
(2.3 ± 0.33 1000/mm3) mice at 10dpi (Figure 3.9D). While IGFtg mice had an increased
density of ectopically localized 3dpi proliferated neurons compared to WT mice, ectopic
neurons represented a similar proportion of the total number of 3dpi proliferated neurons
in the DG for all four groups at 10dpi (Figure 3.9E). Although rapamycin increased the
proportion of proliferated cells that became neurons in IGF1 overexpressing animals, it
did not alter the proportion of proliferated neurons that localized ectopically.
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IGF1 overexpression confers resistance to rapamycin sensitive posttraumatic arbor
development in immature neurons
To determine if IGF1 overexpression stimulates dendritic outgrowth in an mTOR
dependent manner following injury, we used Sholl analysis to measure length and
complexity of dendritic arbors of immature neurons 10dpi in rapamycin and vehicle
treated WT and IGFtg mice (Figure 3.10A-D). Consistent with our previous study
(Carlson et al. 2014), we found that in vehicle treated mice IGF1 overexpression
increased dendritic length of immature neurons compared to WT mice at 10dpi (Figure
3.10E). mTOR inhibition did not significantly alter immature neuron arbor length in
either WT or IGFtg mice compared to their respective vehicles groups (Figure 3.10E).
Since neither genotype’s arbor length was altered by rapamycin treatment, rapamycintreated IGFtg mice still had significantly longer dendrites than the rapamycin-treated WT
mice.
We also averaged the sum of concentric ring intersections per immature neuron
for each group to elucidate the effect of mTOR inhibition and IGF1 overexpression on
dendritic complexity. In vehicle-treated cohorts, IGF1 overexpression did not
significantly increase the total number of arbor crossings of immature neurons compared
to WT (Figure 3.10F). mTOR inhibition dramatically diminished arbor complexity in WT
mice. Rapamycin reduced total dendritic shell intersections 1.5-fold in WT mice
compared to their vehicle-treated controls (5.6 ± 0.5 vs 8.9 ± 0.6 intersections; Figure
3.10F). Immature neurons in IGF1 overexpressing mice were resistant to rapamycin
induced impairment of arbor complexity. Total dendritic shell intersections following
injury for vehicle (11.4 ≤ 0.9 intersections) and rapamycin (11.5 ≤ 0.6 intersections)
77

treated IGFtg mice were similar (Figure 3.10F). The total arbor crossings of immature
neurons in the two rapamycin-treated groups were significantly different from each other,
and the reduction in WT arbor complexity made the IGF1 enhancement of arbors even
more pronounced (Figure 3.10F).
To understand the relationship between dendritic length and complexity, we
analyzed the intersections per shell in relation to the dendritic distance from the soma
(two-way ANOVA; significant interaction, F (51, 2052) = 4.18, p= 0.0001). With
vehicle-treated groups, IGF1 overexpression significantly increased immature neuron
dendritic complexity at 60-80µm from soma compared to WT mice (Figure 3.10G).
mTOR inhibition caused a dramatic downward-shift in dendritic complexity at 50µm
from the cell in WT mice compared to vehicle treatment (Figure 3.10G). IGF1
overexpressing mice were completely protected from rapamycin-induced reduction of
dendritic complexity. At no distance was complexity different between vehicle- and
rapamycin-treated IGFtg cohorts. In the presence of rapamycin, IGFtg arbor complexity
was significantly higher than WT at 40-90µm from soma (Figure 3.10G). IGF1
overexpression relieves posttraumatic dendritic development in immature neurons from
mTOR activity dependence.
Discussion
Summary of findings
The key findings of this study determine if IGF1 overexpression modulates
posttraumatic neurogenesis through mTOR activation. We first investigated the subregional changes in DG mTOR activity and found that while trauma preferentially
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induced mTOR activation in the ML layer, IGF1 selectively potentiated acute traumainduced mTOR activity in the GCL and HL. Next, we found that potentiation of mTOR
activation by IGF1 overexpression did not enhance proliferation and that mTOR
activation is not required for survival of posttrauma proliferated cells. mTOR activation
is not required for posttraumatic neuronal differentiation of NSCs, but its inhibition
potentiates IGF1-induced neuronal differentiation. Finally, we found that mTOR
activation is required for posttraumatic dendritic arborization. However, the IGF1
overexpression enhances dendritic arborization and prevents rapamycin-induced
reduction of dendritic complexity following trauma.
mTOR activation
IGF1 overexpression potentiated injury-induced mTOR activation in the
predominantly neuronal regions of the DG. We show that severe injury significantly
increases mTOR activation in the ML at 24h and 72h after injury. This is consistent with
hippocampal homogenate studies that show that AKT/mTOR/S6K activity is increased
between 24h to 72h after injury (Jenkins et al. 2002, Chen et al. 2007, Park et al. 2012).
Similar to previous studies, we found that mTOR is predominantly activated in glia of
WT mice following injury (Park et al. 2012, Zhu et al. 2014). While the IGF1 receptor is
expressed on glia and essentially all neural cell types, neurons and NSCs have very high
expression of IGF1 receptor (Ocrant et al. 1988). We found that IGF1 potentiates injuryinduced mTOR activation at 24h and 72h after injury in the GCL and HL. IGF1 can
signal through the MAPK/ERK pathway, but predominantly signals through the
IRS1/PI3K/AKT pathway (Nieto-Estevez et al. 2016) in the CNS. Both the mTOR
pathway and the ERK pathway can stimulate aspects of neurogenesis. Injury itself
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upregulates IGF1 receptor signaling, as well as AKT/mTOR and MAPK/ERK signaling
in the hippocampus (Mori et al. 2002, Chen et al. 2007, Madathil et al. 2010, Rubovitch
et al. 2010). We previously showed that IGF1 overexpression potentiates injury-induced
AKT activation in the hippocampal homogenates (Madathil et al. 2013). This expands
our previous understanding of IGF1 overexpression signaling in the context of injury and
reveals preferential IGF1 signaling in predominantly neuronal regions.
Proliferation and early survival
IGF1 overexpression does not enhance early (3d) posttraumatic cell proliferation
and inhibiting mTOR does not alter their survival. IGF1 overexpressing and WT mice
had a similar densities of 3dpi proliferated cells in the DG and similar densities
distributed in the GCL, ML, and HL DG sub-regions cells at 10dpi.

Brain injury

stimulates proliferation throughout all layers of the DG that peaks 3dpi (Dash et al. 2001,
Rola et al. 2006, Gao et al. 2008). Consistent with our previous study, IGF1
overexpression does not potentiate the density of newly divided cells generated by injuryinduced proliferation (Carlson et al. 2014).
When quantifying the magnitude of proliferation using BrdU labeling, both cell
division and programmed cell death must be taken into consideration. Particular attention
is given to the SGZ, a proliferative sub-region of the DG that can generate GCL neurons
throughout adulthood. In the uninjured adult brain, Bax-mediated apoptosis plays an
important role in eliminating proliferated progenitors in the SGZ, as 29% die within 10d
after division (Dayer et al. 2003, Sun et al. 2004). Additionally, expression of proapoptotic mediators of programmed cell death is upregulated during the first 14d after
injury (Schober et al. 2010). During CNS development and in NSC cultures IGF1 can
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increase the density of proliferated neural progenitors through several PI3K dependent
mechanisms including regulation of cell division and cell death (Otaegi et al. 2006, Han
et al. 2008, Ye et al. 2010, O'Kusky et al. 2012, Zhu et al. 2012, Huat et al. 2014, Wahane
et al. 2014). Whether or not IGF1 increases the population of proliferated progenitors and
by what mechanism is regulated in part by the neurogenic environment and
developmental stage (Cao et al. 2003, Joseph D'Ercole et al. 2008, Liu et al. 2009,
Mairet-Coello et al. 2009, Wahane et al. 2014). In the postnatal brain, IGF1
predominantly promotes survival by upregulating expression of anti-apoptotic genes like
BCL-2, which suppresses programmed cell death (Baker et al. 1999, Cao et al. 2003, Kim
et al. 2006). Taken together, IGF1 is not enhancing the density of proliferated cells
directly or indirectly in the context of trauma. It is possible that IGF1 signaling does not
synergistically increase proliferation following injury due to ceiling effect caused by
decreased NSC availability. The dramatic spike in NSC division caused by trauma
reduces the pool of NSC available for future proliferation (Neuberger et al. 2017). Our
study suggests that IGF1 does not potentiate injury-induced cell division, which is
consistent with our previous report (Carlson et al. 2004).
Rapamycin does not modulate early survival of proliferated cells in the DG. At
10dpi vehicle-treated and rapamycin-treated mice had similar densities cells which
proliferated at 3dpi, prior to rapamycin onset. Rapamycin was recently shown to reduce
numbers of degenerating neurons in the DG following TBI (Gao et al. 2008, Nikolaeva et
al. 2016). Our study suggests that posttrauma-born cells are not a population of DG cells
that are protected following rapamycin treatment.
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Differentiation
IGF1 signaling has a well-defined role in stimulating NSC neuronal
differentiation (Otaegi et al. 2006). Further, insulin-induced neuronal differentiation of
cultured rat NSCs was diminished by mTOR inhibition (Han et al. 2008). Our previous
study showed that IGF1 overexpression robustly stimulates injury-induced neuronal
differentiation in NSCs following severe TBI (Carlson et al. 2014). We hypothesized that
IGF1 overexpression would stimulate neuronal differentiation through mTOR activation.
However, in our current study, we found that IGF1 overexpression did not significantly
enhance neuronal differentiation in vehicle-treated mice following moderate injury. The
degree of neurogenesis induced was likely abrogated due to severity; the extent of injury
induced neurogenesis has been shown to be injury severity dependent (Wang et al. 2016).
Nonetheless, we found that mTOR activity is not required for neuronal
differentiation of proliferated NSCs after injury. This is the first study to investigate the
role of posttraumatic mTOR activation in NSC neuronal differentiation in the context of
injury. When mTOR activation is genetically inhibited by knocking out its activator Rheb
or inhibited by rapamycin in the uninjured brain, neuronal differentiation of NSCs is
inhibited (Hartman et al. 2013, Wahane et al. 2014, Garza-Lombo et al. 2016). However,
the function of mTOR signaling is sensitive to cell context, available resources, and
cellular stress (Gunn et al. 2008, Laplante et al. 2009, Hung et al. 2012). We found that
mTOR inhibition by rapamycin does not inhibit neuronal differentiation in the context of
injury.
Interestingly, inhibiting mTOR activation following posttraumatic overexpression
IGF1 increased NSC neuronal differentiation after injury compared to vehicle-treated
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IGFtg and rapamycin-treated WT mice. A plausible explanation is that mTOR negatively
feeds-back on IGF1 receptor signaling. Studies have shown that mTORC1 signaling
provides negative feedback on IGF1/Insulin signaling by inhibitory phosphorylation of
Insulin receptor substrate-1 (IRS-1) (Carlson et al. 2004, Harrington et al. 2004, Um et al.
2004).

There is evidence that mTOR inhibition can stimulate hypersensitivity to

IGF1/insulin signaling by blocking inhibitory feedback of mTOR on IGF1/Insulin
signaling, resulting in increased activation of IRS1/PI3K/AKT signaling (Veilleux et al.
2010). Alternatively, hypersensitivity to IGF1 can potentially redirect signaling through
the alternative MAPK pathway. Studies have shown that rapamycin treatment induces
both AKT activation and ERK activation (Carracedo et al. 2008, Rastogi et al. 2013). Our
study provides evidence that IGF1 overexpression can enhance neuronal differentiation in
the presence of mTOR inhibition.
Migration
We found that neither IGF1 overexpression nor mTOR inhibition altered outward
migration of posttrauma-born immature neurons into the oGCL or ectopic migration into
the HL. Injury increases localization of posttrauma-born neurons to the oGCL, where
more mature neurons reside (Villasana et al. 2015, Ibrahim et al. 2016). Consistent with
these studies, we found that a small number of immature neurons localized to the outer
2/3 layer of the GCL in all injured animals. We found no increase in the proportion of 7day old immature neurons that migrated into the oGCL related to treatment or genotype.
This was surprising, considering that both IGF1 signaling and mTOR activation can
modulate immature neuron migration in an uninjured brain. When the IGF1 receptor is
knocked-out during development, SVZ immature neurons fail to migrate to the olfactory
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bulb and prematurely accumulate en route (Hurtado-Chong et al. 2009). Conversely,
hyperactivation of AKT or mTOR can accelerate newborn neuron dendritic development,
integration, and radial migration into the oGCL (Duan et al. 2007, Kim et al. 2009). Both
AKT and mTOR increase the proportion of immature neurons that localize to the oGCL
in the naïve adult brain, and rapamycin abolishes these effects (Duan et al. 2007, Kim et
al. 2009, Zhou et al. 2013). It is likely that the lack of effect of IGF1 overexpression or
mTOR inhibition in our study is attributed to the immaturity (7-days old) of the
posttrauma proliferated neurons. Duan and colleagues directly hyperactivate mTOR in
newborn neurons of the GCL by silencing Disrupted-In-Schizophrenia 1 protein (Disc1),
an upstream inhibitor of mTOR (Duan et al. 2007). Compared to controls, when neurons
are only 7-days old there is no increase in the proportion that localized to the oGCL
(Duan et al. 2007). However, by 2 weeks of age nearly 50% of immature neurons are
localized to the oGCL (Duan et al. 2007). We have shown that 6 weeks after
proliferation, the proportion of posttrauma-born neurons localized to the oGCL is
increased in injured IGF1tg mice compared to controls (Figure 2.6).
Posttraumatic ectopic migration is not dependent on mTOR activation. At 10dpi,
7-day old posttrauma-born neurons were ectopically localized to the HL in all injured
groups. Neither IGF1 overexpression nor mTOR inhibition altered the distribution of 7day old posttrauma-born neurons that ectopically localized to the HL after injury.
Compared to WT mice, both IGF1 overexpressing treatment groups had a higher density
of 3dpi proliferated neurons in the DG, and both had a significantly higher density of
these 7-day old neurons localized to the HL. The increase in ectopically localized
immature neurons is consistent with a recent moderate injury study. In the fluid
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percussion model of TBI, the density of immature neurons of heterogenous age (1 to 3
weeks old) that ectopically localized to the HL at 7dpi were increased compared to sham
controls (Shapiro 2017). The function of these ectopic immature neurons remains
unclear, and many of them will not survive to maturity. Adult-born, immature neurons
position within 1-2 weeks of their birth (Kuhn et al. 1996, Kempermann et al. 2003,
Myers et al. 2013). The majority of ectopically placed immature neurons undergo
programmed cell death within this time frame (Sun et al. 2004, Buss et al. 2006, Kim et
al. 2007, Ryu et al. 2016). A subset of ectopically localized neurons survive to maturity
following injury (Figure 2.6).
It was surprising that mTOR inhibition did not alter ectopic migration of 3dpi
proliferated neurons. When the function of mTOR suppressor TSC1 is lost, mTOR
activation increases and ectopic migration of adult-born neurons increase (Meikle et al.
2007). Both, mTOR and ectopic neuron localization have been associated with seizure
development (Parent et al. 1997, Butler et al. 2015). Rapamycin inhibition of
posttraumatic seizure development may not be associated with HL ectopic localization
(Guo et al. 2013, Butler et al. 2015). Our study provides evidence that injury does not
mediate ectopic localization of immature neurons via the mTOR pathway. The density of
posttrauma-born neurons localized to the HL was not altered by rapamycin treatment in
either genotype.
Dendritic arbor development
We found that mTOR activity is required for posttraumatic arbor development of
immature neurons. The dendritic arbor complexity of immature neurons in rapamycintreated WT animals was severely stunted compared to that of vehicle-treated WT mice.
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Dendritic arbors of immature neurons in the DG are shorter and less complex following
severe injury (Carlson et al. 2014, Ibrahim et al. 2016). Many studies examining adult
neurogenesis in uninjured animals have shown that mTOR activity regulates dendritic
arborization of developing neurons (Jaworski et al. 2005, Tavazoie et al. 2005, Kim et al.
2009, Feliciano et al. 2012). This is the first study to show that posttraumatic dendritic
arborization is dependent on mTOR activation.
We show that IGF1 overexpression increases dendritic length and complexity of
immature neurons after injury. This is consistent with a previous study that showed that
IGF1 overexpression enhanced dendritic length and arbor complexity of immature
neurons, restoring them to uninjured levels (Carlson et al. 2014). Interestingly, IGF1
overexpression did not mediate enhancement of immature neuron dendritic arborization
through mTOR activation. It was surprising the mTOR inhibition did not alter IGF1induced arbor enhancement. PI3K activation, a major signaling molecule downstream of
IGF1 receptor stimulation, was shown to increase arbor development in neuronal cell
cultures in an mTOR-dependent fashion (Jaworski et al. 2005). Similarly, increased
activity of AKT, which signals downstream of PI3K, increases dendritic arbor length and
complexity in an mTOR dependent manner (Kim et al. 2009). Trauma upregulates mTOR
activation in the hippocampus and in DG neural progenitors (Chen et al. 2007, Wang et
al. 2016). Although PI3K/AKT signaling predominates in mediating IGF1 signaling in
the CNS, the other major arm of IGF1 signaling pathway is still viable. However, very
little data exists about the role of RAS/MAPK/ERK in posttraumatic neurogenesis. Both
AKT/mTOR and MAPK/ERK can mediate dendritic growth. In neuronal cultures it was
shown that MAPK/ERK inhibitors could block exogenous IGF1 induced dendritic arbor
86

length and complexity (Kim et al. 1997). IGF1 overexpression is likely mediating
posttraumatic dendritic enhancement through an alternative pathway. We show here for
the first time that posttraumatic IGF1 overexpression mediates outgrowth independent of
mTOR activation. The function of enhanced dendritic development may underlie the
ability of IGF1 to improve posttraumatic cognitive recovery in DG dependent
assessments (Saatman et al. 1997, Madathil et al. 2013). IGF1 can expand the dendritic
field, possibly enhancing integration of adult-born neurons. Our study provides evidence
that IGF1 can be used in combination with posttraumatic treatments like rapamycin, and
prevent seizure development and simultaneously support proper arbor development.
Considerations
Our study provides evidence that enhancement of posttraumatic neurogenesis by
IGF1 is independent of mTOR activation. This has far reaching implications. In
chemically induced seizure models and trauma induced seizure models, immature neuron
numbers increase. However, whether increased neurogenesis participates in the etiology
of seizure development or is a byproduct of seizure activity remains controversial.
However, there is consensus that treatment with rapamycin reduces seizure development.
Rapamycin inhibits neurogenesis, prevents aberrant sprouting of recurrent mossy fibers,
and reduces seizure behavior (Buckmaster et al. 2011, Butler et al. 2015, Butler et al.
2016, Butler et al. 2017). This study suggests that IGF1 treatment could be administered
with rapamycin as a preclinical therapeutic. This work significantly enhances the body of
knowledge regarding the role of mTOR activation and IGF1 in posttraumatic
neurogenesis.
.
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Figure 3.1: Experimental design.
(A) To assess posttraumatic mTOR activity, cohorts of mice were sacrificed 24h
or 72h after moderate or severe controlled cortical impact (CCI) injury. Sham mice were
sacrificed 72h after receiving a craniotomy. (B) A second cohort of moderately injured
mice were treated daily with 10mg/kg rapamycin (Rapa) or vehicle (Veh) beginning 1hr
after injury for 3 days to validate effective mTOR inhibition by rapamycin. (C) A third
cohort of mice were treated daily with 10mg/kg rapamycin or vehicle beginning 3d after
injury and continuing until euthanasia at 10d after injury to examine the contribution of
mTOR signaling on posttraumatic neurogenesis. These mice received three injections of
BrdU (50mg/kg) 4hrs apart beginning on day 3 post-CCI. Dpi, days post-injury.
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Figure 3.2: IGF1 selectively potentiates injury-induced mTOR activity in the
dentate gyrus GCL and HL after moderate injury.
Representative microphotographs from confocal imaging of immunoreactivity of
phospho-S6 Ribosomal Protein (pS6, white), a well characterized marker of mTOR
activity, in wildtype (WT; A-C) and insulin-like growth factor 1 transgenic (IGFtg; D-F)
mice following (A,D) sham injury and (B,E) 24h and (C,F) 72h after moderate controlled
cortical impact (CCI) injury. In the granule cell layer (GCL), IGFtg mice exhibit a
significantly greater area of pS6 staining at (G) 24h and (H) 72h after CCI when
compared to sham IGFtg mice or injured WT mice. In the molecular layer (ML), neither
moderate CCI or IGF1 overexpression altered pS6 levels at (I) 24h or (J) 72h post-injury.
In the hilus (HL), the area of pS6 labeling was significantly elevated in injured IGFtg
mice at (K) 24h and (L) 72h. Data are presented as mean + SEM. ; One-way ANOVA,
followed by Bonferroni's selected comparisons post-hoc, *p<0.05; **p<0.01; and
***p<0.001 CCI vs Sham. #p<0.05 and ##p<0.01 injured IGFtg vs. injured WT. Scale
bar is 100µm. DAPI is purple
.
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Figure 3.3: IGF1 selectively potentiates injury-induced mTOR activity in the
dentate gyrus GCL and HL after severe injury.
Representative microphotographs from confocal imaging of immunoreactivity of
phospho-S6 Ribosomal Protein (pS6, white) in wildtype (WT; A-C) and insulin-like
growth factor 1 transgenic (IGFtg; D-F) mice following sham (A,D) injury and (B,E) 24h
and (C,F) 72h after severe controlled cortical impact (CCI) injury. In the granule cell
layer (GCL), IGFtg mice exhibit a significantly greater area of pS6 staining compared to
IGFtg sham mice at (G) 24h and (H) 72h after CCI. At 72h after CCI, pS6 levels in the
GCL of IGFtg mice are also increased when compared to injured WT mice. In the
molecular layer (ML), severe CCI increased pS6 levels at (I) 24h post-injury in injured
WT mice, but not injured IGFtg mice compared to their sham controls. (J) Severe injury
increased the levels of pS6 staining in the ML of injured WT and injured IGFtg mice
compared to their sham controls. In the hilus (HL), severe CCI increased the area of pS6
labeling at (K) 24h after CCI in injured WT mice, but not injured IGFtg mice compared
to their sham controls. IGFtg mice exhibit a significantly greater area of pS6 staining at
(I) 72h after CCI when compared to sham IGFtg mice or injured WT mice. Data are
presented as mean + SEM. One-way ANOVA, followed by Bonferroni's selected
comparisons post-hoc, *p<0.05; **p<0.01; and ***p<0.001 CCI vs. Sham. #p<0.05,
##p<0.01 and ###p<0.001 injured IGFtg vs. injured WT. Scale bar is 100µm. DAPI is
purple.
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Figure 3.4: Following injury pS6 is activated in astrocytes and progenitors in the
DG.
(A) Confocal imaging of astrocyte immunoreactivity for phospho-S6 Ribosomal
Protein (pS6, green) and Glial Fibrillary Acidic Protein (GFAP, magenta) in the
molecular layer (ML) 72h after severe injury. Dapi is blue (B) Microphotographs depict
immunolabeling of pS6 positive cells in the granule cell layer (GCL) and its subgranular
zone that are also immunoreactive for the cell division marker Ki67 (red) and the
progenitor marker Nestin (red). Arrows are white.
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Figure 3.5: Moderate injury is sufficient to isolate IGF1 overexpression induced
mTOR activation in neuronal layers of contralateral hemisphere.
Photomicrographs of phospho-S6 Ribosomal Protein (pS6, white)
immunoreactivity in the contralateral dentate gyrus (DG) of injured WT (left panels) and
injured insulin-like growth factor 1 transgenic (IGFtg; right panels) mice 72h after
moderate injury (3 representative animals per group). Posttraumatic upregulation of
mTOR activity 72hr after moderate injury, is observed contralateral to injury in the (A)
granule cell layer (GCL) and (C) hilus (HL) of injured IGFtg mice compared to IGFtg
shams. Moderate injury does not induce mTOR activation in the (B) molecular layer
(ML) of the DG contralateral to injury. Data are presented as mean + SEM. One-way
ANOVA, followed by Bonferroni's selected comparisons post-hoc, **p<0.01; and
***p<0.001 CCI vs. Sham. ###p<0.001 injured IGFtg vs. injured WT. DAPI is purple.
Scale bar is 100µm.
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Figure 3.6: Daily administration of rapamycin inhibits posttraumatic mTOR
activation 72hr following injury.
Representative images of phospho-S6 Ribosomal Protein (pS6, white)
immunoreactivity in the ipsilateral dentate gyrus following daily i.p. injections of (A)
vehicle (veh) and (B) 10mg/kg rapamycin (Rapa) for 3 days after moderate injury (3d
post-injury survival). Scale bar is 50µm.
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Figure 3.7: The density of proliferated cells in the DG is not altered by IGF1
overexpression or rapamycin treatment at 10 days after injury.
Mice received 3 intraperitoneal injections of bromodeoxyuridine (BrdU) at the
peak of trauma-induced proliferation (3 days post-injury) at 4h intervals, ending 4h
before the onset of vehicle or 10mg/kg rapamycin administration. Representative images
of BrdU (yellow) immunoreactivity in the dentate gyrus (DG) of vehicle-treated (A)
Wildtype (WT) and (B) IGF1 transgenic (IGFtg) and 10mg/kg rapamycin-treated (C) WT
and (D) IGFtg at 10 days after moderate injury. (E) Injured WT and IGFtg mice had
similar densities of proliferated cells in the granule cell layer (GCL), molecular layer
(ML) and hilar layer (HL) irrespective of treatment. Data presented as mean + SEM.;
One-way ANOVA, p = not significant. Scale bar is 100µm. DAPI is white. Rapa,
rapamycin. Veh, vehicle.
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Figure 3.8: Rapamycin administration increases posttraumatic neuronal
differentiation in IGF1 overexpressing mice.
Representative images of co-immunoreactivity of doublecortin (Dcx, green), a
marker for immature neurons, and the proliferation marker BrdU (red) in the granule cell
layer (GCL) of (A,B) vehicle treated and (C,D) rapamycin treated wildtype (WT; A, C)
and IGF1 transgenic (IGFtg; B, D) mice 10d after injury. Rapamycin treatment (E)
increased the density of BrdU+Dcx+ neurons as well as (F) the proportion of progenitors
that differentiated into neurons in IGFtg mice compared to vehicle treatment and
compared to rapamycin treatment in WT mice following moderate injury. Data are
presented as mean + SEM. One-way ANOVA, followed by Bonferroni's selected
comparisons post-hoc t-tests, &p<0.05 IGFtg vehicle vs. IGFtg rapamycin. ###p<0.001
rapamycin WT vs. rapamycin IGFtg. Figure A-D, scale bar is 100µm. Rapa, rapamycin.
Veh, vehicle.
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Figure 3.9: Rapamycin does not influence radial migration within the GCL or
ectopic hilar migration or following IGF1 overexpression.
(A) Confocal imaging of doublecortin (Dcx, green) with proliferation reporter,
bromodeoxyuridine (BrdU, red) in examples of immature neurons localized to the inner
granule cell layer (iGCL), the outer 2/3rd region of the granule cell layer (oGCL) and the
hilus (HL, white arrow) at 10 days after moderate injury. (B) Quantification of numbers
of 3 days post-injury (dpi) proliferated immature neurons as a function of their distance
from the subgranular zone (SGZ) as they localize radially toward the oGCL by 10dpi.
Rapamycin treated IGFtg mice have significantly more proliferated immature neurons
localized to the iGCL compared to vehicle treated controls and rapamycin treated WT
mice. (C) However, the proportion of proliferated GCL immature neurons localized to the
iGCL or oGCL is consistent across all groups. Rapamycin did not alter outward
migration. (D) The density of proliferated immature neurons ectopically localized to the
HL is significantly higher in rapamycin-treated IGFtg mice compared to rapamycintreated WT mice. (E) However, rapamycin does not increase ectopic migration to the HL
in IGFtg mice compared WT mice. Data presented as mean + SEM. (B) Two-way
ANOVA with Bonferroni post-hoc, &&p<0.01 and &&&p<0.001 IGFtg vehicle vs.
IGFtg rapamycin. ##p<0.01 and ###p<0.001 rapamycin, WT vs. IGFtg. (C,D,E) Oneway ANOVA, followed by Bonferroni's selected comparisons post-hoc t-tests, !p<0.05
vehicle, WT vs. IGFtg. #p<0.05 rapamycin, WT vs. IGFtg. Scale bar is 10µm. Rapa,
rapamycin. Veh, vehicle.
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Figure 3.10: IGF1 overexpression increases dendritic arbor length and complexity
and provides resistance to rapamycin induced dendritic pruning following moderate
injury.
Representative image of doublecortin (Dcx, green) immunoreactive immature
neurons following (A,B) vehicle or (C,D) rapamycin treatment in wildtype (WT; A, C)
and IGF1 transgenic (IGFtg; B, D) mice 10 days after moderate injury. (E) Irrespective
of treatment, IGFtg mice had increased dendritic length compared to WT mice. (F)
Vehicle-treated IGFtg mice had more complex arbors than vehicle-treated WT mice.
Rapamycin-treated WT mice had a reduction in dendritic complexity compared to
vehicle-treated WT controls. Rapamycin-treated IGFtg mice had significantly more
dendritic complexity than rapamycin-treated WT mice, while rapamycin had no effect on
the dendritic arbor complexity of IGFtg mice compared to their vehicle-treated controls.
(G) Sholl analysis displays dendritic complexity over distance from the cell soma,
reflecting a rapamycin-induced reduction in complexity in WT mice, and resistance to
rapamycin-mediated pruning in IGFtg mice. Data presented as mean + SEM. (E,F) Oneway ANOVA with Bonferroni selected pairs post-hoc, *p<0.05 WT vehicle vs. WT
rapamycin. #p<0.05 and ### p<0.001 rapamycin, WT vs. IGFtg. !p<0.05 vehicle, WT
vs. IGFtg. (G) Two-way ANOVA with Bonferroni post-hoc, **p<0.01 and ***p<0.001
WT vehicle vs. WT rapamycin. !!!p<0.001 vehicle, WT vs. IGFtg. #p<0.05 and
###p<0.001 rapamycin, WT vs. IGFtg. Scale bar is 10µm. White is overlay of traced Dcx
arbor.
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CHAPTER 4: Discussion and Conclusions
Review of major findings
IGF1 overexpression drives the fate, localization, and function of posttrauma-born
neurons in the dentate gyrus following injury. Conditional overexpression of IGF1
increased the population of posttrauma-born neurons that survive to late state maturity
and localize with developmentally born neurons in the GCL. Although IGF1 dramatically
increased numbers of posttrauma-born neurons, it did not potentiate injury-induced
ectopic migration. Injured IGF1 overexpressing mice had improved performance on the
third day of RAWM testing compared to injured WT mice, when the hidden platform was
moved to a novel location. When we investigated the signaling mechanism underlying
IGF1 enhancement of neurogenesis, we found that IGF1 selectively potentiated trauma
induced mTOR activity in the GCL and HL acutely after injury. However, the effects of
IGF1 on posttraumatic neurogenesis were not dependent on mTOR activation. Inhibiting
mTOR activation did not impair posttraumatic differentiation of neurons after trauma. In
fact, only in injured animals overexpressing IGF1 was DG neuronal differentiation
sensitive to rapamycin. Treating injured mice with rapamycin in the presence of IGF1
overexpression increased neuronal differentiation 2-fold. In WT mice mTOR activation is
required for immature neuron dendritic arborization following trauma. IGF1
overexpression increased dendritic arborization and length and conferred resistance to
rapamycin-induced inhibition of arbor complexity and length. This is the first evidence
that uncouples IGF regulation of neurogenesis from down-stream mTOR signaling
events. This compelling data support that IGF1 should be further evaluated for its
therapeutic potential.
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Posttraumatic neuronal differentiation
Injury stimulates proliferation in the hippocampal DG of rodents (Rola et al.
2006). IGF1 overexpression enhanced recovery of the immature DGGC population at 10d
after injury without increasing proliferation within the GCL compared to injured WT
mice (Carlson et al. 2014). In the current work we show that at 6 weeks after injury, the
density of acutely proliferated cells in the GCL remained elevated compared to sham
controls. Hippocampal DG cells proliferated acutely after trauma have been reported to
persist for months after injury (Kernie et al. 2001). Although injured WT and IGFtg mice
had similar numbers of acutely proliferated cells localized to the GCL, IGF1
overexpression increased the proportion that colocalized with a mature neuron marker.
These data suggest that IGF1 overexpression increases posttraumatic neurogenesis
through NSC differentiation and not NSC proliferation. Although IGF1 overexpressing
mice have increased neuronal differentiation, IGF1 does not appear to deplete the NSC
population after injury. Immunolabeling with the stem cell marker nestin revealed that
Type-1 and Type-2a NSCs were present in the SGZ of both WT and IGFtg mice 10d after
injury (Carlson et al. 2014).
Only 40% of proliferating cells in the DG SGZ of an uninjured rodent are NSCs
(Palmer et al. 2000). Majority of these proliferated cells disappear within four weeks of
their division; the remaining proliferated cells are largely neurons (~70%) (Palmer et al.
2000, Kempermann et al. 2003). Experimental TBI potentiates proliferation of the NSC
population in the SGZ acutely after injury compared to controls (Kernie et al. 2001, Gao
et al. 2013, Wang et al. 2016). It is unclear what proportion of acutely proliferated cells in
the injured DG SGZ are NSCs or what proportion of those become neurons. Direct
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assessment of the effect of TBI on NSC neuronal differentiation requires continuous
sampling of posttrauma-proliferated NSC expression of markers of neuronal fate and
degeneration for at least 1 month. Researchers interested in TBI and plasticity must
further elucidate the impact and functional consequences of trauma on DG NSC
differentiation.
Impact of posttraumatic IGF1 overexpression on SVZ neurogenesis
IGF1 is expressed in abundance in the developing rodent brain and its levels
dramatically decline during postnatal development (Ye et al. 1997). IGF1 and the IGF1
receptor are ubiquitously expressed in all CNS cell types (Popken et al. 2005, Joseph
D'Ercole et al. 2008, O'Kusky et al. 2012).

In the postnatal brain, IGF1 expression is

highest in neurons (Bartlett et al. 1991). Subregion examination of the postnatal rodent
brain revealed that in the DG, IGF1 and the IGF1 receptor mRNA levels are 100x higher
in immature neurons and NSCs than in mature granule cells (Zhang et al. 2007).
In addition to the SGZ, the subventricular zone (SVZ) of the lateral ventricle is
highly enriched in NSCs in the adult brain. Newly born neurons from the SVZ migrate
along the rostral migratory stream (RMS) to the olfactory bulb (OB) throughout
adulthood. The regular supply of new neurons may explain why the OB maintains a
relatively high level of IGF1 expression that does not dramatically decline with aging like
most regions (Ye et al. 1997, Lee et al. 2018). When IGF1 expression is genetically
eliminated from the postnatal brain, immature neuron exit from the SVZ niche is
impaired, neuroblast misposition, and the OB number of new neurons is reduced
(Hurtado-Chong et al. 2009). IGF1 has an important role in regulating SVZ adultneurogenesis.
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In our studies, we focus on the fate and functional consequence of posttraumatic
SGZ DG neurogenesis. Our model is dependent on injury-induced hippocampal astrocyte
proliferation and hypertrophy since IGF1 overexpression is coupled to GFAP production.
However, following CCI and FPI, an increase in GFAP mRNA and protein levels was
observed at the site of the contusion and near the lateral ventricle aspect that is proximal
to the site of injury (Dietrich et al. 1999, Madathil et al. 2013). Within the first week after
severe CCI, NSC proliferation is stimulated in the SVZ (Radomski et al. 2013). Onemonth post-CCI, those rodents had reduced numbers of new neurons in the olfactory bulb
and impaired olfactory discrimination compared to shams (Radomski et al. 2013).
Following aspiration injury to the somatosensory cortex, SVZ neuroblasts exit the RMS
and migrate to the injured cortex (Saha et al. 2013). IGF1 overexpression may regulate
SVZ derived neuroblast migration after injury. We must take into consideration that IGF1
overexpression may also have a functional effect in progenitor-enriched brain regions and
locations undergoing reactive astrocytosis.
Mature posttrauma-born neuron integration
While IGF1 increases the number of posttrauma-born granule cells that survive to
late-stage maturity, our design does not allow us to examine their function. The
morphology of the limited number of posttrauma-born neurons that survive to late-stage
maturity in the absence of IGF1 overexpression is atypical compared to age-matched
neurons in sham controls (Villasana et al. 2015). Only one study has investigated the
function of mature posttrauma-born DGGCs compared to controls and these data suggest
that post-trauma born DGGCs can receive input from the circuit. Mature post-trauma
born DGGCs and mature DGGCs in controls had similar frequency and amplitude of
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spontaneous and miniature excitatory synaptic events and evoked potentials (Villasana et
al. 2015). The study also showed that the mature posttrauma-born neurons had similar
paired-pulse facilitation (PPF) responses compared to controls, suggesting similar
presynaptic release. IGF1 can increase expression of NMDA receptor subunits, NMDA
receptor trafficking and potentiation via PI3K/AKT/GS3Kb signaling (Liu et al. 1995,
Skeberdis et al. 2001, Le Greves et al. 2005, Le Greves et al. 2006, Molina et al. 2012, Li
et al. 2017). Future studies should employ electrophysiology to investigate the
spontaneous and evoked responses in new neurons in mice with post-traumatic IGF1
overexpression to determine if the new neurons are appropriately integrated.
A conditional DcxIGF1-eGFP overexpressing mouse would be extremely useful
for accurate and long-term fate mapping and performing cellular recording in the DG.
Our studies show that posttraumatic IGF1 has a dramatic effect on Type-3 neurons in the
DG after injury (Carlson et al. 2014, Carlson et al. 2018). There is no Dcx or PSANCAM conditional tetracycline trans-activator line currently on the market. But with
CRISP/CAS9 precision gene editing the line could be developed in C57 mice. Dr.
Saatman and colleagues have been using a posttraumatic model of conditional IGF1
overexpression using tetracycline mediated expression for over 5 years (Madathil et al.
2013). A Dcx driven overexpression model would allow researchers to narrow the
hypothesis and selectively address IGF1 overexpression effects on immature neurons
after injury. This model has advantages over a nestin driven model because one specific
stage of neurogenesis can be isolated. Directly examining the role IGF1 overexpression
actions on immature neurons will help elucidate the role of IGF1 in posttraumatic
neurogenesis.
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IGF1 and posttraumatic hippocampal remodeling
The ionotropic glutamate receptor, N-methyl-D-aspartate receptor (NMDAr), has
a very important role in facilitating learning and memory. Long-term potentiation (LTP)
and long-term depression (LTD) are opposing mechanisms of NMDAr-dependent
synaptic plasticity. There is evidence from CA1 experiments in the uninjured
hippocampus that IGF1 can regulate LTP and LTD by direct and indirect synapse
remodeling. An increase in the ratio of NMDAr subunits NR2B to NR2A increases
NMDAr activity, lowers the threshold for LTP in the forebrain, and enhances learning
and memory (Bliss et al. 1993, Tang et al. 1999). IGF1 administration has been shown to
increase the ratio of NR2B to NR2A mRNA levels in the hippocampus of juvenile and
aged rats (Le Greves et al. 2005, Le Greves et al. 2006). In the rodent hippocampus,
Glycogen synthase kinase-3 beta (GSK3β) mediates LTP induced inhibition of LTD in a
PI3K/AKT dependent manner (Peineau et al. 2007). When LTP generation is impaired in
a mouse model of Autistic Spectrum Disorder, IGF1 treatment rescues LTP generation in
hippocampal CA1 pyramidal cells (Bozdagi et al. 2013).
IGF1 overexpression may affect postsynaptic remodeling of hippocampal neurons
after injury. This is especially crucial when we considered how glutamate receptor
remodeling could affect competitive survival of new neurons. NMDAr activity is
required to increase spine density and, thereby, LTP in CA1 neurons in the developing
hippocampus (Collin et al. 1997). In the CA1, IGF1 infusion was shown to increase the
spine density in aging mice (Shi et al. 2005). The availability and activity of NMDA
receptors is critical to the NMDAr-dependent competitive survival that takes place when
adult-born DG neurons are 2-3 weeks of age (Tashiro et al. 2006). The effect of IGF1 on
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spine density during the development of adult-born immature neurons in the DG is
unknown.
Studies have also shown that IGF1 has a role in axonal sprouting and guidance.
mTOR activation is heavily implicated in the development of epilepsy and posttraumatic
epilepsy (Guo et al. 2013, Butler et al. 2015, Butler et al. 2016, Butler et al. 2017). This
was a primary driver for initiating a study design to elucidate the role and requirement for
mTOR activation in mediating the effects of IGF1 on posttraumatic hippocampal
plasticity. A common phenotype of the epileptic hippocampus is the presence of mossy
fiber collaterals aberrantly synapsed onto neighboring granule cells (Hunt et al. 2010). In
a model of posttraumatic epilepsy, 8-13 weeks of rapamycin treatment attenuated the
presence of these aberrant fibers (Butler et al. 2015). Future experiments should
investigate the effect of IGF1 on axonal sprouting after injury.
Studies have shown that astrocytes have important interactions with neuroblasts.
Astrocytes release extracellular matrix (ECM) proteins that regulate synaptogenesis
(Frischknecht et al. 2009). ECM proteins create the perineural net which is thought to
prevent aberrant process growth. During development, restrictive ECM proteins are
released after the critical period of neuronal maturation. ECM proteins play a very
important role in regulating neurite outgrowth of developing neurons. In the adult
hippocampus, aggrecan is selectively expressed in the granule cell layer and the
molecular layer of the dentate gyrus and is a potent regulator of process outgrowth
(Dauth et al. 2016). When aggrecan is genetically increased in the molecular layer and
granule cell layer, adult-born neurons have dramatically reduced dendritic complexity
and length compared to controls (Bolos et al. 2018). IGF1 acutely increases reactive
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astrocytosis in the molecular after injury (Madathil et al. 2013) and can regulate aggrecan
expression in non-neural tissues (Wang et al. 2003). IGF1 may indirectly regulate
dendritic arborization through ECM regulation following injury.
A role for adult-born neurons in emotion-related behavior
While learning and memory deficits are of great concern to clinicians and
patients, there is a growing need to understand the effect trauma is having on emotionrelated behavior. Blast-related injury accounts for over 50% of munition related injuries
amongst military personnel (DeWitt et al. 2009). TBI is associated with an increased rate
of suicide and expression of posttraumatic stress disorder symptoms including depression
and aggression (Nakase-Richardson et al. 2009, Brenner et al. 2011, Brenner et al. 2011,
Hart et al. 2011, Walter et al. 2012, Hart et al. 2014). A study showed that over 80% of
inmates report incurring a TBI prior to incarceration (Slaughter et al. 2003). A link is
beginning to emerge between emotional related behavior and trauma. There may be a role
for IGF1 in treating these disorders. Experimental TBI causes chronic atrophy of the
hippocampus and fear conditioning impairment at 3 months post-injury in rodents (Titus
et al. 2016). Studies have shown that neurogenesis is important for fear conditioning and
fear extinction (Snyder et al. 2009, Seo et al. 2015). We show data that IGF1
overexpression increased numbers of posttrauma-born neurons in the dorsal (septal)
GCL. We focus on the septal hippocampus because it is the epicenter of injury. Studies
have shown that the dorsal hippocampus is more important for spatial memory (Moser et
al. 1993) and the ventral (temporal) hippocampus is more important for fear and anxiety
related activities (Kjelstrup et al. 2002). In future studies, we could examine the DG and
immature neurons in the ventral hippocampus, which sends direct input about fear to the
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amygdala (Fanselow et al. 2010). IGF1 may mediate fear associated behavior following
trauma by promoting stable neurogenesis.
A clinical study reported that approximately 26% of TBI patients receiving GCS
scores ranging from 3-15 within 24h of injury reported that they suffered from major
depressive disorder by the 1-year follow up (Hart et al. 2011). Mood disorders affect the
ability to socialize, interact at work and at home and perform daily activities. Decreased
serum levels of nerve growth factor (NGF) and BDNF are implicated in depression and
suicide risk, while increased levels of BDNF and IGF1 are associated with improved
mood in depressed patients (Chen et al. 2001, Evans et al. 2004, Kopczak et al. 2015,
Wiener et al. 2015, Zhang et al. 2018). Exercise is currently a recommended treatment to
reduce depression symptoms and it is associated with increased neurotrophic factors
(Kishi et al. 2017, Phillips 2017). Growth factors may play an important role in mood
enhancing treatments for depression.

There has been difficulty establishing rodent

models of human depression because of the nuance and complex features of
psychological health diseases (Krishnan et al. 2011). Rodents assays that examine
depression-like behaviors including motivation, social interaction, and despair have been
developed (Krishnan et al. 2011). Like clinical data, it is well established in rodents that
one mechanism by which exercise attenuates depression-like behavior is through BDNF
upregulation (Vaynman et al. 2004, Marais et al. 2009, Sleiman et al. 2016). The forced
swim test is a measure of despair behavior in rodents. The forced swim test is an
assessment of how quickly animals give up trying to escape a pool of water (Can et al.
2012, Tucker et al. 2017). In the context of brain injury, mice show depressive-like
behavior during the forced swim behavior test at three weeks after CCI (Washington et
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al. 2012). The forced swim assessment could be used to assess if IGF1 overexpression
could attenuate injury-induced depression-like behavior.
IGF1 and mTOR: posttraumatic signaling relationship in neurogenesis
mTOR is a common downstream target of numerous neurotrophic factors (Feng et
al. 2010, Sengupta et al. 2010, Laplante et al. 2012). Growth factor signaling and mTOR
activation support neuroplasticity in the brain. Depending on the context, both have been
associated with pathogenesis and recovery in neurodegenerative diseases (Buch 2014,
Perluigi et al. 2015). These findings raise concern about the efficacy and safety of
targeting neurotrophic factors as potential therapeutics. IGF1 and mTOR signaling are
extremely complex and dynamic dependent on the physiological context. Subtle
variability between experiments, not limited to species selection, disease state, in vivo
versus in vitro, tissue type, and temporal factors, are likely to contribute to paradoxical
reports about IGF1/mTOR signaling, fueling controversy among investigators (Wrigley
et al. 2017). Although IGF1 stimulation and mTOR activation may produce the same
effect, this does not necessarily mean that IGF1 is mediating that effect through its
downstream target mTOR. We found that dendritic arbor development of immature
neurons in injured IGF1 overexpressing mice was enhanced compared to injured WT
mice. mTOR inhibition impaired dendritic outgrowth in recovering WT mice, while the
effects of IGF1 on arbor development were insensitive to mTOR inhibition. Rapamycin
treatment stimulated neuronal differentiation in IGFtg mice compared to vehicle-treated
controls and injured WT mice. Our data suggest that varying pathways of IGF1 signaling
mediate distinct aspects of neural development within immature neurons after injury.
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Two well-characterized pathways that stimulate growth, differentiation, survival,
and neurogenesis downstream of IGF1 signaling include IRS1/PI3K/AKT/mTOR and
SHC/RAS/MAPK/MEK (Joseph D'Ercole et al. 2008, Liu et al. 2009). Both pathways
have been shown to stimulate dendritic growth in neurons (Jaworski et al. 2005, Kumar et
al. 2005, Karelina et al. 2012). Cross talk between the two pathways may also mediate
effects of IGF1 signaling in trauma. A role for crosstalk between RAS and PI3K
signaling is well described in tumorigenesis (Castellano et al. 2011, Mendoza et al.
2011). Recently, a study showed crosstalk between these pathways in neuronal cultures
of dissociated CA1 and CA3 neurons (Kumar et al. 2005). mTOR inhibition blocked
RAS/MAPK/MEK dendritic outgrowth but not RAS/PI3K mediated outgrowth (Kumar
et al. 2005). Expression of RAS-L16S35 (constitutively active Ras that activates the PI3K
pathway) or RAS-L16S40 (constitutively active Ras that activates the MAPK/MEK
pathway) in these neurons stimulated dendritic complexity compared to controls.
Rapamycin impaired dendritic outgrowth in control neurons and in RAS-MAPK neurons,
but not RAS-PI3K expressing neurons (Kumar et al. 2005).
Compensatory

signaling

between

the

IRS1/PI3K/AKT/mTOR

and

SHC/RAS/MEK/ERK pathway has been described in insulin insensitivity studies. When
the IRS1 arm is inactivated by negative feedback, the SHC arm can become more
sensitive to stimulation. Hyperactivation of the insulin receptor by prolonged growth
hormone (GH) administration prior to insulin treatment prevents further activation of
IRS1 by insulin in rat hindlimbs (Thirone et al. 1998). Meanwhile, SHC activation
sensitivity to insulin treatment was dramatically increased following chronic GH
administration (Thirone et al. 1998).
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Studies suggest that hyperactivation insensitivity of the IGF1 receptor to IGF1
and the insulin receptor to insulin is mediated by posttranslational negative feedback on
IRS1 by mTOR (Um et al. 2004, Shah et al. 2006, Copps et al. 2012). A study showed
that IGF1 treatment stimulates migration and enhanced survival of cultured fibroblast
(Harrington et al. 2004). TSC1/2 mutation (TSC1/2-) in cultured fibroblasts resulted in
constitutively active RHEB, which directly activates the mTORC1 complex (Harrington
et al. 2004). The IRS1 substrate was downregulated in TSC1/2- fibroblasts and they were
unresponsive to IGF1 treatment. Rapamycin treatment restored sensitivity to IGF1
treatment, enhancing survival in fibroblast from TSC1/2 mutants (Harrington et al. 2004).
Activated mTOR/S6 has been shown to directly downregulate IRS1 activity in response
in fibroblasts with a mutation in TSC1/2 (Shah et al. 2006).
mTOR can also provide negative feedback on the IGF1/PI3K/AKT signaling
through IRS1 independent mechanisms (Wan et al. 2007). mTOR inhibition can
potentiate IGF1 signaling when IGF1 effects are not mediated through an mTORdependent mechanism. These studies challenge the dogma of insulin and IGF1 signaling.
These studies and the data presented here suggest looking at insulin/IGF1 signaling from
a holistic view. The overarching purpose of growth factors is to balance homeostasis.
Narrowly focusing on isolated effects of individual substrates risks losing sight of
compensatory shifts that take place elsewhere and oversimplifying mechanisms.
The data presented here expands the understanding of the mechanisms underlying
enhanced plasticity in the posttraumatic DG following IGF1 overexpression. Our goal
was to identify the effects of mTOR inhibition on the IGF1-induced enhancement of
neurogenesis. IGF1 may enhance posttraumatic differentiation and dendritic outgrowth in
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immature neurons following trauma by two different mechanisms. Neuronal
differentiation was increased following mTOR inhibition in IGF1 overexpressing mice.
Follow-up studies should examine if posttraumatic IGF1-induced neuronal differentiation
is dependent on IRS1/PI3K signaling. Studies should investigate the effect of
posttraumatic IGF1 overexpression on hippocampal IRS1 substrate phosphorylation and
expression and if rapamycin treatment prevents alteration of the substrate. This would
suggest that mTOR is a negative regulator of posttraumatic IGF1 action. There is also
evidence that the mTOR effector, S6 kinase (pS6K) may downregulate IRS1 activity.
pS6K negatively regulates IRS1 activity in response to insulin stimulation. In the absence
of S6K insulin sensitivity is increased (Um et al. 2004) and increased S6K activation
inhibits IRS1 activation of PI3K (Draznin 2006). S6K hyper-phosphorylates IRS1
inhibitory serine sites and inhibits the ability of IRS1 to bind and activate PI3K. It was
recently shown in cultured fibroblasts that constitutively active mTORC1 causes
inhibitory phosphorylation and mRNA downregulation of IRS1 (Harrington et al. 2004).
Insulin and IGF1 could not activate AKT because constitutively active mTOR/pS6K was
negatively feeding back on IRS1 (Harrington et al. 2004). The phenotype was rescued by
mTOR inhibition by rapamycin and S6K mRNA silencing.
Dendritic

arborization

of

immature

neurons

was

enhanced

by

IGF1

overexpression following injury; this effect was insensitive to mTOR inhibition. Our
interpretation of the signaling underlying enhanced posttraumatic dendritic arborization
following IGF1 overexpression is limited. While mTOR inhibition does not inhibit the
arborization effects of IGF1 overexpression on immature neurons, it is unclear if these
effects are independent of mTOR activation. mTOR activity may enhance dendritic
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arborization in IGFtg mice. However, IGF1 may stimulate dendritic outgrowth through
an alternative pathway when IRS1/PI3K/AKT/mTOR signaling is inhibited. Rapamycin
diminished dendritic outgrowth in cultured neurons expressing constitutively activated
PI3K (Jaworski et al. 2005). However, rapamycin treatment only partially blocked the
dendritic outgrowth induced by cultured neurons expressing constitutively activated RAS
(Kumar et al. 2005). The inhibition of MAPK or PI3K was able to diminish the enhanced
dendritic outgrowth stimulated by Glial Cell-derived Neurotrophic Factor (GDNF) in
cultured striatal neurons (Garcia-Martinez et al. 2006). Overactivation of the IGF1
receptor following posttraumatic IGF1 overexpression may lead to downregulation of the
IRS1/PI3K/AKT/mTOR and increased activation of the SHC/RAS/MAPK pathway. It is
well known that prolonged IGF1 stimulation of the IGF1 receptor can induce
PI3K/mTOR dependent downregulation of IRS1/PI3K activation and upregulation of
compensatory pathway activation (Rozengurt et al. 2014). As prolonged IGF1 treatment
continues to activate the IGF1 receptor, cultured melanoma cells shift to upregulation of
the SHC/RAS/MAPK/ERK when IRS1 activity is lost (Reuveni et al. 2013). The
incorporation of IRS1 and SHC inhibitors into future studies could elucidate the signaling
underlying IGF1 overexpression effects on dendritic outgrowth following trauma.
Considerations
The function of adult neurogenesis in human diseases of the brain is not well
understood. The persistence and extent of hippocampal neurogenesis in the uninjured
human brain is a continuing point of controversy (Eriksson et al. 1998, Knoth et al. 2010,
Dennis et al. 2016, Boldrini et al. 2018, Sorrells et al. 2018). Gerd Kempermann and
colleagues have shown that like rodents, neurogenesis in humans dramatically declines
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with age (Knoth et al. 2010). Variation between specimen collection protocols and patient
history may contribute to conflicting data regarding the degree of adult neurogenesis
between studies. The adult brain tissue from studies reporting nearly no persistent adult
neurogenesis was acquired from patients with a variety of causes of death including
cancer, epilepsy, brain injury, and chronic illness (Dennis et al. 2016, Sorrells et al.
2018). Gage and colleagues controlled for the cause of death confounders by examining
brain specimen from a population of patients with squamous carcinoma of the tongue,
larynx, and pharynx (Eriksson et al. 1998). This study also controlled for drugs that may
inhibit neurogenesis, and possibly confound results. Proliferation assessments in the DG
of the specimens from the Gage study were from patients who did not receive anti-cancer
proliferation drugs (Eriksson et al. 1998). When Rene Hen and colleagues designed their
experiments to exclude specimen from patients with a history of chronic disease, mental
illness, drugs-use for mental illness, and brain injury, they found persistent adultneurogenesis in the DG (Boldrini et al. 2018). Variations in tissue preservation protocols
between studies using human tissue can dramatically influence the interpretation of
findings. Studies find that increasing the amount of time between patient death and
chemical tissue preservation, postmortem interval (PMI) can decrease brain tissue
immunoreactivity for many antigens (Shiurba et al. 1998, Unal-Cevik et al. 2004, Birdsill
et al. 2011). Studies that found little to no adult neurogenesis in the DG examined
specimen from patients with a PMI of less than 35h in less than 35% of cases, or they did
not directly report PMI (Dennis et al. 2016, Sorrells et al. 2018). Studies that support
persistent adult neurogenesis collected specimens from patients with a PMI of less than
35h in approximately 78% to 100% of cases (Eriksson et al. 1998, Boldrini et al. 2018).
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Future studies elucidating the pattern and extent of human adult neurogenesis in the DG
are prerequisites to determining the implications of neurogenesis on recovery from TBI.
The potential clinical value of IGF1 in treating brain injury should not be limited
to its effects on adult neurogenesis. IGF1 has been shown to be an effective therapeutic
in treating TBI-induced metabolic dysfunction (Hatton et al. 2006). Clinical studies that
have shown promising IGF1 treatment outcomes have often administered IGF1 with
factors that prolong its systemic circulation and effectiveness. IGF1 was administered
with growth hormone (GH) within 72h of moderate to severe brain injury to reduce
hypercatabolic metabolism in patients after trauma (Hatton et al. 1997). All patients had
improved protein metabolism within 1 week of treatment (Hatton et al. 1997). Patients
receiving moderate GCS scores but not poor GSC scores had improved outcomes 6
months following IGF1 treatment (Hatton et al. 1997). A clinical malnutrition study and
an efficacy study in TBI patients found that administering growth hormone with IGF1
increased serum levels of IGF1 and the IGF1 binding protein 3 (IGFBP-3) (Rockich et al.
1999, Justova et al. 2001). Circulating IGF1 is often found in complex with IGFBP-3,
IGFBP-3 extends IGF1 activity by 20hr (4hrs of action) (Rosenfeld 2006). The
combination of IGF1 and GH was sufficient to improve protein metabolism within 24h of
treatment onset in TBI patients (Hatton et al. 2006). However, using GH in clinical
treatment is controversial, since several studies have reported that GH increases mortality
rate long-term (Divall et al. 2013). IGF1 is now commercially available and prescribed
under the brand name Mecasermin in combination with IGFBP-3 (Cohen et al. 2014).
Future preclinical models elevating effects of IGF1 overexpression should incorporate
IGFBPs into the study design, considering their effect on IGF1 half-life. IGF1 needs
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further preclinical evaluation to determine the best mode of delivery and what binding
protein to accompany it.
The goal of investigating the effects of IGF1 modulation of hippocampal
plasticity and understanding the mechanisms underlying those changes is to further
evaluate

IGF1

as

a

potential

treatment

TBI.

Drugs

that

stimulate

the

IRS1/PI3K/AKT/mTOR pathway are a safety concern because activation of the pathway
is contraindicated in diabetes, cancer development, and aspects of seizure development
(Mendoza et al. 2011, Tolcher et al. 2015, Wheless 2015, Patnaik et al. 2016). Seizures
are a common feature of the human disease Tubular Sclerosis. Tubular sclerosis is a
disease caused by an inherited mutation to TSC1/2.

The mutation is thought to

profoundly affect neurogenesis during development (Rosset et al. 2017). More than 50%
of children with TSC mutations die from brain tumors while those that survivor develop
seizures, symptoms of autism, and suffer from a low IQ (Joinson et al. 2003, Feliciano et
al. 2012, Kotulska et al. 2014). Patients with a TSC mutation frequently have seizures;
many have not been responsive to treatment. Recent clinical trials have shown that
mTOR inhibition is effective in reducing seizures in children and juveniles with TSC
mutations (Wheless 2015, Samueli et al. 2016, Kilincaslan et al. 2017).
Patients with TSC may benefit from IGF1 driven plasticity combined with
inhibition of mTOR induced maladaptive plasticity. A recent study has shown that the
hippocampi of patients suffering from temporal lobe epilepsy have significantly high
mTOR activity compared to controls (Talos et al. 2018). Seizure development has also
been reported in TBI patients (Ferguson et al. 2010, Bramlett et al. 2015). It is unclear
whether mTOR contributes to the etiology of these forms of epilepsy or if its inhibition
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would reduce seizure activity. The data presented here is essential to the preclinical
evaluation of IGF1 for TBI because it introduces the impact of combining IGF1 with
mTOR inhibitor. Further studies should be done to evaluate the effect of combining IGF1
and mTOR to treat human diseases of the brain.

118

References
Abraham, RT and Wiederrecht, GJ (1996). "Immunopharmacology of rapamycin." Annu
Rev Immunol 14: 483-510.
Aimone, JB, Deng, W and Gage, FH (2010). "Adult neurogenesis: integrating theories
and separating functions." Trends Cogn Sci 14(7): 325-337.
Alamed, J, Wilcock, DM, Diamond, DM, Gordon, MN and Morgan, D (2006). "Two-day
radial-arm water maze learning and memory task; robust resolution of amyloidrelated memory deficits in transgenic mice." Nat Protoc 1(4): 1671-1679.
Altman, J and Bayer, SA (1990). "Migration and distribution of two populations of
hippocampal granule cell precursors during the perinatal and postnatal periods." J
Comp Neurol 301(3): 365-381.
Altman, J and Das, GD (1967). "Postnatal neurogenesis in the guinea-pig." Nature
214(5093): 1098-1101.
Alvarez-Buylla, A and Lim, DA (2004). "For the long run: maintaining germinal niches
in the adult brain." Neuron 41(5): 683-686.
Amaral, DG, Scharfman, HE and Lavenex, P (2007). "The dentate gyrus: fundamental
neuroanatomical organization (dentate gyrus for dummies)." Prog Brain Res 163:
3-22.
Anacker, C and Hen, R (2017). "Adult hippocampal neurogenesis and cognitive
flexibility - linking memory and mood." Nat Rev Neurosci 18(6): 335-346.
Anlar, B, Sullivan, KA and Feldman, EL (1999). "Insulin-like growth factor-I and central
nervous system development." Horm Metab Res 31(2-3): 120-125.
Ariza, M, Serra-Grabulosa, JM, Junque, C, Ramirez, B, Mataro, M, Poca, A, Bargallo, N
and Sahuquillo, J (2006). "Hippocampal head atrophy after traumatic brain
injury." Neuropsychologia 44(10): 1956-1961.
Ashton, RS, Conway, A, Pangarkar, C, Bergen, J, Lim, KI, Shah, P, Bissell, M and
Schaffer, DV (2012). "Astrocytes regulate adult hippocampal neurogenesis
through ephrin-B signaling." Nat Neurosci 15(10): 1399-1406.
Atkins, CM (2011). "Decoding hippocampal signaling deficits after traumatic brain
injury." Transl Stroke Res 2(4): 546-555.
Baker, NL, Carlo Russo, V, Bernard, O, D'Ercole, AJ and Werther, GA (1999).
"Interactions between bcl-2 and the IGF system control apoptosis in the
developing mouse brain." Brain Res Dev Brain Res 118(1-2): 109-118.
Bareyre, F, Wahl, F, McIntosh, TK and Stutzmann, JM (1997). "Time course of cerebral
edema after traumatic brain injury in rats: effects of riluzole and mannitol." J
Neurotrauma 14(11): 839-849.
Barha, CK, Ishrat, T, Epp, JR, Galea, LA and Stein, DG (2011). "Progesterone treatment
normalizes the levels of cell proliferation and cell death in the dentate gyrus of the
hippocampus after traumatic brain injury." Exp Neurol 231(1): 72-81.
Bartlett, WP, Li, XS, Williams, M and Benkovic, S (1991). "Localization of insulin-like
growth factor-1 mRNA in murine central nervous system during postnatal
development." Dev Biol 147(1): 239-250.

119

Becker, D, Zahn, N, Deller, T and Vlachos, A (2013). "Tumor necrosis factor alpha
maintains denervation-induced homeostatic synaptic plasticity of mouse dentate
granule cells." Front Cell Neurosci 7: 257.
Bekinschtein, P, Kent, BA, Oomen, CA, Clemenson, GD, Gage, FH, Saksida, LM and
Bussey, TJ (2013). "BDNF in the dentate gyrus is required for consolidation of
"pattern-separated" memories." Cell Rep 5(3): 759-768.
Bekinschtein, P, Kent, BA, Oomen, CA, Clemenson, GD, Gage, FH, Saksida, LM and
Bussey, TJ (2014). "Brain-derived neurotrophic factor interacts with adult-born
immature cells in the dentate gyrus during consolidation of overlapping
memories." Hippocampus 24(8): 905-911.
Birdsill, AC, Walker, DG, Lue, L, Sue, LI and Beach, TG (2011). "Postmortem interval
effect on RNA and gene expression in human brain tissue." Cell Tissue Bank
12(4): 311-318.
Blaiss, CA, Yu, TS, Zhang, G, Chen, J, Dimchev, G, Parada, LF, Powell, CM and
Kernie, SG (2011). "Temporally specified genetic ablation of neurogenesis
impairs cognitive recovery after traumatic brain injury." J Neurosci 31(13): 49064916.
Bliss, TV and Collingridge, GL (1993). "A synaptic model of memory: long-term
potentiation in the hippocampus." Nature 361(6407): 31-39.
Boldrini, M, Fulmore, CA, Tartt, AN, Simeon, LR, Pavlova, I, Poposka, V, Rosoklija,
GB, Stankov, A, Arango, V, Dwork, AJ, Hen, R and Mann, JJ (2018). "Human
Hippocampal Neurogenesis Persists throughout Aging." Cell Stem Cell 22(4):
589-599 e585.
Bolkvadze, T and Pitkanen, A (2012). "Development of post-traumatic epilepsy after
controlled cortical impact and lateral fluid-percussion-induced brain injury in the
mouse." J Neurotrauma 29(5): 789-812.
Bolos, M, Perea, JR, Terreros-Roncal, J, Pallas-Bazarra, N, Jurado-Arjona, J, Avila, J and
Llorens-Martin, M (2018). "Absence of microglial CX3CR1 impairs the synaptic
integration of adult-born hippocampal granule neurons." Brain Behav Immun 68:
76-89.
Bondi, CO, Cheng, JP, Tennant, HM, Monaco, CM and Kline, AE (2014). "Old dog, new
tricks: the attentional set-shifting test as a novel cognitive behavioral task after
controlled cortical impact injury." J Neurotrauma 31(10): 926-937.
Bondy, CA, Bach, MA and Lee, W-H (1992). "Mapping of brain insulin and insulin-like
growth factor receptor gene expression by in situ hybridization." Neuroprotocols
1(3): 240-249.
Borges, K, McDermott, D, Irier, H, Smith, Y and Dingledine, R (2006). "Degeneration
and proliferation of astrocytes in the mouse dentate gyrus after pilocarpineinduced status epilepticus." Exp Neurol 201(2): 416-427.
Bozdagi, O, Tavassoli, T and Buxbaum, JD (2013). "Insulin-like growth factor-1 rescues
synaptic and motor deficits in a mouse model of autism and developmental
delay." Mol Autism 4(1): 9.
Bramlett, HM and Dietrich, WD (2015). "Long-Term Consequences of Traumatic Brain
Injury: Current Status of Potential Mechanisms of Injury and Neurological
Outcomes." J Neurotrauma 32(23): 1834-1848.

120

Brenner, LA, Betthauser, LM, Homaifar, BY, Villarreal, E, Harwood, JE, Staves, PJ and
Huggins, JA (2011). "Posttraumatic stress disorder, traumatic brain injury, and
suicide attempt history among veterans receiving mental health services." Suicide
Life Threat Behav 41(4): 416-423.
Brenner, LA, Ignacio, RV and Blow, FC (2011). "Suicide and traumatic brain injury
among individuals seeking Veterans Health Administration services." J Head
Trauma Rehabil 26(4): 257-264.
Bromley-Brits, K, Deng, Y and Song, W (2011). "Morris water maze test for learning and
memory deficits in Alzheimer's disease model mice." J Vis Exp(53).
Buch, S (2014). "Growth factor signaling: implications for disease & therapeutics." J
Neuroimmune Pharmacol 9(2): 65-68.
Buckmaster, PS and Lew, FH (2011). "Rapamycin suppresses mossy fiber sprouting but
not seizure frequency in a mouse model of temporal lobe epilepsy." J Neurosci
31(6): 2337-2347.
Burghardt, NS, Park, EH, Hen, R and Fenton, AA (2012). "Adult-born hippocampal
neurons promote cognitive flexibility in mice." Hippocampus 22(9): 1795-1808.
Buss, RR, Sun, W and Oppenheim, RW (2006). "Adaptive roles of programmed cell
death during nervous system development." Annu Rev Neurosci 29: 1-35.
Butler, CR, Boychuk, JA and Smith, BN (2015). "Effects of Rapamycin Treatment on
Neurogenesis and Synaptic Reorganization in the Dentate Gyrus after Controlled
Cortical Impact Injury in Mice." Front Syst Neurosci 9: 163.
Butler, CR, Boychuk, JA and Smith, BN (2016). "Differential effects of rapamycin
treatment on tonic and phasic GABAergic inhibition in dentate granule cells after
focal brain injury in mice." Exp Neurol 280: 30-40.
Butler, CR, Boychuk, JA and Smith, BN (2017). "Brain Injury-Induced Synaptic
Reorganization in Hilar Inhibitory Neurons Is Differentially Suppressed by
Rapamycin." eNeuro 4(5).
Bye, N, Carron, S, Han, X, Agyapomaa, D, Ng, SY, Yan, E, Rosenfeld, JV and
Morganti-Kossmann, MC (2011). "Neurogenesis and glial proliferation are
stimulated following diffuse traumatic brain injury in adult rats." J Neurosci Res
89(7): 986-1000.
Cameron, HA and McKay, RD (2001). "Adult neurogenesis produces a large pool of new
granule cells in the dentate gyrus." J Comp Neurol 435(4): 406-417.
Can, A, Dao, DT, Arad, M, Terrillion, CE, Piantadosi, SC and Gould, TD (2012). "The
mouse forced swim test." J Vis Exp(59): e3638.
Cantu, RC (2001). "Posttraumatic Retrograde and Anterograde Amnesia:
Pathophysiology and Implications in Grading and Safe Return to Play." J Athl
Train 36(3): 244-248.
Cao, Y, Gunn, AJ, Bennet, L, Wu, D, George, S, Gluckman, PD, Shao, XM and Guan, J
(2003). "Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3
activation and increases glial proliferation after ischemia in near-term fetal
sheep." J Cereb Blood Flow Metab 23(6): 739-747.
Carlson, CJ, White, MF and Rondinone, CM (2004). "Mammalian target of rapamycin
regulates IRS-1 serine 307 phosphorylation." Biochem Biophys Res Commun
316(2): 533-539.

121

Carlson, SW, Madathil, SK, Sama, DM, Gao, X, Chen, J and Saatman, KE (2014).
"Conditional overexpression of insulin-like growth factor-1 enhances
hippocampal neurogenesis and restores immature neuron dendritic processes after
traumatic brain injury." J Neuropathol Exp Neurol 73(8): 734-746.
Carlson, SW and Saatman, KE (2018). "Central Infusion of Insulin-Like Growth Factor-1
Increases Hippocampal Neurogenesis and Improves Neurobehavioral Function
after Traumatic Brain Injury." J Neurotrauma.
Carracedo, A, Ma, L, Teruya-Feldstein, J, Rojo, F, Salmena, L, Alimonti, A, Egia, A,
Sasaki, AT, Thomas, G, Kozma, SC, Papa, A, Nardella, C, Cantley, LC, Baselga,
J and Pandolfi, PP (2008). "Inhibition of mTORC1 leads to MAPK pathway
activation through a PI3K-dependent feedback loop in human cancer." J Clin
Invest 118(9): 3065-3074.
Castellano, E and Downward, J (2011). "RAS Interaction with PI3K: More Than Just
Another Effector Pathway." Genes Cancer 2(3): 261-274.
Chen, B, Dowlatshahi, D, MacQueen, GM, Wang, JF and Young, LT (2001). "Increased
hippocampal BDNF immunoreactivity in subjects treated with antidepressant
medication." Biol Psychiatry 50(4): 260-265.
Chen, C, Ma, TZ, Wang, LN, Wang, JJ, Tu, Y, Zhao, ML, Zhang, S, Sun, HT and Li, XH
(2016). "Mild hypothermia facilitates the long-term survival of newborn cells in
the dentate gyrus after traumatic brain injury by diminishing a pro-apoptotic
microenvironment." Neuroscience 335: 114-121.
Chen, S, Atkins, CM, Liu, CL, Alonso, OF, Dietrich, WD and Hu, BR (2007).
"Alterations in mammalian target of rapamycin signaling pathways after traumatic
brain injury." J Cereb Blood Flow Metab 27(5): 939-949.
Chen, Y and Swanson, RA (2003). "Astrocytes and brain injury." J Cereb Blood Flow
Metab 23(2): 137-149.
Chiaretti, A, Antonelli, A, Riccardi, R, Genovese, O, Pezzotti, P, Di Rocco, C, Tortorolo,
L and Piedimonte, G (2008). "Nerve growth factor expression correlates with
severity and outcome of traumatic brain injury in children." Eur J Paediatr Neurol
12(3): 195-204.
Chou, A, Morganti, JM and Rosi, S (2016). "Frontal Lobe Contusion in Mice Chronically
Impairs Prefrontal-Dependent Behavior." PLoS One 11(3): e0151418.
Cicerone, K, Levin, H, Malec, J, Stuss, D and Whyte, J (2006). "Cognitive rehabilitation
interventions for executive function: moving from bench to bedside in patients
with traumatic brain injury." J Cogn Neurosci 18(7): 1212-1222.
Cifu, DX, Keyser-Marcus, L, Lopez, E, Wehman, P, Kreutzer, JS, Englander, J and High,
W (1997). "Acute predictors of successful return to work 1 year after traumatic
brain injury: a multicenter analysis." Arch Phys Med Rehabil 78(2): 125-131.
Clelland, CD, Choi, M, Romberg, C, Clemenson, GD, Jr., Fragniere, A, Tyers, P,
Jessberger, S, Saksida, LM, Barker, RA, Gage, FH and Bussey, TJ (2009). "A
functional role for adult hippocampal neurogenesis in spatial pattern separation."
Science 325(5937): 210-213.
Cohen, J, Blethen, S, Kuntze, J, Smith, SL, Lomax, KG and Mathew, PM (2014).
"Managing the child with severe primary insulin-like growth factor-1 deficiency
(IGFD): IGFD diagnosis and management." Drugs R D 14(1): 25-29.

122

Collin, C, Miyaguchi, K and Segal, M (1997). "Dendritic spine density and LTP
induction in cultured hippocampal slices." J Neurophysiol 77(3): 1614-1623.
Conover, JC and Todd, KL (2017). "Development and aging of a brain neural stem cell
niche." Exp Gerontol 94: 9-13.
Copps, KD and White, MF (2012). "Regulation of insulin sensitivity by serine/threonine
phosphorylation of insulin receptor substrate proteins IRS1 and IRS2."
Diabetologia 55(10): 2565-2582.
Coronado, VG, McGuire, LC, Sarmiento, K, Bell, J, Lionbarger, MR, Jones, CD, Geller,
AI, Khoury, N and Xu, L (2012). "Trends in Traumatic Brain Injury in the U.S.
and the public health response: 1995-2009." J Safety Res 43(4): 299-307.
Cortez, SC, McIntosh, TK and Noble, LJ (1989). "Experimental fluid percussion brain
injury: vascular disruption and neuronal and glial alterations." Brain Res 482(2):
271-282.
Dajani, DR and Uddin, LQ (2015). "Demystifying cognitive flexibility: Implications for
clinical and developmental neuroscience." Trends Neurosci 38(9): 571-578.
Dash, PK, Mach, SA and Moore, AN (2001). "Enhanced neurogenesis in the rodent
hippocampus following traumatic brain injury." J Neurosci Res 63(4): 313-319.
Dash, PK, Orsi, SA and Moore, AN (2006). "Spatial memory formation and memoryenhancing effect of glucose involves activation of the tuberous sclerosis complexMammalian target of rapamycin pathway." J Neurosci 26(31): 8048-8056.
Dauth, S, Grevesse, T, Pantazopoulos, H, Campbell, PH, Maoz, BM, Berretta, S and
Parker, KK (2016). "Extracellular matrix protein expression is brain region
dependent." J Comp Neurol 524(7): 1309-1336.
Day, LB, Weisand, M, Sutherland, RJ and Schallert, T (1999). "The hippocampus is not
necessary for a place response but may be necessary for pliancy." Behav Neurosci
113(5): 914-924.
Dayer, AG, Ford, AA, Cleaver, KM, Yassaee, M and Cameron, HA (2003). "Short-term
and long-term survival of new neurons in the rat dentate gyrus." J Comp Neurol
460(4): 563-572.
DeKosky, ST, Taffe, KM, Abrahamson, EE, Dixon, CE, Kochanek, PM and Ikonomovic,
MD (2004). "Time course analysis of hippocampal nerve growth factor and
antioxidant enzyme activity following lateral controlled cortical impact brain
injury in the rat." J Neurotrauma 21(5): 491-500.
Deller, T, Haas, CA, Naumann, T, Joester, A, Faissner, A and Frotscher, M (1997). "Upregulation of astrocyte-derived tenascin-C correlates with neurite outgrowth in the
rat dentate gyrus after unilateral entorhinal cortex lesion." Neuroscience 81(3):
829-846.
Deng, W, Aimone, JB and Gage, FH (2010). "New neurons and new memories: how does
adult hippocampal neurogenesis affect learning and memory?" Nat Rev Neurosci
11(5): 339-350.
Dennis, CV, Suh, LS, Rodriguez, ML, Kril, JJ and Sutherland, GT (2016). "Human adult
neurogenesis across the ages: An immunohistochemical study." Neuropathol Appl
Neurobiol 42(7): 621-638.
DeWitt, DS and Prough, DS (2009). "Blast-induced brain injury and posttraumatic
hypotension and hypoxemia." J Neurotrauma 26(6): 877-887.

123

Dietrich, WD, Truettner, J, Zhao, W, Alonso, OF, Busto, R and Ginsberg, MD (1999).
"Sequential changes in glial fibrillary acidic protein and gene expression
following parasagittal fluid-percussion brain injury in rats." J Neurotrauma 16(7):
567-581.
Dikmen, SS, Corrigan, JD, Levin, HS, Machamer, J, Stiers, W and Weisskopf, MG
(2009). "Cognitive outcome following traumatic brain injury." J Head Trauma
Rehabil 24(6): 430-438.
Dillon, SE, Tsivos, D, Knight, M, McCann, B, Pennington, C, Shiel, AI, Conway, ME,
Newson, MA, Kauppinen, RA and Coulthard, EJ (2017). "The impact of ageing
reveals distinct roles for human dentate gyrus and CA3 in pattern separation and
object recognition memory." Sci Rep 7(1): 14069.
Divall, SA and Radovick, S (2013). "Growth Hormone and Treatment Controversy; Long
Term Safety of rGH." Curr Pediatr Rep 1(2): 128-132.
Dixon, CE, Kochanek, PM, Yan, HQ, Schiding, JK, Griffith, RG, Baum, E, Marion, DW
and DeKosky, ST (1999). "One-year study of spatial memory performance, brain
morphology, and cholinergic markers after moderate controlled cortical impact in
rats." J Neurotrauma 16(2): 109-122.
Draznin, B (2006). "Molecular mechanisms of insulin resistance: serine phosphorylation
of insulin receptor substrate-1 and increased expression of p85alpha: the two sides
of a coin." Diabetes 55(8): 2392-2397.
Duan, X, Chang, JH, Ge, S, Faulkner, RL, Kim, JY, Kitabatake, Y, Liu, XB, Yang, CH,
Jordan, JD, Ma, DK, Liu, CY, Ganesan, S, Cheng, HJ, Ming, GL, Lu, B and
Song, H (2007). "Disrupted-In-Schizophrenia 1 regulates integration of newly
generated neurons in the adult brain." Cell 130(6): 1146-1158.
Eakin, K, Rowe, RK and Lifshitz, J (2015). Modeling Fluid Percussion Injury: Relevance
to Human Traumatic Brain Injury. Brain Neurotrauma: Molecular,
Neuropsychological, and Rehabilitation Aspects. F. H. Kobeissy. Boca Raton
(FL).
Eriksson, PS, Perfilieva, E, Bjork-Eriksson, T, Alborn, AM, Nordborg, C, Peterson, DA
and Gage, FH (1998). "Neurogenesis in the adult human hippocampus." Nat Med
4(11): 1313-1317.
Evans, SJ, Choudary, PV, Neal, CR, Li, JZ, Vawter, MP, Tomita, H, Lopez, JF,
Thompson, RC, Meng, F, Stead, JD, Walsh, DM, Myers, RM, Bunney, WE,
Watson, SJ, Jones, EG and Akil, H (2004). "Dysregulation of the fibroblast
growth factor system in major depression." Proc Natl Acad Sci U S A 101(43):
15506-15511.
Fanselow, MS and Dong, HW (2010). "Are the dorsal and ventral hippocampus
functionally distinct structures?" Neuron 65(1): 7-19.
Farioli-Vecchioli, S, Saraulli, D, Costanzi, M, Pacioni, S, Cina, I, Aceti, M, Micheli, L,
Bacci, A, Cestari, V and Tirone, F (2008). "The timing of differentiation of adult
hippocampal neurons is crucial for spatial memory." PLoS Biol 6(10): e246.
Faul, M and Coronado, V (2015). "Epidemiology of traumatic brain injury." Handb Clin
Neurol 127: 3-13.
Feeney, C, Sharp, DJ, Hellyer, PJ, Jolly, AE, Cole, JH, Scott, G, Baxter, D, Jilka, S,
Ross, E, Ham, TE, Jenkins, PO, Li, LM, Gorgoraptis, N, Midwinter, M and
Goldstone, AP (2017). "Serum insulin-like growth factor-I levels are associated
124

with improved white matter recovery after traumatic brain injury." Ann Neurol
82(1): 30-43.
Feliciano, DM, Quon, JL, Su, T, Taylor, MM and Bordey, A (2012). "Postnatal
neurogenesis generates heterotopias, olfactory micronodules and cortical
infiltration following single-cell Tsc1 deletion." Hum Mol Genet 21(4): 799-810.
Feng, Z and Levine, AJ (2010). "The regulation of energy metabolism and the IGF1/mTOR pathways by the p53 protein." Trends Cell Biol 20(7): 427-434.
Ferguson, PL, Smith, GM, Wannamaker, BB, Thurman, DJ, Pickelsimer, EE and
Selassie, AW (2010). "A population-based study of risk of epilepsy after
hospitalization for traumatic brain injury." Epilepsia 51(5): 891-898.
Flanagan, SR (2015). "Invited Commentary on "Centers for Disease Control and
Prevention Report to Congress: Traumatic Brain Injury in the United States:
Epidemiology and Rehabilitation"." Arch Phys Med Rehabil 96(10): 1753-1755.
Fleminger, S and Ponsford, J (2005). "Long term outcome after traumatic brain injury."
BMJ 331(7530): 1419-1420.
Forslund, MV, Arango-Lasprilla, JC, Roe, C, Perrin, PB, Sigurdardottir, S and Andelic,
N (2014). "Multi-level modelling of employment probability trajectories and
employment stability at 1, 2 and 5 years after traumatic brain injury." Brain Inj
28(7): 980-986.
Friedland, D and Swash, M (2016). "Post-traumatic amnesia and confusional state:
hazards of retrospective assessment." J Neurol Neurosurg Psychiatry 87(10):
1068-1074.
Frischknecht, R, Heine, M, Perrais, D, Seidenbecher, CI, Choquet, D and Gundelfinger,
ED (2009). "Brain extracellular matrix affects AMPA receptor lateral mobility
and short-term synaptic plasticity." Nat Neurosci 12(7): 897-904.
Gao, X and Chen, J (2013). "Moderate traumatic brain injury promotes neural precursor
proliferation without increasing neurogenesis in the adult hippocampus." Exp
Neurol 239: 38-48.
Gao, X, Deng-Bryant, Y, Cho, W, Carrico, KM, Hall, ED and Chen, J (2008). "Selective
death of newborn neurons in hippocampal dentate gyrus following moderate
experimental traumatic brain injury." J Neurosci Res 86(10): 2258-2270.
Garcia-Martinez, JM, Perez-Navarro, E, Gavalda, N and Alberch, J (2006). "Glial cell
line-derived neurotrophic factor promotes the arborization of cultured striatal
neurons through the p42/p44 mitogen-activated protein kinase pathway." J
Neurosci Res 83(1): 68-79.
Garthe, A, Behr, J and Kempermann, G (2009). "Adult-generated hippocampal neurons
allow the flexible use of spatially precise learning strategies." PLoS One 4(5):
e5464.
Garthe, A and Kempermann, G (2013). "An old test for new neurons: refining the Morris
water maze to study the functional relevance of adult hippocampal neurogenesis."
Front Neurosci 7: 63.
Garza-Lombo, C and Gonsebatt, ME (2016). "Mammalian Target of Rapamycin: Its Role
in Early Neural Development and in Adult and Aged Brain Function." Front Cell
Neurosci 10: 157.
Ge, S, Pradhan, DA, Ming, GL and Song, H (2007). "GABA sets the tempo for activitydependent adult neurogenesis." Trends Neurosci 30(1): 1-8.
125

Ge, S, Sailor, KA, Ming, GL and Song, H (2008). "Synaptic integration and plasticity of
new neurons in the adult hippocampus." J Physiol 586(16): 3759-3765.
Gong, C, Wang, TW, Huang, HS and Parent, JM (2007). "Reelin regulates neuronal
progenitor migration in intact and epileptic hippocampus." J Neurosci 27(8):
1803-1811.
Gotz, M and Barde, YA (2005). "Radial glial cells defined and major intermediates
between embryonic stem cells and CNS neurons." Neuron 46(3): 369-372.
Greve, MW and Zink, BJ (2009). "Pathophysiology of traumatic brain injury." Mt Sinai J
Med 76(2): 97-104.
Griesbach, GS, Hovda, DA, Molteni, R, Wu, A and Gomez-Pinilla, F (2004). "Voluntary
exercise following traumatic brain injury: brain-derived neurotrophic factor
upregulation and recovery of function." Neuroscience 125(1): 129-139.
Gunn, RM and Hailes, HC (2008). "Insights into the PI3-K-PKB-mTOR signalling
pathway from small molecules." J Chem Biol 1(1-4): 49-62.
Guo, D, Zeng, L, Brody, DL and Wong, M (2013). "Rapamycin attenuates the
development of posttraumatic epilepsy in a mouse model of traumatic brain
injury." PLoS One 8(5): e64078.
Guzowski, JF, McNaughton, BL, Barnes, CA and Worley, PF (1999). "Environmentspecific expression of the immediate-early gene Arc in hippocampal neuronal
ensembles." Nat Neurosci 2(12): 1120-1124.
Hall, ED, Sullivan, PG, Gibson, TR, Pavel, KM, Thompson, BM and Scheff, SW (2005).
"Spatial and temporal characteristics of neurodegeneration after controlled
cortical impact in mice: more than a focal brain injury." J Neurotrauma 22(2):
252-265.
Han, J, Kim, HJ, Schafer, ST, Paquola, A, Clemenson, GD, Toda, T, Oh, J, Pankonin,
AR, Lee, BS, Johnston, ST, Sarkar, A, Denli, AM and Gage, FH (2016).
"Functional Implications of miR-19 in the Migration of Newborn Neurons in the
Adult Brain." Neuron 91(1): 79-89.
Han, J, Wang, B, Xiao, Z, Gao, Y, Zhao, Y, Zhang, J, Chen, B, Wang, X and Dai, J
(2008). "Mammalian target of rapamycin (mTOR) is involved in the neuronal
differentiation of neural progenitors induced by insulin." Mol Cell Neurosci
39(1): 118-124.
Harrington, LS, Findlay, GM, Gray, A, Tolkacheva, T, Wigfield, S, Rebholz, H, Barnett,
J, Leslie, NR, Cheng, S, Shepherd, PR, Gout, I, Downes, CP and Lamb, RF
(2004). "The TSC1-2 tumor suppressor controls insulin-PI3K signaling via
regulation of IRS proteins." J Cell Biol 166(2): 213-223.
Hart, T, Brenner, L, Clark, AN, Bogner, JA, Novack, TA, Chervoneva, I, NakaseRichardson, R and Arango-Lasprilla, JC (2011). "Major and minor depression
after traumatic brain injury." Arch Phys Med Rehabil 92(8): 1211-1219.
Hart, T, Kozlowski, AJ, Whyte, J, Poulsen, I, Kristensen, K, Nordenbo, A and
Heinemann, AW (2014). "Functional recovery after severe traumatic brain injury:
an individual growth curve approach." Arch Phys Med Rehabil 95(11): 21032110.
Hartman, NW, Lin, TV, Zhang, L, Paquelet, GE, Feliciano, DM and Bordey, A (2013).
"mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1/2, to
regulate neural stem cell self-renewal in vivo." Cell Rep 5(2): 433-444.
126

Hatton, J, Kryscio, R, Ryan, M, Ott, L and Young, B (2006). "Systemic metabolic effects
of combined insulin-like growth factor-I and growth hormone therapy in patients
who have sustained acute traumatic brain injury." J Neurosurg 105(6): 843-852.
Hatton, J, Rapp, RP, Kudsk, KA, Brown, RO, Luer, MS, Bukar, JG, Chen, SA, McClain,
CJ, Gesundheit, N, Dempsey, RJ and Young, B (1997). "Intravenous insulin-like
growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and
efficacy trial." J Neurosurg 86(5): 779-786.
Hawryluk, GW and Manley, GT (2015). "Classification of traumatic brain injury: past,
present, and future." Handb Clin Neurol 127: 15-21.
Hayward, NM, Tuunanen, PI, Immonen, R, Ndode-Ekane, XE, Pitkanen, A and Grohn, O
(2011). "Magnetic resonance imaging of regional hemodynamic and
cerebrovascular recovery after lateral fluid-percussion brain injury in rats." J
Cereb Blood Flow Metab 31(1): 166-177.
Heigele, S, Sultan, S, Toni, N and Bischofberger, J (2016). "Bidirectional GABAergic
control of action potential firing in newborn hippocampal granule cells." Nat
Neurosci 19(2): 263-270.
Hill, JL, Kobori, N, Zhao, J, Rozas, NS, Hylin, MJ, Moore, AN and Dash, PK (2016).
"Traumatic brain injury decreases AMP-activated protein kinase activity and
pharmacological enhancement of its activity improves cognitive outcome." J
Neurochem 139(1): 106-119.
Holland, MC, Mackersie, RC, Morabito, D, Campbell, AR, Kivett, VA, Patel, R,
Erickson, VR and Pittet, JF (2003). "The development of acute lung injury is
associated with worse neurologic outcome in patients with severe traumatic brain
injury." J Trauma 55(1): 106-111.
Horster, H, Garthe, A, Walker, TL, Ichwan, M, Steiner, B, Khan, MA, Lie, DC, Nicola,
Z, Ramirez-Rodriguez, G and Kempermann, G (2017). "p27kip1 Is Required for
Functionally Relevant Adult Hippocampal Neurogenesis in Mice." Stem Cells
35(3): 787-799.
Huat, TJ, Khan, AA, Pati, S, Mustafa, Z, Abdullah, JM and Jaafar, H (2014). "IGF-1
enhances cell proliferation and survival during early differentiation of
mesenchymal stem cells to neural progenitor-like cells." BMC Neurosci 15: 91.
Hung, CM, Garcia-Haro, L, Sparks, CA and Guertin, DA (2012). "mTOR-dependent cell
survival mechanisms." Cold Spring Harb Perspect Biol 4(12).
Hunt, RF, Scheff, SW and Smith, BN (2010). "Regionally localized recurrent excitation
in the dentate gyrus of a cortical contusion model of posttraumatic epilepsy." J
Neurophysiol 103(3): 1490-1500.
Hunt, RF, Scheff, SW and Smith, BN (2011). "Synaptic reorganization of inhibitory hilar
interneuron circuitry after traumatic brain injury in mice." J Neurosci 31(18):
6880-6890.
Hurtado-Chong, A, Yusta-Boyo, MJ, Vergano-Vera, E, Bulfone, A, de Pablo, F and
Vicario-Abejon, C (2009). "IGF-I promotes neuronal migration and positioning in
the olfactory bulb and the exit of neuroblasts from the subventricular zone." Eur J
Neurosci 30(5): 742-755.
Husson, EC, Ribbers, GM, Willemse-van Son, AH, Verhagen, AP and Stam, HJ (2010).
"Prognosis of six-month functioning after moderate to severe traumatic brain

127

injury: a systematic review of prospective cohort studies." J Rehabil Med 42(5):
425-436.
Hyde, LA, Hoplight, BJ and Denenberg, VH (1998). "Water version of the radial-arm
maze: learning in three inbred strains of mice." Brain Res 785(2): 236-244.
Ibrahim, S, Hu, W, Wang, X, Gao, X, He, C and Chen, J (2016). "Traumatic Brain Injury
Causes Aberrant Migration of Adult-Born Neurons in the Hippocampus." Sci Rep
6: 21793.
Idris, N, Neill, J, Grayson, B, Bang-Andersen, B, Witten, LM, Brennum, LT and Arnt, J
(2010). "Sertindole improves sub-chronic PCP-induced reversal learning and
episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A)
receptor mechanisms." Psychopharmacology (Berl) 208(1): 23-36.
Ishikawa, R, Fukushima, H, Frankland, PW and Kida, S (2016). "Hippocampal
neurogenesis enhancers promote forgetting of remote fear memory after
hippocampal reactivation by retrieval." Elife 5.
Jacotte-Simancas, A, Costa-Miserachs, D, Coll-Andreu, M, Torras-Garcia, M,
Borlongan, CV and Portell-Cortes, I (2015). "Effects of voluntary physical
exercise, citicoline, and combined treatment on object recognition memory,
neurogenesis, and neuroprotection after traumatic brain injury in rats." J
Neurotrauma 32(10): 739-751.
Jagger, J, Vernberg, K and Jane, JA (1987). "Air bags: reducing the toll of brain trauma."
Neurosurgery 20(5): 815-817.
Jaworski, J, Spangler, S, Seeburg, DP, Hoogenraad, CC and Sheng, M (2005). "Control
of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target
of rapamycin pathway." J Neurosci 25(49): 11300-11312.
Jenkins, LW, Peters, GW, Dixon, CE, Zhang, X, Clark, RS, Skinner, JC, Marion, DW,
Adelson, PD and Kochanek, PM (2002). "Conventional and functional proteomics
using large format two-dimensional gel electrophoresis 24 hours after controlled
cortical impact in postnatal day 17 rats." J Neurotrauma 19(6): 715-740.
Jessberger, S, Aigner, S, Clemenson, GD, Jr., Toni, N, Lie, DC, Karalay, O, Overall, R,
Kempermann, G and Gage, FH (2008). "Cdk5 regulates accurate maturation of
newborn granule cells in the adult hippocampus." PLoS Biol 6(11): e272.
Jessberger, S, Romer, B, Babu, H and Kempermann, G (2005). "Seizures induce
proliferation and dispersion of doublecortin-positive hippocampal progenitor
cells." Exp Neurol 196(2): 342-351.
Jessberger, S, Zhao, C, Toni, N, Clemenson, GD, Jr., Li, Y and Gage, FH (2007).
"Seizure-associated, aberrant neurogenesis in adult rats characterized with
retrovirus-mediated cell labeling." J Neurosci 27(35): 9400-9407.
Jinde, S, Zsiros, V and Nakazawa, K (2013). "Hilar mossy cell circuitry controlling
dentate granule cell excitability." Front Neural Circuits 7: 14.
Jinnou, H, Sawada, M, Kawase, K, Kaneko, N, Herranz-Perez, V, Miyamoto, T, Kawaue,
T, Miyata, T, Tabata, Y, Akaike, T, Garcia-Verdugo, JM, Ajioka, I, Saitoh, S and
Sawamoto, K (2018). "Radial Glial Fibers Promote Neuronal Migration and
Functional Recovery after Neonatal Brain Injury." Cell Stem Cell 22(1): 128-137
e129.
Johnson, VE, Meaney, DF, Cullen, DK and Smith, DH (2015). "Animal models of
traumatic brain injury." Handb Clin Neurol 127: 115-128.
128

Joinson, C, O'Callaghan, FJ, Osborne, JP, Martyn, C, Harris, T and Bolton, PF (2003).
"Learning disability and epilepsy in an epidemiological sample of individuals
with tuberous sclerosis complex." Psychol Med 33(2): 335-344.
Jones, DM, Tucker, BA, Rahimtula, M and Mearow, KM (2003). "The synergistic effects
of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on
the PI 3-kinase signaling pathway." J Neurochem 86(5): 1116-1128.
Joseph D'Ercole, A and Ye, P (2008). "Expanding the mind: insulin-like growth factor I
and brain development." Endocrinology 149(12): 5958-5962.
Justova, V, Lacinova, Z, Melenovsky, V, Marek, J, Holly, JM and Hass, T (2001). "The
changes of IGF binding proteins after rhGH administration to patients totally
dependent on parenteral nutrition." Growth Horm IGF Res 11(6): 407-415.
Kappeler, L, De Magalhaes Filho, C, Dupont, J, Leneuve, P, Cervera, P, Perin, L,
Loudes, C, Blaise, A, Klein, R, Epelbaum, J, Le Bouc, Y and Holzenberger, M
(2008). "Brain IGF-1 receptors control mammalian growth and lifespan through a
neuroendocrine mechanism." PLoS Biol 6(10): e254.
Karelina, K, Hansen, KF, Choi, YS, DeVries, AC, Arthur, JS and Obrietan, K (2012).
"MSK1 regulates environmental enrichment-induced hippocampal plasticity and
cognitive enhancement." Learn Mem 19(11): 550-560.
Kempermann, G and Gage, FH (2002). "Genetic influence on phenotypic differentiation
in adult hippocampal neurogenesis." Brain Res Dev Brain Res 134(1-2): 1-12.
Kempermann, G, Gast, D, Kronenberg, G, Yamaguchi, M and Gage, FH (2003). "Early
determination and long-term persistence of adult-generated new neurons in the
hippocampus of mice." Development 130(2): 391-399.
Kempermann, G, Song, H and Gage, FH (2015). "Neurogenesis in the Adult
Hippocampus." Cold Spring Harb Perspect Biol 7(9): a018812.
Kernie, SG, Erwin, TM and Parada, LF (2001). "Brain remodeling due to neuronal and
astrocytic proliferation after controlled cortical injury in mice." J Neurosci Res
66(3): 317-326.
Kilincaslan, A, Kok, BE, Tekturk, P, Yalcinkaya, C, Ozkara, C and Yapici, Z (2017).
"Beneficial Effects of Everolimus on Autism and Attention-Deficit/Hyperactivity
Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex." J
Child Adolesc Psychopharmacol 27(4): 383-388.
Kim, B, Leventhal, PS, Saltiel, AR and Feldman, EL (1997). "Insulin-like growth factorI-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase
activation." J Biol Chem 272(34): 21268-21273.
Kim, JY, Duan, X, Liu, CY, Jang, MH, Guo, JU, Pow-anpongkul, N, Kang, E, Song, H
and Ming, GL (2009). "DISC1 regulates new neuron development in the adult
brain via modulation of AKT-mTOR signaling through KIAA1212." Neuron
63(6): 761-773.
Kim, S, Lee, SH, Kim, JH, Jeong, YW, Hashem, MA, Koo, OJ, Park, SM, Lee, EG,
Hossein, MS, Kang, SK, Lee, BC and Hwang, WS (2006). "Anti-apoptotic effect
of insulin-like growth factor (IGF)-I and its receptor in porcine preimplantation
embryos derived from in vitro fertilization and somatic cell nuclear transfer." Mol
Reprod Dev 73(12): 1523-1530.
Kim, WR, Kim, Y, Eun, B, Park, OH, Kim, H, Kim, K, Park, CH, Vinsant, S,
Oppenheim, RW and Sun, W (2007). "Impaired migration in the rostral migratory
129

stream but spared olfactory function after the elimination of programmed cell
death in Bax knock-out mice." J Neurosci 27(52): 14392-14403.
Kishi, T, Yoshimura, R, Ikuta, T and Iwata, N (2017). "Brain-Derived Neurotrophic
Factor and Major Depressive Disorder: Evidence from Meta-Analyses." Front
Psychiatry 8: 308.
Kjelstrup, KG, Tuvnes, FA, Steffenach, HA, Murison, R, Moser, EI and Moser, MB
(2002). "Reduced fear expression after lesions of the ventral hippocampus." Proc
Natl Acad Sci U S A 99(16): 10825-10830.
Kleindienst, A, McGinn, MJ, Harvey, HB, Colello, RJ, Hamm, RJ and Bullock, MR
(2005). "Enhanced hippocampal neurogenesis by intraventricular S100B infusion
is associated with improved cognitive recovery after traumatic brain injury." J
Neurotrauma 22(6): 645-655.
Kleinknecht, KR, Bedenk, BT, Kaltwasser, SF, Grunecker, B, Yen, YC, Czisch, M and
Wotjak, CT (2012). "Hippocampus-dependent place learning enables spatial
flexibility in C57BL6/N mice." Front Behav Neurosci 6: 87.
Knierim, JJ (2015). "The hippocampus." Curr Biol 25(23): R1116-1121.
Knoth, R, Singec, I, Ditter, M, Pantazis, G, Capetian, P, Meyer, RP, Horvat, V, Volk, B
and Kempermann, G (2010). "Murine features of neurogenesis in the human
hippocampus across the lifespan from 0 to 100 years." PLoS One 5(1): e8809.
Konigs, M, Engenhorst, PJ and Oosterlaan, J (2016). "Intelligence after traumatic brain
injury: meta-analysis of outcomes and prognosis." Eur J Neurol 23(1): 21-29.
Kopczak, A, Stalla, GK, Uhr, M, Lucae, S, Hennings, J, Ising, M, Holsboer, F and
Kloiber, S (2015). "IGF-I in major depression and antidepressant treatment
response." Eur Neuropsychopharmacol 25(6): 864-872.
Kotulska, K, Borkowska, J, Mandera, M, Roszkowski, M, Jurkiewicz, E, Grajkowska, W,
Bilska, M and Jozwiak, S (2014). "Congenital subependymal giant cell
astrocytomas in patients with tuberous sclerosis complex." Childs Nerv Syst
30(12): 2037-2042.
Krishnan, V and Nestler, EJ (2011). "Animal models of depression: molecular
perspectives." Curr Top Behav Neurosci 7: 121-147.
Kuhn, HG, Dickinson-Anson, H and Gage, FH (1996). "Neurogenesis in the dentate
gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation." J
Neurosci 16(6): 2027-2033.
Kumar, V, Zhang, MX, Swank, MW, Kunz, J and Wu, GY (2005). "Regulation of
dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling
pathways." J Neurosci 25(49): 11288-11299.
Kurland, D, Hong, C, Aarabi, B, Gerzanich, V and Simard, JM (2012). "Hemorrhagic
progression of a contusion after traumatic brain injury: a review." J Neurotrauma
29(1): 19-31.
Langlois, JA, Rutland-Brown, W and Wald, MM (2006). "The epidemiology and impact
of traumatic brain injury: a brief overview." J Head Trauma Rehabil 21(5): 375378.
Laplante, M and Sabatini, DM (2009). "mTOR signaling at a glance." J Cell Sci 122(Pt
20): 3589-3594.
Laplante, M and Sabatini, DM (2012). "mTOR signaling in growth control and disease."
Cell 149(2): 274-293.
130

Larpthaveesarp, A, Ferriero, DM and Gonzalez, FF (2015). "Growth factors for the
treatment of ischemic brain injury (growth factor treatment)." Brain Sci 5(2): 165177.
Le Greves, M, Le Greves, P and Nyberg, F (2005). "Age-related effects of IGF-1 on the
NMDA-, GH- and IGF-1-receptor mRNA transcripts in the rat hippocampus."
Brain Res Bull 65(5): 369-374.
Le Greves, M, Zhou, Q, Berg, M, Le Greves, P, Fholenhag, K, Meyerson, B and Nyberg,
F (2006). "Growth hormone replacement in hypophysectomized rats affects
spatial performance and hippocampal levels of NMDA receptor subunit and PSD95 gene transcript levels." Exp Brain Res 173(2): 267-273.
Lee, C and Agoston, DV (2010). "Vascular endothelial growth factor is involved in
mediating increased de novo hippocampal neurogenesis in response to traumatic
brain injury." J Neurotrauma 27(3): 541-553.
Lee, DY (2015). "Roles of mTOR Signaling in Brain Development." Exp Neurobiol
24(3): 177-185.
Lee, TK, Chen, BH, Lee, JC, Shin, MC, Cho, JH, Lee, HA, Choi, JH, Hwang, IK, Kang,
IJ, Ahn, JH, Park, JH, Choi, SY and Won, MH (2018). "Agedependent decreases
in insulinlike growth factorI and its receptor expressions in the gerbil olfactory
bulb." Mol Med Rep 17(6): 8161-8166.
Leunissen, I, Coxon, JP, Caeyenberghs, K, Michiels, K, Sunaert, S and Swinnen, SP
(2014). "Subcortical volume analysis in traumatic brain injury: the importance of
the fronto-striato-thalamic circuit in task switching." Cortex 51: 67-81.
Li, Y, Sun, W, Han, S, Li, J, Ding, S, Wang, W and Yin, Y (2017). "IGF-1-Involved
Negative Feedback of NR2B NMDA Subunits Protects Cultured Hippocampal
Neurons Against NMDA-Induced Excitotoxicity." Mol Neurobiol 54(1): 684-696.
Liu, L, Brown, JC, 3rd, Webster, WW, Morrisett, RA and Monaghan, DT (1995).
"Insulin potentiates N-methyl-D-aspartate receptor activity in Xenopus oocytes
and rat hippocampus." Neurosci Lett 192(1): 5-8.
Liu, W, Ye, P, O'Kusky, JR and D'Ercole, AJ (2009). "Type 1 insulin-like growth factor
receptor signaling is essential for the development of the hippocampal formation
and dentate gyrus." J Neurosci Res 87(13): 2821-2832.
Lovblad, KO, Schaller, K and Vargas, MI (2014). "The fornix and limbic system." Semin
Ultrasound CT MR 35(5): 459-473.
Lowenstein, DH, Thomas, MJ, Smith, DH and McIntosh, TK (1992). "Selective
vulnerability of dentate hilar neurons following traumatic brain injury: a potential
mechanistic link between head trauma and disorders of the hippocampus." J
Neurosci 12(12): 4846-4853.
Lu, D, Mahmood, A, Qu, C, Goussev, A, Schallert, T and Chopp, M (2005).
"Erythropoietin enhances neurogenesis and restores spatial memory in rats after
traumatic brain injury." J Neurotrauma 22(9): 1011-1017.
Lu, D, Qu, C, Goussev, A, Jiang, H, Lu, C, Schallert, T, Mahmood, A, Chen, J, Li, Y and
Chopp, M (2007). "Statins increase neurogenesis in the dentate gyrus, reduce
delayed neuronal death in the hippocampal CA3 region, and improve spatial
learning in rat after traumatic brain injury." J Neurotrauma 24(7): 1132-1146.
Lyeth, BG, Jenkins, LW, Hamm, RJ, Dixon, CE, Phillips, LL, Clifton, GL, Young, HF
and Hayes, RL (1990). "Prolonged memory impairment in the absence of
131

hippocampal cell death following traumatic brain injury in the rat." Brain Res
526(2): 249-258.
Maas, AI, Marmarou, A, Murray, GD, Teasdale, SG and Steyerberg, EW (2007).
"Prognosis and clinical trial design in traumatic brain injury: the IMPACT study."
J Neurotrauma 24(2): 232-238.
Madathil, SK, Carlson, SW, Brelsfoard, JM, Ye, P, D'Ercole, AJ and Saatman, KE
(2013). "Astrocyte-Specific Overexpression of Insulin-Like Growth Factor-1
Protects Hippocampal Neurons and Reduces Behavioral Deficits following
Traumatic Brain Injury in Mice." PLoS One 8(6): e67204.
Madathil, SK, Evans, HN and Saatman, KE (2010). "Temporal and regional changes in
IGF-1/IGF-1R signaling in the mouse brain after traumatic brain injury." J
Neurotrauma 27(1): 95-107.
Magri, L and Galli, R (2013). "mTOR signaling in neural stem cells: from basic biology
to disease." Cell Mol Life Sci 70(16): 2887-2898.
Mahmood, A, Lu, D, Qu, C, Goussev, A, Zhang, ZG, Lu, C and Chopp, M (2007).
"Treatment of traumatic brain injury in rats with erythropoietin and carbamylated
erythropoietin." J Neurosurg 107(2): 392-397.
Mairet-Coello, G, Tury, A and DiCicco-Bloom, E (2009). "Insulin-like growth factor-1
promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins
and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt
pathway in developing rat cerebral cortex." J Neurosci 29(3): 775-788.
Mander, BA, Rao, V, Lu, B, Saletin, JM, Lindquist, JR, Ancoli-Israel, S, Jagust, W and
Walker, MP (2013). "Prefrontal atrophy, disrupted NREM slow waves and
impaired hippocampal-dependent memory in aging." Nat Neurosci 16(3): 357364.
Marais, L, Stein, DJ and Daniels, WM (2009). "Exercise increases BDNF levels in the
striatum and decreases depressive-like behavior in chronically stressed rats."
Metab Brain Dis 24(4): 587-597.
Marklund, N and Hillered, L (2011). "Animal modelling of traumatic brain injury in
preclinical drug development: where do we go from here?" Br J Pharmacol
164(4): 1207-1229.
Martin, LA, Tan, SS and Goldowitz, D (2002). "Clonal architecture of the mouse
hippocampus." J Neurosci 22(9): 3520-3530.
Matsuo, R, Ago, T, Kamouchi, M, Kuroda, J, Kuwashiro, T, Hata, J, Sugimori, H,
Fukuda, K, Gotoh, S, Makihara, N, Fukuhara, M, Awano, H, Isomura, T, Suzuki,
K, Yasaka, M, Okada, Y, Kiyohara, Y and Kitazono, T (2013). "Clinical
significance of plasma VEGF value in ischemic stroke - research for biomarkers
in ischemic stroke (REBIOS) study." BMC Neurol 13: 32.
Meehan, WP, 3rd, Mannix, RC, O'Brien, MJ and Collins, MW (2013). "The prevalence
of undiagnosed concussions in athletes." Clin J Sport Med 23(5): 339-342.
Meikle, L, Talos, DM, Onda, H, Pollizzi, K, Rotenberg, A, Sahin, M, Jensen, FE and
Kwiatkowski, DJ (2007). "A mouse model of tuberous sclerosis: neuronal loss of
Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity,
and limited survival." J Neurosci 27(21): 5546-5558.
Mendoza, MC, Er, EE and Blenis, J (2011). "The Ras-ERK and PI3K-mTOR pathways:
cross-talk and compensation." Trends Biochem Sci 36(6): 320-328.
132

Meng, Y, Chopp, M, Zhang, Y, Liu, Z, An, A, Mahmood, A and Xiong, Y (2014).
"Subacute intranasal administration of tissue plasminogen activator promotes
neuroplasticity and improves functional recovery following traumatic brain injury
in rats." PLoS One 9(9): e106238.
Miller, JF, Neufang, M, Solway, A, Brandt, A, Trippel, M, Mader, I, Hefft, S, Merkow,
M, Polyn, SM, Jacobs, J, Kahana, MJ and Schulze-Bonhage, A (2013). "Neural
activity in human hippocampal formation reveals the spatial context of retrieved
memories." Science 342(6162): 1111-1114.
Miltiadous, P, Stamatakis, A, Koutsoudaki, PN, Tiniakos, DG and Stylianopoulou, F
(2011). "IGF-I ameliorates hippocampal neurodegeneration and protects against
cognitive deficits in an animal model of temporal lobe epilepsy." Exp Neurol
231(2): 223-235.
Molina, DP, Ariwodola, OJ, Linville, C, Sonntag, WE, Weiner, JL, Brunso-Bechtold, JK
and Adams, MM (2012). "Growth hormone modulates hippocampal excitatory
synaptic transmission and plasticity in old rats." Neurobiol Aging 33(9): 19381949.
Morales, DM, Marklund, N, Lebold, D, Thompson, HJ, Pitkanen, A, Maxwell, WL,
Longhi, L, Laurer, H, Maegele, M, Neugebauer, E, Graham, DI, Stocchetti, N and
McIntosh, TK (2005). "Experimental models of traumatic brain injury: do we
really need to build a better mousetrap?" Neuroscience 136(4): 971-989.
Morganti, JM, Jopson, TD, Liu, S, Riparip, LK, Guandique, CK, Gupta, N, Ferguson, AR
and Rosi, S (2015). "CCR2 antagonism alters brain macrophage polarization and
ameliorates cognitive dysfunction induced by traumatic brain injury." J Neurosci
35(2): 748-760.
Mori, T, Wang, X, Jung, JC, Sumii, T, Singhal, AB, Fini, ME, Dixon, CE, Alessandrini,
A and Lo, EH (2002). "Mitogen-activated protein kinase inhibition in traumatic
brain injury: in vitro and in vivo effects." J Cereb Blood Flow Metab 22(4): 444452.
Moser, E, Moser, MB and Andersen, P (1993). "Spatial learning impairment parallels the
magnitude of dorsal hippocampal lesions, but is hardly present following ventral
lesions." J Neurosci 13(9): 3916-3925.
Muhic, M, Vardjan, N, Chowdhury, HH, Zorec, R and Kreft, M (2015). "Insulin and
Insulin-like Growth Factor 1 (IGF-1) Modulate Cytoplasmic Glucose and
Glycogen Levels but Not Glucose Transport across the Membrane in Astrocytes."
J Biol Chem 290(17): 11167-11176.
Myers, CE, Bermudez-Hernandez, K and Scharfman, HE (2013). "The influence of
ectopic migration of granule cells into the hilus on dentate gyrus-CA3 function."
PLoS One 8(6): e68208.
Nakase-Richardson, R, Sepehri, A, Sherer, M, Yablon, SA, Evans, C and Mani, T (2009).
"Classification schema of posttraumatic amnesia duration-based injury severity
relative to 1-year outcome: analysis of individuals with moderate and severe
traumatic brain injury." Arch Phys Med Rehabil 90(1): 17-19.
Neuberger, EJ, Swietek, B, Corrubia, L, Prasanna, A and Santhakumar, V (2017).
"Enhanced Dentate Neurogenesis after Brain Injury Undermines Long-Term
Neurogenic Potential and Promotes Seizure Susceptibility." Stem Cell Reports
9(3): 972-984.
133

Ng, T, Hor, CH, Chew, B, Zhao, J, Zhong, Z, Ryu, JR and Goh, EL (2016). "Neuropilin 2
Signaling Is Involved in Cell Positioning of Adult-born Neurons through
Glycogen Synthase Kinase-3beta (GSK3beta)." J Biol Chem 291(48): 2508825095.
Nieto-Estevez, V, Defterali, C and Vicario-Abejon, C (2016). "IGF-I: A Key Growth
Factor that Regulates Neurogenesis and Synaptogenesis from Embryonic to Adult
Stages of the Brain." Front Neurosci 10: 52.
Nieto-Estevez, V, Oueslati-Morales, CO, Li, L, Pickel, J, Morales, AV and VicarioAbejon, C (2016). "Brain Insulin-Like Growth Factor-I Directs the Transition
from Stem Cells to Mature Neurons During Postnatal/Adult Hippocampal
Neurogenesis." Stem Cells 34(8): 2194-2209.
Nikolaeva, I, Crowell, B, Valenziano, J, Meaney, D and D'Arcangelo, G (2016).
"Beneficial Effects of Early mTORC1 Inhibition after Traumatic Brain Injury." J
Neurotrauma 33(2): 183-193.
Ning, R, Xiong, Y, Mahmood, A, Zhang, Y, Meng, Y, Qu, C and Chopp, M (2011).
"Erythropoietin promotes neurovascular remodeling and long-term functional
recovery in rats following traumatic brain injury." Brain Res 1384: 140-150.
Niv, F, Keiner, S, Krishna, Witte, OW, Lie, DC and Redecker, C (2012). "Aberrant
neurogenesis after stroke: a retroviral cell labeling study." Stroke 43(9): 24682475.
Nixon, K, Kim, DH, Potts, EN, He, J and Crews, FT (2008). "Distinct cell proliferation
events during abstinence after alcohol dependence: microglia proliferation
precedes neurogenesis." Neurobiol Dis 31(2): 218-229.
O'Kusky, J and Ye, P (2012). "Neurodevelopmental effects of insulin-like growth factor
signaling." Front Neuroendocrinol 33(3): 230-251.
Ocrant, I, Valentino, KL, Eng, LF, Hintz, RL, Wilson, DM and Rosenfeld, RG (1988).
"Structural and immunohistochemical characterization of insulin-like growth
factor I and II receptors in the murine central nervous system." Endocrinology
123(2): 1023-1034.
Orozco, OE, Walus, L, Sah, DW, Pepinsky, RB and Sanicola, M (2001). "GFRalpha3 is
expressed predominantly in nociceptive sensory neurons." Eur J Neurosci 13(11):
2177-2182.
Osier, ND and Dixon, CE (2016). "The Controlled Cortical Impact Model: Applications,
Considerations for Researchers, and Future Directions." Front Neurol 7: 134.
Otaegi, G, Yusta-Boyo, MJ, Vergano-Vera, E, Mendez-Gomez, HR, Carrera, AC, Abad,
JL, Gonzalez, M, de la Rosa, EJ, Vicario-Abejon, C and de Pablo, F (2006).
"Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN
regulates the differentiation of neural stem/precursor cells." J Cell Sci 119(Pt 13):
2739-2748.
Paliouras, GN, Hamilton, LK, Aumont, A, Joppe, SE, Barnabe-Heider, F and Fernandes,
KJ (2012). "Mammalian target of rapamycin signaling is a key regulator of the
transit-amplifying progenitor pool in the adult and aging forebrain." J Neurosci
32(43): 15012-15026.
Palmer, TD, Willhoite, AR and Gage, FH (2000). "Vascular niche for adult hippocampal
neurogenesis." J Comp Neurol 425(4): 479-494.

134

Parent, JM, Yu, TW, Leibowitz, RT, Geschwind, DH, Sloviter, RS and Lowenstein, DH
(1997). "Dentate granule cell neurogenesis is increased by seizures and
contributes to aberrant network reorganization in the adult rat hippocampus." J
Neurosci 17(10): 3727-3738.
Park, J, Zhang, J, Qiu, J, Zhu, X, Degterev, A, Lo, EH and Whalen, MJ (2012).
"Combination therapy targeting Akt and mammalian target of rapamycin
improves functional outcome after controlled cortical impact in mice." J Cereb
Blood Flow Metab 32(2): 330-340.
Patel, AD, Gerzanich, V, Geng, Z and Simard, JM (2010). "Glibenclamide reduces
hippocampal injury and preserves rapid spatial learning in a model of traumatic
brain injury." J Neuropathol Exp Neurol 69(12): 1177-1190.
Patnaik, A, et al. (2016). "First-in-human phase I study of copanlisib (BAY 80-6946), an
intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with
advanced solid tumors and non-Hodgkin's lymphomas." Ann Oncol 27(10): 19281940.
Peineau, S, Taghibiglou, C, Bradley, C, Wong, TP, Liu, L, Lu, J, Lo, E, Wu, D, Saule, E,
Bouschet, T, Matthews, P, Isaac, JT, Bortolotto, ZA, Wang, YT and Collingridge,
GL (2007). "LTP inhibits LTD in the hippocampus via regulation of GSK3beta."
Neuron 53(5): 703-717.
Perera, TD, Dwork, AJ, Keegan, KA, Thirumangalakudi, L, Lipira, CM, Joyce, N,
Lange, C, Higley, JD, Rosoklija, G, Hen, R, Sackeim, HA and Coplan, JD (2011).
"Necessity of hippocampal neurogenesis for the therapeutic action of
antidepressants in adult nonhuman primates." PLoS One 6(4): e17600.
Perluigi, M, Di Domenico, F and Butterfield, DA (2015). "mTOR signaling in aging and
neurodegeneration: At the crossroad between metabolism dysfunction and
impairment of autophagy." Neurobiol Dis 84: 39-49.
Phillips, C (2017). "Brain-Derived Neurotrophic Factor, Depression, and Physical
Activity: Making the Neuroplastic Connection." Neural Plast 2017: 7260130.
Pierce, JE, Smith, DH, Trojanowski, JQ and McIntosh, TK (1998). "Enduring cognitive,
neurobehavioral and histopathological changes persist for up to one year
following severe experimental brain injury in rats." Neuroscience 87(2): 359-369.
Pleasant, JM, Carlson, SW, Mao, H, Scheff, SW, Yang, KH and Saatman, KE (2011).
"Rate of neurodegeneration in the mouse controlled cortical impact model is
influenced by impactor tip shape: implications for mechanistic and therapeutic
studies." J Neurotrauma 28(11): 2245-2262.
Pomerance, M, Gavaret, JM, Jacquemin, C, Matricon, C, Toru-Delbauffe, D and Pierre,
M (1988). "Insulin and insulin-like growth factor 1 receptors during postnatal
development of rat brain." Brain Res 470(1): 77-83.
Popescu, C, Anghelescu, A, Daia, C and Onose, G (2015). "Actual data on
epidemiological evolution and prevention endeavours regarding traumatic brain
injury." J Med Life 8(3): 272-277.
Popken, GJ, Dechert-Zeger, M, Ye, P and D'Ercole, AJ (2005). "Brain development."
Adv Exp Med Biol 567: 187-220.
Rabinowitz, AR and Levin, HS (2014). "Cognitive sequelae of traumatic brain injury."
Psychiatr Clin North Am 37(1): 1-11.

135

Radomski, KL, Zhou, Q, Yi, KJ and Doughty, ML (2013). "Cortical contusion injury
disrupts olfactory bulb neurogenesis in adult mice." BMC Neurosci 14: 142.
Rastogi, R, Jiang, Z, Ahmad, N, Rosati, R, Liu, Y, Beuret, L, Monks, R, Charron, J,
Birnbaum, MJ and Samavati, L (2013). "Rapamycin induces mitogen-activated
protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of
protein kinase B and mitogen-activated protein kinase kinase pathways." J Biol
Chem 288(47): 33966-33977.
Ratcliff, G, Colantonio, A, Escobar, M, Chase, S and Vernich, L (2005). "Long-term
survival following traumatic brain injury." Disabil Rehabil 27(6): 305-314.
Reneer, DV, Hisel, RD, Hoffman, JM, Kryscio, RJ, Lusk, BT and Geddes, JW (2011). "A
multi-mode shock tube for investigation of blast-induced traumatic brain injury."
J Neurotrauma 28(1): 95-104.
Reuveni, H, Flashner-Abramson, E, Steiner, L, Makedonski, K, Song, R, Shir, A, Herlyn,
M, Bar-Eli, M and Levitzki, A (2013). "Therapeutic destruction of insulin
receptor substrates for cancer treatment." Cancer Res 73(14): 4383-4394.
Rhim, JH, Luo, X, Gao, D, Xu, X, Zhou, T, Li, F, Wang, P, Wong, ST and Xia, X (2016).
"Cell type-dependent Erk-Akt pathway crosstalk regulates the proliferation of
fetal neural progenitor cells." Sci Rep 6: 26547.
Robel, S, Berninger, B and Gotz, M (2011). "The stem cell potential of glia: lessons from
reactive gliosis." Nat Rev Neurosci 12(2): 88-104.
Robinson, C, Apgar, C and Shapiro, LA (2016). "Astrocyte Hypertrophy Contributes to
Aberrant Neurogenesis after Traumatic Brain Injury." Neural Plast 2016:
1347987.
Rockich, KT, Hatton, JC, Kryscio, RJ, Young, BA and Blouin, RA (1999). "Effect of
recombinant human growth hormone and insulin-like growth factor-1
administration on IGF-1 and IGF-binding protein-3 levels in brain injury."
Pharmacotherapy 19(12): 1432-1436.
Rola, R, Mizumatsu, S, Otsuka, S, Morhardt, DR, Noble-Haeusslein, LJ, Fishman, K,
Potts, MB and Fike, JR (2006). "Alterations in hippocampal neurogenesis
following traumatic brain injury in mice." Exp Neurol 202(1): 189-199.
Rong, Z, Pan, R, Chang, L and Lee, W (2015). "Combination treatment with ethyl
pyruvate and IGF-I exerts neuroprotective effects against brain injury in a rat
model of neonatal hypoxic-ischemic encephalopathy." Int J Mol Med 36(1): 195203.
Rosenfeld, RG (2006). "Molecular mechanisms of IGF-I deficiency." Horm Res 65
Suppl 1: 15-20.
Rosset, C, Netto, CBO and Ashton-Prolla, P (2017). "TSC1 and TSC2 gene mutations
and their implications for treatment in Tuberous Sclerosis Complex: a review."
Genet Mol Biol 40(1): 69-79.
Rozas, NS, Redell, JB, Hill, JL, McKenna, J, 3rd, Moore, AN, Gambello, MJ and Dash,
PK (2015). "Genetic activation of mTORC1 signaling worsens neurocognitive
outcome after traumatic brain injury." J Neurotrauma 32(2): 149-158.
Rozengurt, E, Soares, HP and Sinnet-Smith, J (2014). "Suppression of feedback loops
mediated by PI3K/mTOR induces multiple overactivation of compensatory
pathways: an unintended consequence leading to drug resistance." Mol Cancer
Ther 13(11): 2477-2488.
136

Rubin, RD, Watson, PD, Duff, MC and Cohen, NJ (2014). "The role of the hippocampus
in flexible cognition and social behavior." Front Hum Neurosci 8: 742.
Rubovitch, V, Edut, S, Sarfstein, R, Werner, H and Pick, CG (2010). "The intricate
involvement of the Insulin-like growth factor receptor signaling in mild traumatic
brain injury in mice." Neurobiol Dis 38(2): 299-303.
Ryu, JR, Hong, CJ, Kim, JY, Kim, EK, Sun, W and Yu, SW (2016). "Control of adult
neurogenesis by programmed cell death in the mammalian brain." Mol Brain 9:
43.
Saatman, KE, Contreras, PC, Smith, DH, Raghupathi, R, McDermott, KL, Fernandez,
SC, Sanderson, KL, Voddi, M and McIntosh, TK (1997). "Insulin-like growth
factor-1 (IGF-1) improves both neurological motor and cognitive outcome
following experimental brain injury." Exp Neurol 147(2): 418-427.
Saatman, KE, Duhaime, AC, Bullock, R, Maas, AI, Valadka, A, Manley, GT, Workshop
Scientific, T and Advisory Panel, M (2008). "Classification of traumatic brain
injury for targeted therapies." J Neurotrauma 25(7): 719-738.
Saha, B, Peron, S, Murray, K, Jaber, M and Gaillard, A (2013). "Cortical lesion
stimulates adult subventricular zone neural progenitor cell proliferation and
migration to the site of injury." Stem Cell Res 11(3): 965-977.
Saha, R, Knapp, S, Chakraborty, D, Horovitz, O, Albrecht, A, Kriebel, M, Kaphzan, H,
Ehrlich, I, Volkmer, H and Richter-Levin, G (2017). "GABAergic Synapses at the
Axon Initial Segment of Basolateral Amygdala Projection Neurons Modulate Fear
Extinction." Neuropsychopharmacology 42(2): 473-484.
Sahay, A, Scobie, KN, Hill, AS, O'Carroll, CM, Kheirbek, MA, Burghardt, NS, Fenton,
AA, Dranovsky, A and Hen, R (2011). "Increasing adult hippocampal
neurogenesis is sufficient to improve pattern separation." Nature 472(7344): 466470.
Samueli, S, Abraham, K, Dressler, A, Groppel, G, Muhlebner-Fahrngruber, A, Scholl, T,
Kasprian, G, Laccone, F and Feucht, M (2016). "Efficacy and safety of
Everolimus in children with TSC - associated epilepsy - Pilot data from an open
single-center prospective study." Orphanet J Rare Dis 11(1): 145.
Sasaoka, T, Ishiki, M, Wada, T, Hori, H, Hirai, H, Haruta, T, Ishihara, H and Kobayashi,
M (2001). "Tyrosine phosphorylation-dependent and -independent role of Shc in
the regulation of IGF-1-induced mitogenesis and glycogen synthesis."
Endocrinology 142(12): 5226-5235.
Schachar, RJ, Park, LS and Dennis, M (2015). "Mental Health Implications of Traumatic
Brain Injury (TBI) in Children and Youth." J Can Acad Child Adolesc Psychiatry
24(2): 100-108.
Scharfman, H, Goodman, J, Macleod, A, Phani, S, Antonelli, C and Croll, S (2005).
"Increased neurogenesis and the ectopic granule cells after intrahippocampal
BDNF infusion in adult rats." Exp Neurol 192(2): 348-356.
Scharfman, H, Goodman, J and McCloskey, D (2007). "Ectopic granule cells of the rat
dentate gyrus." Dev Neurosci 29(1-2): 14-27.
Scharfman, HE (2016). "The enigmatic mossy cell of the dentate gyrus." Nat Rev
Neurosci 17(9): 562-575.
Scharfman, HE, Goodman, JH and Sollas, AL (2000). "Granule-like neurons at the
hilar/CA3 border after status epilepticus and their synchrony with area CA3
137

pyramidal cells: functional implications of seizure-induced neurogenesis." J
Neurosci 20(16): 6144-6158.
Scharfman, HE, Sollas, AE, Berger, RE, Goodman, JH and Pierce, JP (2003). "Perforant
path activation of ectopic granule cells that are born after pilocarpine-induced
seizures." Neuroscience 121(4): 1017-1029.
Scheff, SW, Baldwin, SA, Brown, RW and Kraemer, PJ (1997). "Morris water maze
deficits in rats following traumatic brain injury: lateral controlled cortical impact."
J Neurotrauma 14(9): 615-627.
Schmidt-Hieber, C, Jonas, P and Bischofberger, J (2004). "Enhanced synaptic plasticity
in newly generated granule cells of the adult hippocampus." Nature 429(6988):
184-187.
Schober, ME, Block, B, Beachy, JC, Statler, KD, Giza, CC and Lane, RH (2010). "Early
and sustained increase in the expression of hippocampal IGF-1, but not EPO, in a
developmental rodent model of traumatic brain injury." J Neurotrauma 27(11):
2011-2020.
Schoch, KM, Madathil, SK and Saatman, KE (2012). "Genetic manipulation of cell death
and neuroplasticity pathways in traumatic brain injury." Neurotherapeutics 9(2):
323-337.
Schumacher, R, Mosthaf, L, Schlessinger, J, Brandenburg, D and Ullrich, A (1991).
"Insulin and insulin-like growth factor-1 binding specificity is determined by
distinct regions of their cognate receptors." J Biol Chem 266(29): 19288-19295.
Selassie, AW, Zaloshnja, E, Langlois, JA, Miller, T, Jones, P and Steiner, C (2008).
"Incidence of long-term disability following traumatic brain injury
hospitalization, United States, 2003." J Head Trauma Rehabil 23(2): 123-131.
Selenica, ML, Benner, L, Housley, SB, Manchec, B, Lee, DC, Nash, KR, Kalin, J,
Bergman, JA, Kozikowski, A, Gordon, MN and Morgan, D (2014). "Histone
deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse
model of tau deposition." Alzheimers Res Ther 6(1): 12.
Sengupta, S, Peterson, TR and Sabatini, DM (2010). "Regulation of the mTOR complex
1 pathway by nutrients, growth factors, and stress." Mol Cell 40(2): 310-322.
Seo, DO, Carillo, MA, Chih-Hsiung Lim, S, Tanaka, KF and Drew, MR (2015). "Adult
Hippocampal Neurogenesis Modulates Fear Learning through Associative and
Nonassociative Mechanisms." J Neurosci 35(32): 11330-11345.
Seto, B (2012). "Rapamycin and mTOR: a serendipitous discovery and implications for
breast cancer." Clin Transl Med 1(1): 29.
Shah, A, Jhawar, SS and Goel, A (2012). "Analysis of the anatomy of the Papez circuit
and adjoining limbic system by fiber dissection techniques." J Clin Neurosci
19(2): 289-298.
Shah, OJ and Hunter, T (2006). "Turnover of the active fraction of IRS1 involves raptormTOR- and S6K1-dependent serine phosphorylation in cell culture models of
tuberous sclerosis." Mol Cell Biol 26(17): 6425-6434.
Shapiro, LA (2017). "Altered Hippocampal Neurogenesis during the First 7 Days after a
Fluid Percussion Traumatic Brain Injury." Cell Transplant 26(7): 1314-1318.
Sherer, M, Struchen, MA, Yablon, SA, Wang, Y and Nick, TG (2008). "Comparison of
indices of traumatic brain injury severity: Glasgow Coma Scale, length of coma
and post-traumatic amnesia." J Neurol Neurosurg Psychiatry 79(6): 678-685.
138

Shi, L, Linville, MC, Tucker, EW, Sonntag, WE and Brunso-Bechtold, JK (2005).
"Differential effects of aging and insulin-like growth factor-1 on synapses in CA1
of rat hippocampus." Cereb Cortex 15(5): 571-577.
Shiurba, RA, Spooner, ET, Ishiguro, K, Takahashi, M, Yoshida, R, Wheelock, TR,
Imahori, K, Cataldo, AM and Nixon, RA (1998). "Immunocytochemistry of
formalin-fixed human brain tissues: microwave irradiation of free-floating
sections." Brain Res Brain Res Protoc 2(2): 109-119.
Shively, S, Scher, AI, Perl, DP and Diaz-Arrastia, R (2012). "Dementia resulting from
traumatic brain injury: what is the pathology?" Arch Neurol 69(10): 1245-1251.
Shukitt-Hale, B, McEwen, JJ, Szprengiel, A and Joseph, JA (2004). "Effect of age on the
radial arm water maze-a test of spatial learning and memory." Neurobiol Aging
25(2): 223-229.
Skeberdis, VA, Lan, J, Zheng, X, Zukin, RS and Bennett, MV (2001). "Insulin promotes
rapid delivery of N-methyl-D- aspartate receptors to the cell surface by
exocytosis." Proc Natl Acad Sci U S A 98(6): 3561-3566.
Slaughter, B, Fann, JR and Ehde, D (2003). "Traumatic brain injury in a county jail
population: prevalence, neuropsychological functioning and psychiatric
disorders." Brain Inj 17(9): 731-741.
Sleiman, SF, Henry, J, Al-Haddad, R, El Hayek, L, Abou Haidar, E, Stringer, T, Ulja, D,
Karuppagounder, SS, Holson, EB, Ratan, RR, Ninan, I and Chao, MV (2016).
"Exercise promotes the expression of brain derived neurotrophic factor (BDNF)
through the action of the ketone body beta-hydroxybutyrate." Elife 5.
Snyder, JS, Choe, JS, Clifford, MA, Jeurling, SI, Hurley, P, Brown, A, Kamhi, JF and
Cameron, HA (2009). "Adult-born hippocampal neurons are more numerous,
faster maturing, and more involved in behavior in rats than in mice." J Neurosci
29(46): 14484-14495.
Song, H, Stevens, CF and Gage, FH (2002). "Astroglia induce neurogenesis from adult
neural stem cells." Nature 417(6884): 39-44.
Song, J, Zhong, C, Bonaguidi, MA, Sun, GJ, Hsu, D, Gu, Y, Meletis, K, Huang, ZJ, Ge,
S, Enikolopov, G, Deisseroth, K, Luscher, B, Christian, KM, Ming, GL and Song,
H (2012). "Neuronal circuitry mechanism regulating adult quiescent neural stemcell fate decision." Nature 489(7414): 150-154.
Sorrells, SF, Paredes, MF, Cebrian-Silla, A, Sandoval, K, Qi, D, Kelley, KW, James, D,
Mayer, S, Chang, J, Auguste, KI, Chang, EF, Gutierrez, AJ, Kriegstein, AR,
Mathern, GW, Oldham, MC, Huang, EJ, Garcia-Verdugo, JM, Yang, Z and
Alvarez-Buylla, A (2018). "Human hippocampal neurogenesis drops sharply in
children to undetectable levels in adults." Nature 555(7696): 377-381.
Spalding, KL, Bergmann, O, Alkass, K, Bernard, S, Salehpour, M, Huttner, HB,
Bostrom, E, Westerlund, I, Vial, C, Buchholz, BA, Possnert, G, Mash, DC, Druid,
H and Frisen, J (2013). "Dynamics of hippocampal neurogenesis in adult
humans." Cell 153(6): 1219-1227.
Stallock, J, Molyneaux, K, Schaible, K, Knudson, CM and Wylie, C (2003). "The proapoptotic gene Bax is required for the death of ectopic primordial germ cells
during their migration in the mouse embryo." Development 130(26): 6589-6597.

139

Sun, W, Winseck, A, Vinsant, S, Park, OH, Kim, H and Oppenheim, RW (2004).
"Programmed cell death of adult-generated hippocampal neurons is mediated by
the proapoptotic gene Bax." J Neurosci 24(49): 11205-11213.
Taib, T, Leconte, C, Van Steenwinckel, J, Cho, AH, Palmier, B, Torsello, E, Lai Kuen,
R, Onyeomah, S, Ecomard, K, Benedetto, C, Coqueran, B, Novak, AC, Deou, E,
Plotkine, M, Gressens, P, Marchand-Leroux, C and Besson, VC (2017).
"Neuroinflammation, myelin and behavior: Temporal patterns following mild
traumatic brain injury in mice." PLoS One 12(9): e0184811.
Talos, DM, Jacobs, LM, Gourmaud, S, Coto, CA, Sun, H, Lim, KC, Lucas, TH, Davis,
KA, Martinez-Lage, M and Jensen, FE (2018). "Mechanistic target of rapamycin
complex 1 and 2 in human temporal lobe epilepsy." Ann Neurol 83(2): 311-327.
Tang, YP, Shimizu, E, Dube, GR, Rampon, C, Kerchner, GA, Zhuo, M, Liu, G and
Tsien, JZ (1999). "Genetic enhancement of learning and memory in mice." Nature
401(6748): 63-69.
Tashiro, A, Sandler, VM, Toni, N, Zhao, C and Gage, FH (2006). "NMDA-receptormediated, cell-specific integration of new neurons in adult dentate gyrus." Nature
442(7105): 929-933.
Tate, DF and Bigler, ED (2000). "Fornix and hippocampal atrophy in traumatic brain
injury." Learn Mem 7(6): 442-446.
Taupin, P (2007). "BrdU immunohistochemistry for studying adult neurogenesis:
paradigms, pitfalls, limitations, and validation." Brain Res Rev 53(1): 198-214.
Tavazoie, SF, Alvarez, VA, Ridenour, DA, Kwiatkowski, DJ and Sabatini, BL (2005).
"Regulation of neuronal morphology and function by the tumor suppressors Tsc1
and Tsc2." Nat Neurosci 8(12): 1727-1734.
Taylor, CA, Bell, JM, Breiding, MJ and Xu, L (2017). "Traumatic Brain Injury-Related
Emergency Department Visits, Hospitalizations, and Deaths - United States, 2007
and 2013." MMWR Surveill Summ 66(9): 1-16.
Thirone, AC, Paez-Espinosa, EV, Carvalho, CR and Saad, MJ (1998). "Regulation of
insulin-stimulated tyrosine phosphorylation of Shc and IRS-1 in the muscle of
rats: effect of growth hormone and epinephrine." FEBS Lett 421(3): 191-196.
Titus, DJ, Wilson, NM, Freund, JE, Carballosa, MM, Sikah, KE, Furones, C, Dietrich,
WD, Gurney, ME and Atkins, CM (2016). "Chronic Cognitive Dysfunction after
Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor." J
Neurosci 36(27): 7095-7108.
Tolcher, AW, Patnaik, A, Papadopoulos, KP, Rasco, DW, Becerra, CR, Allred, AJ,
Orford, K, Aktan, G, Ferron-Brady, G, Ibrahim, N, Gauvin, J, Motwani, M and
Cornfeld, M (2015). "Phase I study of the MEK inhibitor trametinib in
combination with the AKT inhibitor afuresertib in patients with solid tumors and
multiple myeloma." Cancer Chemother Pharmacol 75(1): 183-189.
Tucker, LB, Burke, JF, Fu, AH and McCabe, JT (2017). "Neuropsychiatric Symptom
Modeling in Male and Female C57BL/6J Mice after Experimental Traumatic
Brain Injury." J Neurotrauma 34(4): 890-905.
Um, SH, Frigerio, F, Watanabe, M, Picard, F, Joaquin, M, Sticker, M, Fumagalli, S,
Allegrini, PR, Kozma, SC, Auwerx, J and Thomas, G (2004). "Absence of S6K1
protects against age- and diet-induced obesity while enhancing insulin
sensitivity." Nature 431(7005): 200-205.
140

Unal-Cevik, I, Kilinc, M, Gursoy-Ozdemir, Y, Gurer, G and Dalkara, T (2004). "Loss of
NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell
loss: a cautionary note." Brain Res 1015(1-2): 169-174.
van Praag, H, Schinder, AF, Christie, BR, Toni, N, Palmer, TD and Gage, FH (2002).
"Functional neurogenesis in the adult hippocampus." Nature 415(6875): 10301034.
Vaynman, S, Ying, Z and Gomez-Pinilla, F (2004). "Hippocampal BDNF mediates the
efficacy of exercise on synaptic plasticity and cognition." Eur J Neurosci 20(10):
2580-2590.
Veilleux, A, Houde, VP, Bellmann, K and Marette, A (2010). "Chronic inhibition of the
mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits
Akt2 and glucose transport stimulation in 3T3-L1 adipocytes." Mol Endocrinol
24(4): 766-778.
Villasana, LE, Kim, KN, Westbrook, GL and Schnell, E (2015). "Functional Integration
of Adult-Born Hippocampal Neurons after Traumatic Brain Injury(1,2,3)."
eNeuro 2(5).
Vink, R, Mullins, PG, Temple, MD, Bao, W and Faden, AI (2001). "Small shifts in
craniotomy position in the lateral fluid percussion injury model are associated
with differential lesion development." J Neurotrauma 18(8): 839-847.
Voermans, NC, Petersson, KM, Daudey, L, Weber, B, Van Spaendonck, KP, Kremer, HP
and Fernandez, G (2004). "Interaction between the human hippocampus and the
caudate nucleus during route recognition." Neuron 43(3): 427-435.
Vorhees, CV and Williams, MT (2014). "Assessing spatial learning and memory in
rodents." ILAR J 55(2): 310-332.
Wahane, SD, Hellbach, N, Prentzell, MT, Weise, SC, Vezzali, R, Kreutz, C, Timmer, J,
Krieglstein, K, Thedieck, K and Vogel, T (2014). "PI3K-p110-alpha-subtype
signalling mediates survival, proliferation and neurogenesis of cortical progenitor
cells via activation of mTORC2." J Neurochem 130(2): 255-267.
Walter, KH, Barnes, SM and Chard, KM (2012). "The influence of comorbid MDD on
outcome after residential treatment for veterans with PTSD and a history of TBI."
J Trauma Stress 25(4): 426-432.
Wan, X, Harkavy, B, Shen, N, Grohar, P and Helman, LJ (2007). "Rapamycin induces
feedback activation of Akt signaling through an IGF-1R-dependent mechanism."
Oncogene 26(13): 1932-1940.
Wang, C, Hu, Z, Zou, Y, Xiang, M, Jiang, Y, Botchway, BOA, Huo, X, Du, X and Fang,
M (2017). "The post-therapeutic effect of rapamycin in mild traumatic braininjured rats ensuing in the upregulation of autophagy and mitophagy." Cell Biol
Int 41(9): 1039-1047.
Wang, J, Elewaut, D, Veys, EM and Verbruggen, G (2003). "Insulin-like growth factor 1induced interleukin-1 receptor II overrides the activity of interleukin-1 and
controls the homeostasis of the extracellular matrix of cartilage." Arthritis Rheum
48(5): 1281-1291.
Wang, JM, Hayashi, T, Zhang, WR, Sakai, K, Shiro, Y and Abe, K (1999). "Insulin-like
growth factor-1 affects expressions of cyclin-dependent kinase 5 and its activator
p35 in reperfused rat brain." Neurosci Lett 277(1): 17-20.

141

Wang, X, Gao, X, Michalski, S, Zhao, S and Chen, J (2016). "Traumatic Brain Injury
Severity Affects Neurogenesis in Adult Mouse Hippocampus." J Neurotrauma
33(8): 721-733.
Wang, X, Seekaew, P, Gao, X and Chen, J (2016). "Traumatic Brain Injury Stimulates
Neural Stem Cell Proliferation via Mammalian Target of Rapamycin Signaling
Pathway Activation." eNeuro 3(5).
Warner, MA, Youn, TS, Davis, T, Chandra, A, Marquez de la Plata, C, Moore, C,
Harper, C, Madden, CJ, Spence, J, McColl, R, Devous, M, King, RD and DiazArrastia, R (2010). "Regionally selective atrophy after traumatic axonal injury."
Arch Neurol 67(11): 1336-1344.
Washington, PM, Forcelli, PA, Wilkins, T, Zapple, DN, Parsadanian, M and Burns, MP
(2012). "The effect of injury severity on behavior: a phenotypic study of cognitive
and emotional deficits after mild, moderate, and severe controlled cortical impact
injury in mice." J Neurotrauma 29(13): 2283-2296.
Watson, MR, Fenton, GW, McClelland, RJ, Lumsden, J, Headley, M and Rutherford,
WH (1995). "The post-concussional state: neurophysiological aspects." Br J
Psychiatry 167(4): 514-521.
Wheless, JW (2015). "Use of the mTOR inhibitor everolimus in a patient with multiple
manifestations of tuberous sclerosis complex including epilepsy." Epilepsy Behav
Case Rep 4: 63-66.
Whiteneck, GG, Gerhart, KA and Cusick, CP (2004). "Identifying environmental factors
that influence the outcomes of people with traumatic brain injury." J Head
Trauma Rehabil 19(3): 191-204.
Whiting, MD, Baranova, AI and Hamm, RJ (2006). Cognitive Impairment following
Traumatic Brain Injury. Animal Models of Cognitive Impairment. E. D. Levin
and J. J. Buccafusco. Boca Raton (FL).
Wiener, CD, de Mello Ferreira, S, Pedrotti Moreira, F, Bittencourt, G, de Oliveira, JF,
Lopez Molina, M, Jansen, K, de Mattos Souza, LD, Rizzato Lara, D, Portela, LV,
da Silva, RA and Oses, JP (2015). "Serum levels of nerve growth factor (NGF) in
patients with major depression disorder and suicide risk." J Affect Disord 184:
245-248.
Wildburger, R, Zarkovic, N, Leb, G, Borovic, S, Zarkovic, K and Tatzber, F (2001).
"Post-traumatic changes in insulin-like growth factor type 1 and growth hormone
in patients with bone fractures and traumatic brain injury." Wien Klin
Wochenschr 113(3-4): 119-126.
Witgen, BM, Lifshitz, J, Smith, ML, Schwarzbach, E, Liang, SL, Grady, MS and Cohen,
AS (2005). "Regional hippocampal alteration associated with cognitive deficit
following experimental brain injury: a systems, network and cellular evaluation."
Neuroscience 133(1): 1-15.
Wrigley, S, Arafa, D and Tropea, D (2017). "Insulin-Like Growth Factor 1: At the
Crossroads of Brain Development and Aging." Front Cell Neurosci 11: 14.
Xavier, GF, Oliveira-Filho, FJ and Santos, AM (1999). "Dentate gyrus-selective
colchicine lesion and disruption of performance in spatial tasks: difficulties in
"place strategy" because of a lack of flexibility in the use of environmental cues?"
Hippocampus 9(6): 668-681.

142

Xiong, Y, Mahmood, A and Chopp, M (2013). "Animal models of traumatic brain
injury." Nat Rev Neurosci 14(2): 128-142.
Yagita, Y, Kitagawa, K, Ohtsuki, T, Takasawa, K, Miyata, T, Okano, H, Hori, M and
Matsumoto, M (2001). "Neurogenesis by progenitor cells in the ischemic adult rat
hippocampus." Stroke 32(8): 1890-1896.
Yang, LY, Greig, NH, Huang, YN, Hsieh, TH, Tweedie, D, Yu, QS, Hoffer, BJ, Luo, Y,
Kao, YC and Wang, JY (2016). "Post-traumatic administration of the p53
inactivator pifithrin-alpha oxygen analogue reduces hippocampal neuronal loss
and improves cognitive deficits after experimental traumatic brain injury."
Neurobiol Dis 96: 216-226.
Ye, P, Hu, Q, Liu, H, Yan, Y and D'Ercole A, J (2010). "beta-catenin mediates insulinlike growth factor-I actions to promote cyclin D1 mRNA expression, cell
proliferation and survival in oligodendroglial cultures." Glia 58(9): 1031-1041.
Ye, P, Popken, GJ, Kemper, A, McCarthy, K, Popko, B and D'Ercole, AJ (2004).
"Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain
overgrowth and glial fibrillary acidic protein expression." J Neurosci Res 78(4):
472-484.
Ye, P, Umayahara, Y, Ritter, D, Bunting, T, Auman, H, Rotwein, P and D'Ercole, AJ
(1997). "Regulation of insulin-like growth factor I (IGF-I) gene expression in
brain of transgenic mice expressing an IGF-I-luciferase fusion gene."
Endocrinology 138(12): 5466-5475.
Yellinek, S, Cohen, A, Merkin, V, Shelef, I and Benifla, M (2016). "Clinical significance
of skull base fracture in patients after traumatic brain injury." J Clin Neurosci 25:
111-115.
Yu, S, Kaneko, Y, Bae, E, Stahl, CE, Wang, Y, van Loveren, H, Sanberg, PR and
Borlongan, CV (2009). "Severity of controlled cortical impact traumatic brain
injury in rats and mice dictates degree of behavioral deficits." Brain Res 1287:
157-163.
Yu, TS, Zhang, G, Liebl, DJ and Kernie, SG (2008). "Traumatic brain injury-induced
hippocampal neurogenesis requires activation of early nestin-expressing
progenitors." J Neurosci 28(48): 12901-12912.
Zhang, J, Moats-Staats, BM, Ye, P and D'Ercole, AJ (2007). "Expression of insulin-like
growth factor system genes during the early postnatal neurogenesis in the mouse
hippocampus." J Neurosci Res 85(8): 1618-1627.
Zhang, W, Wang, W and Kuang, L (2018). "The relation between insulin-like growth
factor 1 levels and risk of depression in ischemic stroke." Int J Geriatr Psychiatry
33(2): e228-e233.
Zhao, C, Teng, EM, Summers, RG, Jr., Ming, GL and Gage, FH (2006). "Distinct
morphological stages of dentate granule neuron maturation in the adult mouse
hippocampus." J Neurosci 26(1): 3-11.
Zhao, Z, Loane, DJ, Murray, MG, 2nd, Stoica, BA and Faden, AI (2012). "Comparing
the predictive value of multiple cognitive, affective, and motor tasks after rodent
traumatic brain injury." J Neurotrauma 29(15): 2475-2489.
Zheng, W, ZhuGe, Q, Zhong, M, Chen, G, Shao, B, Wang, H, Mao, X, Xie, L and Jin, K
(2013). "Neurogenesis in adult human brain after traumatic brain injury." J
Neurotrauma 30(22): 1872-1880.
143

Zheng, WH and Quirion, R (2004). "Comparative signaling pathways of insulin-like
growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons
and the role of the PI3 kinase pathway in cell survival." J Neurochem 89(4): 844852.
Zhou, H, Chen, L, Gao, X, Luo, B and Chen, J (2012). "Moderate traumatic brain injury
triggers rapid necrotic death of immature neurons in the hippocampus." J
Neuropathol Exp Neurol 71(4): 348-359.
Zhou, M, Li, W, Huang, S, Song, J, Kim, JY, Tian, X, Kang, E, Sano, Y, Liu, C, Balaji,
J, Wu, S, Zhou, Y, Zhou, Y, Parivash, SN, Ehninger, D, He, L, Song, H, Ming,
GL and Silva, AJ (2013). "mTOR Inhibition ameliorates cognitive and affective
deficits caused by Disc1 knockdown in adult-born dentate granule neurons."
Neuron 77(4): 647-654.
Zhou, Z, Chen, H, Zhang, K, Yang, H, Liu, J and Huang, Q (2003). "Protective effect of
nerve growth factor on neurons after traumatic brain injury." J Basic Clin Physiol
Pharmacol 14(3): 217-224.
Zhu, G, Chow, LM, Bayazitov, IT, Tong, Y, Gilbertson, RJ, Zakharenko, SS, Solecki, DJ
and Baker, SJ (2012). "Pten deletion causes mTorc1-dependent ectopic neuroblast
differentiation without causing uniform migration defects." Development
139(18): 3422-3431.
Zhu, X, Park, J, Golinski, J, Qiu, J, Khuman, J, Lee, CC, Lo, EH, Degterev, A and
Whalen, MJ (2014). "Role of Akt and mammalian target of rapamycin in
functional outcome after concussive brain injury in mice." J Cereb Blood Flow
Metab 34(9): 1531-1539.

144

VITA

Erica L. Littlejohn, Ph.D.
Spinal Cord and Brain Injury Research Center
Department of Physiology
College of Medicine, University of Kentucky

Citizenship: USA

Educational Experience

2011-2018

University of Kentucky: Lexington, Kentucky
Doctor of Philosophy in Physiology

2003-2008

University of Iowa: Iowa City, Iowa
B.S. in Microbiology

Professional Experience
2012-2018

Predoctoral Graduate Research Assistant—Lexington, KY
Ph.D. Mentorship and training under Kathryn E. Saatman, Ph.D.

2016

Instructor for Anatomy and Physiology course, Bluegrass Community
and Technical College, Lexington, KY

2016

University of Kentucky Area Health Education Center (AHEC)
Physiology Lecturer —Lexington, KY

2015-2018

Mentor for NIH Kentucky Bridge to a Biomedical Doctorate for
Appalachian Students —Lexington, KY
145

2015

University of Kentucky Course Facilitator —Lexington, KY

2011

Mentor for Illinois Mathematics and Science Academy-Student
Inquiry and Research (SIR) Student — Chicago IL

2008-2011

Research Technologist — Chicago IL

Selected Awards
2018

National Neurotrauma Society Diversity Grant

2017

Neuroscience Scholars Program Professional Development Award

2016

Annual Central Kentucky Multicultural Opportunities, Strategies and
Institutional Inclusiveness Consortium Award

2016

University of Kentucky Center for Graduate and Professional
Diversity Initiatives Essence Award

2016

Shane Carlin and Annie Sit Inclusion Award

2015

Inaugural Thomas V. Getchell, Ph.D. Memorial Award

2015

National Neurotrauma Society Symposium Travel Award

2011

Illinois Mathematics and Science Academy Mentor Appreciation
Award

Service
2015-2018

University of Kentucky Graduate School Diversity Advisory Council,
Graduate Student Representative

2015-2016

Representative for Physiology Graduate Students

2014-2016

University of Kentucky Black Graduate and Professional Student
Association
President

146

Professional Membership
2012 to present

Bluegrass Chapter of the Society for Neuroscience

2012 to present

National Neurotrauma Society

2012 to present

Society for Neuroscience

Manuscripts:
Mascarenhas JB, Littlejohn EL, Wolsky RJ, Young KP, Nelson M, Salgia R,
Lang D. (2010). “PAX3 and SOX10 activate MET receptor expression in
melanoma”. Pigment Cell & Melanoma Research. Volume 23, p 225-237
Mascarenhas JB, Young KP, Littlejohn EL, Yoo BK, Salgia R, Lang D. “PAX6
is expressed in pancreatic cancer and actively participates in cancer progression
through activation of the MET tyrosine kinase receptor gene.” Journal of
Biological Chemistry. Volume 284, 27524-27532

147

Grants:

2017

Lyman T. Johnson Fellowship, “Insulin-like growth factor-1
overexpression mediates hippocampal remodeling and plasticity following
tbi”

2015-2017

NIH T32 trainee, “Neurobiology of CNS Injury and Repair” (Drs. Ed
Hall and Jim Geddes, co-PI)

2012-2015

NIH Research Supplement Award trainee, “Insulin-like growth factor-1
overexpression” (Drs. Kathryn Saatman)

Speaking Engagements:
2017

Littlejohn EL “Insulin-like growth factor-1 overexpression mediates
hippocampal remodeling and plasticity following TBI”.
Kentucky Spinal Cord and Head Injury Research Trust Symposium,
Louisville, KY

2017

Littlejohn EL “The need for student-led activism: The model, tools, and a
modern approach”. Inaugural Sister Circle Forum: The Power of Your
Reach,
University of Kentucky, Lexington, KY

2016

Littlejohn EL “UK Call to Action”. Inaugural Town Hall on Inclusion
and Diversity.
University of Kentucky, Lexington, KY

2013

Littlejohn EL “How I did it”.
GEM Consortium, Statewide Kentucky STEM Undergraduates at
GRADLAB —Lexington, KY
Abstracts and Presentations:
*Denotes presenter

Insulin-like growth factor-1 overexpression enhances neurogenesis and activates the
mTOR pathway after moderate TBI. Littlejohn EL*, Scott DA, DeSana AJ, Juras AJ,
and Saatman KE. Society for Neuroscience (SFN) Annual Meeting. Washington, DC.
November 11-15, 2017.
148

Insulin-like growth factor-1 overexpression enhances neurogenesis and activates the
mTOR pathway after moderate TBI Littlejohn EL*, Scott DA, DeSana AJ, Saatman
KE. Journal of Neurotrauma (Vol. 34, No. 13, pp. A137-A137). Snowbird, UT. July
7-12, 2017.
Insulin-like growth factor-1 overexpression mediates hippocampal remodeling and
plasticity following TBI. Littlejohn EL*, DeSana AJ, Juras AJ, and Saatman KE. The
23rd Annual Kentucky Spinal Cord and Head Injury Research Trust Symposium
(KSCHIRT). Louisville, KY. May 17-18, 2017 (Oral)
Insulin-like growth factor-1 overexpression mediates long-term survival and
migration of immature neurons in the hippocampus following TBI. Littlejohn EL*,
DeSana AJ, Madathil SK, Stewart TM, Saatman KE. Society for Neuroscience (SFN)
Annual Meeting. San Diego, CA. November 12-16, 2016
Insulin-like growth factor-1 mediates regional alterations to the mTOR signaling
pathway in the hippocampus following TBI. Littlejohn EL*, Madathil SK, DeSana
AJ, Stewart TM, Saatman KE. Journal of Neurotrauma (vol. 33, no. 13, pp. A130a130). Lexington, KY. June 26-29, 2016.
Intranasal delivery of human insulin-like growth factor-1 mediates regional
alterations to the mTOR signaling pathway in the hippocampus following TBI.
Littlejohn EL*, Sama AM, Stewart TM, Saatman KE. 31st Annual BGSFN Spring
Neuroscience Research Day (BGSFN) Annual Meeting. Lexington Convention
Center, Lexington, KY. April 21, 2016
Insulin-like growth factor-1 Overexpression Promotes Survival of Adult-born
Neurons After Traumatic Brain Injury. Littlejohn EL*, Madathil SK, Stewart TM,
Saatman KE. National Neurotrauma Symposium (NNS) Annual Meeting. Santa Fe
Convention Center, Santa Fe, NM. June 28-2, 2015
Rin GTPase deficiency promotes neuroprotection following traumatic brain injury.
Pannell M*, Cai W, Brelsfoard JM, Carlson SW, Littlejohn EL, Stewart TM,
Saatman KE, Andres DA. (2015) The FASEB Journal. 29, 727.15
Inhibition of PAX3 Leads to Growth Arrest and a Change in Morphology of
Melanoma cells. Littlejohn EL, Kubic JD, Mascarenhas JB, Smithberger E, Lang D*.
American Association for Cancer Research (AACR) Annual Meeting. Orange County
Convention Center, Orlando, FL. April 2-6, 2011.
Pax3 Contributes to Cancer Phenotype of Melanoma. Littlejohn EL*, Kubic JD,
Ludvik AE, Sun DX and Lang D. University of Chicago Department of Medicine
Research Symposium. Duchossois Center for Advanced Medicine at the University of
Chicago, Chicago, IL. March 11, 2010.

149

